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• Low tissue reaction
• Soft—on the surgeon s
hands
• Complete absorption
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• High in vivo tensile
strength
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New Addition to the PRE-OP Family

Now PRE-OP sponges with
chlorhexidine gluconate:
The most popular antiseptic and the most popular
sponges com binedinto a complete system.
PRE-OP* sponges with
chlorhexidine... the advantages of
the complete system:
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• PRE-OP and PRE-OP II.. .choice:of sponge or
sponge/brush formats.
• Excellent antiseptic.. .chlorhexidine has a
broad antibacterial spectrum, is bacteric/da/and
fungic/cfa/, has a rapid bacterial kill rate, f f
persistent effect, and is safe and virtually
non-irritating.
• Maximum convenience.. complete system
eliminates need for a separatebrush.
• Economical, controlled antiseptic dose... J j
eliminates the frequent overuse of liquid soaps
from dispensers.
• Sterile, single-use sponges or s p o n g e /H
brushes.. .can’t harbor pathogenic organisms
as soap dispensers0 23) and reusable
brushes can.
• Always ready to use... no dispenser refilling, no
clogging, no mechanical problems, and no
maintenance.
• Fast, pleasant lather.. .and special
emollient-containing formula is easy on the
hands.
• Minimal possibility of reactions.. .dilution during
use avoids high antiseptic concentration on
skin.
• Superior removal of resident as well as transient
micro-organisms.. .sponge or sponge/brush
format more likely to dislodge resistant bacteria.

A nd, most importantly, proven
chlorhexidine effectiveness:
Improved log kill.. .the recommended scrub
time of PRE-OP and PRE-OP II sponges with
chlorhexidine provides a significantly improved
log kill when compared to that achieved with
the chlorhexidine soap recommended scrub
time.
Standard “Glove Juice" Antiseptic test proves
that the highly recommended 5-minute scrub
effectively utilizes the full potential of 1
chlorhexidine and yields a significantly greater
log kill... a valuable extra margin of safety.
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Narcotic
analgesia
can be
shadowed by
respiratory
depression
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nuBRin
Nalbuphine HC1 Injection

Casts new light _
on narcotic analgesia
Provides the same analgesic efficacy as
meperidine or morphine

Nubain, anew injectable analgesic, has an onset, a
peak of action, and analgesic effectiveness similar to
those of meperidine or morphine. Nubain generally
provides longer analgesia (3-6 hours) than
meperidine (2-4 hours), helping to reduce the
amount of narcotic required.

A recent study showed that nalbuphine is an effective
supplement to balanced anesthesia. Post-operative
recovery time may be reduced due to limited
respiratory depression and good post-operative

Significantly fewer side effects

With a greater margin of safety
Unlike other narcotics which can cause undesirable
respiratory depression even at moderate doses', the
respiratory depressant effect of Nubain is limited and
does not increase appreciably beyond a peak effect
equivalent to that produced by 20 mg/70 kg of
morphine1. Therapeutic doses of nalbuphine have
been associated with hemodynamic stability, and
clinical studies of the hemodynamic effects of
Nubain in patients with coronary artery disease and
acute myocardial infarction demonstrated that
nalbuphine HC1 produced no major untoward clinical
or cardiocirculatory effects2’3.

■ i __■ ■ ■ ■ H

As an adjunct, to supplement surgical
anesthesia, Nubain provides
hemodynamic stability, good
postoperative analgesia and limits
postoperative respiratory depression

■■■

Nubain has a lower incidence of reported side effects
than other narcotics or pentazocine6, causing
significantly less nausea and vomiting than
meperidine or morphine7. Psychotomimetic effects
have rarely been reported1. The incidence of
constipation is less than 1%6.
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NUBAIN INJECTION
(Nalbuphine Hydrochloride) Analgesic
ACTION
Nubain (nalbuphine hydrochloride) is a synthetic narcotic
agonist-antagonist analgesic for parenteral use, related
chemically to the narcotic oxymorphone and to the
narcotic antagonist naloxone. Nabulphine has an
analgesic (agonist action) potency equivalent to that of
morphine on a milligram basis, and an antagonist activity
(reversal of major effects of opioid drugs) about
one-fourth that of nalorphine and ten times that of
pentazocine. The analgesic effect of 10 mg of nalbuphine
is about equal to that of 10 mg of morphine sulfate. The
onset of action begins within 2 to 3 minutes after
intravenous administration, and within 15 minutes
following subcutaneous or intramuscular injection. The
plasma half life of nalbuphine is five hours and the
duration of action has ranged from three to six hours.
At the usual dose of 10 mg, nalbuphine produces
respiratory depression equivalent to that of equianalgesic
doses of morphine. At much higher doses, above 30 mg
i.v. (which produces a respiratory depressant activity
equivalent to 20 mg of morphine i.v.), the respiratory
depressant effect of nalbuphine does not appear to
increase appreciably. Nalbuphine may precipitate
abstinence, when administered to individuals taking
narcotics chronically or produce withdrawal symptoms
when discontinued abruptly after prolonged use. It is
reported to have an abuse potential comparable to that of
pentazocine. The mechanism of action of nalbuphine has
not yet been established.
INDICATIONS AND CLINICAL USE
NUBAIN (nalbuphine hydrochloride) is indicated for the
relief of moderate to severe pain.
Clinical studies indicate that it can also be used for
preoperative analgesia, as a supplement to surgical
anesthesia, and for obstetrical analgesia during labor.
CONTRAINDICATIONS
NUBAIN (nalbuphine hydrochloride) should not be
administered to patients who are hypersensitive to the
drug or to its inactive ingredients (see section on
AVAILABILITY).
WARNINGS
In patients physically dependent on opiate drugs,
NUBAIN (nalbuphine hydrochloride) should not be given
prior to detoxication since withdrawal symptoms are
likely to be produced.
Drug Dependence:
On the basis of behavioural, substitution and direct
addiction studies in humans. NUBAIN has been shown to
have low abuse potential which approximates that of
pentazocine. Psychological and physical dependence and
tolerance may follow the abuse or misuse of nalbuphine.
Therefore, caution should be observed in prescribing it
for emotionally unstable patients or for individuals with a
history of narcotic abuse. Such patients should be closely
supervised, since increases in dosage or frequency of
administration in susceptible individuals might result in
physical dependence.
Abrupt discontinuation of NUBAIN following prolonged
use has been followed by symptoms of narcotic
withdrawal, such as abdominal cramps, nausea and
vomiting, rhinorrhea, lacrimation, restlessness, anxiety,
elevated temperature and piloerection.
Use in Ambulatory Patients:
NUBAIN may impair the mental or physical abilities
required for the performance of potentially dangerous
tasks such as driving a car or operating machinery.
Therefore, NUBAIN should be administered with caution
to ambulatory patients, who should be warned to avoid
such hazards until recovered from the effects of the drug.

Interaction With Other Central Nervous System
ADVERSE REACTIONS
Depressants:
In clinical trials with NUBAIN (nalbuphine
Although NUBAIN possesses narcotic antagonist
hydrochloride) the most frequently reported side effects
activity, there is evidence that in non-dependent patients
were: sedation (36%) of 1066 patients treated), sweating
it may not antagonize the analgesic effect of narcotic
or clamminess (9%), nausea or vomiting (6%), dizziness
analgesics. Patients receiving narcotic analgesic, general
or vertigo (5%), dry mouth (4%) and headache (3%).
anesthetics, phenothiazines or other tranquilizers,
Other adverse reactions which may occur:
sedatives, hypnotics, or other CNS depressants (including
Central Nervous System: nervousness, crying,
alcohol) concomitantly with NUBAIN may exhibit an
depression, restlessness, euphoria, hostility, confusion,
additive effect. When such combined therapy is
faintness, floating, unusual dreams, numbness, feeling of
contemplated, the dose of one or both agents should
be reduced.
heaviness, and psychotomimetic effects such as
hallucinations, feeling of unreality and dysphoria.
Use in Children:
Cardiovascular: Hypertension, hypotension,
Because clinical experience in children under the age of
bradycardia, tachycardia.
12 years is limited, the administration of NUBAIN in this
age group is not recommended.
Gastrointestinal: Cramps, dyspepsia, bitter taste.
Use in Pregnancy:
Respiration: Depression, dyspnea, asthma.
Safe use of NUBAIN in pregnancy (other than labor) has
Dermatological: Itching, burning, urticaria.
not been established. Although animal reproductive
Miscellaneous: Speech difficulty, urinary urgency,
studies have not revealed teratogenic or embryotoxic
blurred vision, flushing and warmth.
effects, NUBAIN should only be administered to
pregnant women when, in the judgement of the
SYMPTOMS AND TREATMENT
physician, the potential benefits outweigh the possible
OF OVERDOSAGE
hazards.
Symptoms:
These are expected to be similar to those of other drugs of
Use in Labor and Delivery:
this class. (The administration of single I.M. doses of
Since NUBAIN can produce respiratory depression in the
72
mg of NUBAIN to eight normal subjects has been
neonate, it should be administered with caution to women
reported to have resulted primarily in symptoms of
delivering premature infants.
sleepiness and mild dysphoria.)
Head Injury and Increased Intracranial Pressure:
Treatment:
The possible respiratory depressant effects and the
NARCAN (naloxone hydrochloride) administered
potential of potent analgesics to elevate cerebrospinal
intravenously is a specific antidote for NUBAIN. Since
fluid pressure (resulting from vasodilation following CO2
the
duration of action of NUBAIN may exceed that of
retention) may be markedly exaggerated in the presence
NARCAN,
the patient should be kept under continued
of head injury, intracranial lesions, or a pre-existing
surveillance and repeated doses of NARCAN should be
increase in intracranial pressure. Furthermore, potent
administered as necessary. Oxygen, intravenous fluids,
analgesics can produce effects which may obscure the
vasopressors and other supportive measures should be
clinical course of patients with head injuries. Therefore
employed
as indicated.
NUBAIN should be administered in these circumstances
only when essential, and with extreme caution.
DOSAGE AND ADMINISTRATION
The usual recommended dose of NUBAIN (nalbuphine
PRECAUTIONS
hydrochloride) is 10 mg for a 70 kg individual
Impaired Respiration:
administered subcutaneously, intramuscularly or
Caution should be observed when administering
intravenously . This dose may be repeated every 3 to 6
NUBAIN (nalbuphine hydrochloride) to patients with
hours
as required. The recommended dosage range is 10
impaired respiration, or who are receiving other
mg to 20 mg, with a maximum single dose of 20 mg and a
medications which produce respiratory depression. In the
maximum total daily dose of 160 mg. Dosage should be
presence of bronchial asthma, uremia, severe infection,
adjusted according to the severity of the pain, physical
cyanosis, or respiratory obstruction, NUBAIN should be
status
of the patient, and other medications which the
administered only with great caution and in reduced
patient may be receiving. (See Interaction with Other
doses. Respiratory depression induced by NUBAIN can
Central Nervous System Depressants under
be reversed by the administration of naloxone
WARNINGS .)
hydrochloride.
Patients who have been taking narcotics chronically for
Impaired Renal or Hepatic Function:
pain under medical supervision may experience
Because NUBAIN is metabolized in the liver and
withdrawal symptoms upon the administration of
excreted by the kidneys, patients with renal or liver
NUBAIN. If NUBAIN is administered to these patients
dysfunction may show an exaggerated response to
as an analgesic, it should be introduced gradually.
customary doses. Therefore, in these individuals
NUBAIN should not be used as a substitute for other
NUBAIN should be used with caution and administered
narcotics or for withdrawal purposes in individuals
in reduced amounts.
dependent on these drugs.
Myocardial Infarction:
AVAILABILITY
As with all potent analgesics, NUBAIN should be used
NUBAIN (nalbuphine hydrochloride) is supplied in glass
with caution in patients with myocardial infarction who
ampoules of 1 mi and 2 ml, and in multiple-dose vials of
have nausea or vomiting. Hemodynamic studies in
10 ml containg 10 mg of nalbuphine hydrochloride per
patients with severe arteriosclerotic heart changes reveal
ml. Each ml also contains 0.1% sodium chloride, 0.94%
that NUBAIN has circulatory effects similar to those of
sodium citrate, 1.26% citric acid anhydrous, 0.1%
morphine, i.e., a minimal decrease in oxygen
sodium metabisulfite and 0.2% of a 9/1 mixture of
consumption, cardiac index, left ventricular end-diastolic
methylparaben and propylparaben as preservatives.
pressure and cardiac work.
STORE AT CONTROLLED ROOM TEMPERATURE
Management of Narcotic Withdrawal Symptoms:
(15° TO 30°C). PROTECT FROM EXCESSIVE LIGHT.
If NUBAIN is inadvertently administered to a patient
physically dependent on narcotics and unduly
NUBAIN (nalbuphine hydrochloride) is a Schedule G
"<
(Controlled) drug.
troublesome narcotic withdrawal symptoms develop,
these symptoms may be controlled by the slow
intravenous administration of small increments of
morphine, until relief occurs.
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QUILL ON SCALPEL

This se ctio n provides a m edium throu gh w h ich C anadian surgeons can d e cla re the m se lve s, b rie fly
and in fo rm a lly, on the day-to-day a ffa irs o f surgery.

Complications of Gastroduodenal Surgery
Postgastrectomy syndrome is too in
definite a term for the variety of com
plications of gastroduodenal opera
tions. Although some apply it only to
the early and late postprandial syn
dromes, most use it to describe the
complications of any gastroduodenal
operation whether or not resection was
performed. Some of the complications
of gastroduodenal operations occur
only after gastrectomy, some may
occur after gastroenterostomy without
gastric resection, some after vagotomy
alone and some after any operation
that alters the pyloric sphincter. Per
haps it is time for a redefinition of
these complications.
Early Postprandial (Dumping)
Syndrome

This term refers to vasomotor symp
toms, such as sweating, faintness,
tachycardia, weakness, a sensation of
fullness and nausea that occur within
30 minutes of the ingestion of food.
Many patients also have colicky cen
tral abdominal pain and some have
diarrhea. It is believed that rapid
emptying of the fluid contents of the
stomach occurs because the pyloric
sphincter is disrupted or absent.
Hyperosmolar chyme, increased je
junal secretion, hypovolemia and other
factors are associated with sympathe
tic vasomotor responses. Jejunal dis
tension stimulates hyperperistalsis.
These symptoms are virtually elimin
ated by dry meals; liquids are not
taken within an hour of any meal.
It is interesting that this syndrome is
apparently confined to patients with
duodenal ulcer diathesis.
Late Postprandial (Dumping)
Syndrome

Anxiety, restlessness, hunger, pal
pitations, flushing of the face, sweat
V O L U M E 24, NO. 2, M A R C H 1981
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ing and unsteady gait occurring 2 to 3
hours after a meal are features of the
late postprandial syndrome. These
signs and symptoms are believed to
be due to hypoglycemia that follows
postprandial hyperglycemia, which
stimulates excessive secretion of in
sulin and perhaps glucagon. The syn
drome is eliminated by severe re
striction of carbohydrate intake.
Again, the syndrome is mainly con
fined to patients with duodenal ulcer
diathesis.
Recurrent or Stomal lllcer

This results from failure of an oper
ation to control peptic ulcer disease.
Recurrent or stomal ulcer occurs
mainly in patients who are acid hypersecretors such as those with duodenal
ulcer, simultaneous duodenal and
gastric ulcer, prepyloric gastric ulcer
or gastrin-secreting tumours. Patients
with recurrent or stomal ulcer have:
(a) had an inadequate operation such
as incomplete vagotomy, inadequate
gastric resection, inadequate gastric
drainage or retained gastric antrum;
(b) an endocrine abnormality such as
a secreting gastrinoma, hyperparathy
roidism or multiple endocrine adeno
pathy syndrome; or (c) recurrent ul
ceration due to drugs such as acetylsalicylic acid, alcohol, nonsteroidal
anti-inflammatory drugs or corticos
teroids. Stomal ulcer rarely develops
in patients with gastric ulcer who are
not acid hypersecretors. Gastric ulcer
rarely recurs after antrectomy. How
ever, if a healed gastric ulcer recurs
it does so usually at the same site.
Diarrhea

Following gastroduodenal operation
diarrhea is a major disability for a
few patients but many experience a
mild increase in fluidity or frequency

of bowel movements. Many causes
have been found such as altered bac
terial growth because of reduced gas
tric acidity, altered secretion and ab
sorption, altered enzyme or hormonal
effects, unmasking of pre-existing ab
normalities such as intolerance to
gluten, lactose or sucrose, exaggera
tion of pre-existing irritable bowel
syndrome and surgical complication or
error such as anastomosis of stomach
to ileum or transverse colon, or gastrojejunocolic fistula. Permanent control
of diarrhea is possible only if a cor
rectable cause is found, otherwise
treatment is for symptoms only.
Acute Afferent Loop Syndrome
(Duodenal Rupture)

Complete obstruction of the af
ferent loop at the gastrojejunal stoma
due to a mechanical fault in con
structing the anastomosis or to an
early complication such as volvulus or
internal hernia is termed acute af
ferent loop syndrome. It is serious only
if the pylorus is divided or obstructed.
If the pylorus has been divided and
a complete obstruction remains, the
duodenal stump will rupture resulting
in severe diffuse peritonitis. The im
portant contributory factors are ische
mia and technical difficulties with the
duodenal closure. Death is likely un
less peritonitis is recognized imme
diately and adequate drainage is
provided. If duodenal closure is in
secure, rupture of the stump can be
prevented by tube duodenostomy.
Chronic Afferent Loop Syndrome

This complication occurs with in
complete obstruction of the afferent
loop at the gastrojejunal anastomosis
when the pylorus is divided or ob
structed. Following a meal, bile and
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pancreatic juice accumulate in the
afferent loop causing increasing steady
pain in the right upper abdomen. Fi
nally the afferent loop contents flood
the gastric remnant causing nausea and
vomiting. The vomitus contains little
food as most of the stomach contents
have emptied into the efferent loop
before the afferent loop decompresses.
The longer the afferent loop the
greater is its capacity and so the pain
and bilious vomiting are less severe.
Pancreatitis and cholangitis are pos
sible complications and bacterial
growth may cause vitamin B,2 malab
sorption, steatorrhea and malnutrition.
Surgical drainage of the afferent loop
into the efferent loop cures this com
plication. Diversion of duodenal con
tents away from the gastrojejunostomy
is safe only if acid hypersecretion is
controlled.
Preferential Filling of the
Afferent Loop

When the afferent loop is more
in line with the gastric chyme when it
leaves the stomach than the efferent
limb or when there is an obstruction
of the efferent limb at the gastro
jejunostomy, preferential filling of the
afferent loop takes place. This causes
steady postprandial pain in the right
upper abdomen. The pain subsides
slowly in about an hour or more
abruptly with vomiting of food mixed
with bile. This syndrome can be a
complication of any side-to-side gas
trojejunostomy in which the pylorus
is divided or obstructed. The compli
cation can be demonstrated by roent
genography using a food and barium
mixture. Either the anastomosis is re
constructed or the afferent loop is
drained into the efferent limb provided
that acid hypersecretion is controlled.
Too Small a Gastric Pouch

This may be a problem after ex
tensive gastric resection. After a small
amount of food is taken the patient
feels the distress of an overfilled
stomach. If there is a small gastric
outlet the patient will be able to eat
enough provided that food is taken
slowly and fluids are taken with solids
to increase the fluidity of the gastric
contents. Otherwise small frequent
meals are needed to maintain nutri
tion.
Gastric Outlet (Efferent Limb)
Obstruction

Gastroduodenostomy or gastrojeju
nostomy may be complicated by ob
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struction of the gastric outlet. Gastric
emptying into the small bowel is de
layed or absent because of functional
or mechanical narrowing at the gastric
outlet. Functional obstruction may
result from gastric atony or a poorly
placed anastomosis. Incomplete ob
struction may result from postoper
ative edema or hematoma, excessive
tension or torsion or too small an an
astomosis. Complete obstruction may
occur with volvulus, internal hernia,
intussusception or scar complicating
a difficult anastomosis. Incomplete
and complete obstructions may be
diagnosed by endoscopy and roent
genography; cholinergic drugs may be
used to distinguish between functional
and mechanical obstructions. With a
side-to-side gastrojejunostomy and
obstruction of the efferent limb, the
patient will experience pain followed
by vomiting of food mixed with bile
because of preferential filling of the
afferent loop. With an obstructed gas
troduodenostomy pain is followed by
vomiting of food but no bile.

Anemia

Gastroduodenal
operations fre
quently are complicated by anemia,
most often iron deficiency anemia
due to decreased iron absorption. Oc
casionally decreased iron intake and
chronic blood loss are factors. Follow
ing gastric resection a vitamin B,2
deficiency may slowly develop owing
to failure of secretion or the absence
of intrinsic factor. Bacteria in a blind
loop will compete for the vitamin B,2intrinsic factor complex and may
cause a deficiency. A few patients
have folic acid deficiency. Each de
ficiency is treated by replenishment
although bacterial overgrowth in the
duodenum requires antibiotics.
Bone Disease

Bone disease may occur long after
gastric resections particularly those
complicated by malabsorption. Both
osteomalacia and osteoporosis occur
and are major problems for a few
patients.
1

Alkaline or Bile Reflux Gastritis

This complication presents as upper
abdominal pain for which no cause
other than bile reflux and distal gas
tritis is found and vomiting affords
little relief of pain. It is believed that
the mucosa of the stomach closest to
the duodenum or jejunum becomes
sensitive to reflux of bile and pancre
atic juice. A biopsy specimen shows
nonspecific gastritis. Medical manage
ment is disappointing so most patients
require an operation to divert bile and
pancreatic juice into the intestinal
tract some distance distal to the sto
mach. This procedure should be con
sidered only after acid hypersecretion
has been controlled by adequate
vagotomy otherwise a stomal ulcer
may occur.
Reflux Esophagitis

Reflux esophagitis causes heart
burn due to reflux of gastric contents
into the lower esophagus. If acidity is
present, reflux of acid pepsin and bile
cause the symptoms. If there is no
acidity, bile and pancreatic enzymes,
especially trypsin, are the irritants.
Mild preoperative symptoms of reflux
are often made worse by gastroduo
denal operations. Symptoms of gas
troesophageal reflux are often caused
by extensive gastric resection. If con
servative management fails, heartburn
may be controlled by a procedure de
signed to prevent gastroesophageal
reflux.
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Loss of Weight

Weight loss or failure to regain
preoperative weight is common and
is probably related to reduced caloric
intake. It is more common after resec
tions than after other gastroduodenal
operations and is particularly evident
in women.
Carcinoma
1

This disease occurs in the gastric
remnant after gastrectomy with
greater frequency than in the normal
population but it may not appear for
20 years.
Summary

Y

Postgastrectomy syndrome is too
imprecise a term for the numerous
complications that may follow gastro
duodenal operations. A carefully
taken history from a patient able to
describe symptoms followed by ap
propriate investigations will allow ac
curate identification and effective
treatment for most. There are many
patients presently suffering these com
plications of gastroduodenal opera
tions. We must remain aware of the
problems in order to help them.
D o n a l d J. C u r r i e , m d .
FRCS, FRCSfC], FACS
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Simple, low-cost therapy
for decubitus ulcers:

“Decubitus ulcers present a great problem in prolonged bed
occupancy and expensive and protracted nursing care."l4]

•
•
•
•

Helps speed healing through enzymatic debridement1'
Has a highly selective lytic function; '
Total elimination of odour and necrotic tissue"
As high as 95.9% show improvement or healing"

References: 1. Lee, M. et al: The decubitus ulcer patient: Statement of the problem. Contemporary Surgery/Vol. 14, 3/79. 2. Landi. G.: Local enzymatic
treatment in dermatology: First results with fibrinolysin and desoxyribonuclease. Clin. Ter. 25: 47-57, 1963. 3. Coon, W.W., et al: Enzymatic debridement with
bovine fibrinolysin. Am. J. Surg. 98: 4-8, 1959. 4. Vasile, J., Chaitin, H .: Prognostic factors in decubitus ulcers of the aged. Geriatrics 27: 126-129. 1972.
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sinus tracts; (2) otorhinolaryngologic wounds; (3) superficial hematomas
(except when the hematoma is adjacent to or within adipose tissue).
If in the judgement of the physician both a debriding agent and a topical
antibiotic are indicated, Elase-Chloromycetin* Ointment provides both
types of therapeutic action Establishment in the laboratory of bacterial
sensitivities will guide the physician in selecting the proper antibiotic
Elase-Chloromycetin may be useful in the topical treatment ot infected
burns ulcers wounds, cervicitis and vaginitis when the organisms are
susceptible to chloramphenicol and utilize a process of fibrin deposition
as a protection device.
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The usual precautions against allergic reactions should be observed,
particularly in persons sensitive to materials ot bovine origin, anti
biotics or thimerosal If Elase-Chloromycetin Ointment is used, it should
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by organisms which are susceptible to the anti-bacterial action of
chloramphenicol.
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Chloramphenicol when absorbed systemically from topical application
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types of dermatitis.
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The Case for Perioperative Antibiotics
Evaluation of antimicrobial prophy dinarily sterile sites. In all such cases
laxis in surgery involves two consider antimicrobial use should be aimed at
ations. First, is it effective? Second, therapy rather than prophylaxis.
if so, do the benefits clearly outweigh
In surgical procedures involving the
the hazards and costs? Ronald in this gastrointestinal or genital tracts, pro
issue (page 113) has carefully sum phylaxis must include an antimicrobial
marized the present evidence for and agent having activity against Bacagainst antimicrobial use for pre teroides fragilis. Cover must also be
venting infective complications of sur provided against gram-negative or
gery and whilst there is much in ganisms such as Escherichia coli. Of
favour of antimicrobial prophylaxis the newer cephalosporin type drugs,
Ronald has rightly emphasized the cefoxitin is active against both aerobic
concerns that still apply over the and anaerobic organisms. Clindamy
possible emergence of antimicrobial
cin and metronidazole are effective
resistance.
against B. fragilis but should be com
Since one quarter to one half of bined with an aminoglycoside such as
all antimicrobial drugs in hospitals are gentamicin or tobramycin to cover
used to prevent rather than treat in the gram-negative rods. Metronidazole
fections,1'4 it follows that such use alone has been shown recently to re
should be based on sound evidence. duce the incidence of wound infection
The principles of antimicrobial pro in colorectal surgery.8
phylaxis are: (a) organisms that cause
It is still unclear how useful anti
surgical infections come from the microbial prophylaxis may be for all
patient or the surgical team and con elective biliary tract procedures. There
taminate the wound at the time of is an increased frequency of wound
operation, (b) adequate concentration infection in patients who: are over 70
of an antimicrobial agent must be years old, have had biliary tract sur
present in tissues and microhematomas gery, have a history of jaundice or
at the time the surgical wound is jaundice at the time of operation, have
made, to prevent establishment of the common bile duct obstruction due to
organisms and (c) no benefit will re stones or a recent history of fever
sult from maintaining antibiotic levels and chills. It has been suggested that
for longer than 3 to 4 hours after the prophylaxis would be of greatest
surgical procedure unless there is benefit in these patients.6
continuing entry of organisms.5
The use of antimicrobial prophy
In surgery that does not involve laxis in pulmonary resection remains
opening a hollow viscus the risk of debatable.7 In cardiac valve replace
wound infection is so low6 that the ment the major organisms of concern
cost of the drugs and the risk of are Staphylococcus aureus and
changing the microbial flora do not Staphylococcus epidermidis and it has
justify the use of antimicrobial pro become standard medical practice to
phylaxis except when a foreign body use antibiotics prophylactically against
is left behind, such as cardiac valves, these organisms. Cephalothin is the
vascular grafts and artificial joints, most commonly used drug in these
where an established infection is likely patients although one of the newer
to have catastrophic effects.7
cephalosporins such as cefamandole
The major value of perioperative may be even more effective. In coro
antimicrobial prophylaxis is the pre nary artery bypass operations the
vention of wound infection following number of postoperative infections is
operations in which a hollow viscus is so low that prophylaxis is not just
opened. Such prophylaxis reduces post ified. There is reasonable support for
operative morbidity as well as the cost the use of a cephalosporin in vascular
and duration of hospitalization and grafts involving the abdominal aorta
is likely to reduce the total use of anti or lower extremity arteries.10
microbial agents because it decreases
There is little evidence to support
the need for protracted therapy in the prophylactic use of antimicrobial
treating established postoperative in agents in clean orthopedic procedures”
fections.7
or in the management of fractures of
Antimicrobial agents should not be the hip12 but prophylaxis with a ce
used prophylactically in “contamin phalosporin or with cloxacillin is re
ated” or “dirty" operations where commended for prosthetic surgery of
organisms are already present at or the hip.
10
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The optimal duration of antibiotic
administration is still debatable al
though it is now generally accepted
that the agent or agents should be
given intravenously starting at the
time of, or immediately before, the
induction of anesthesia so as to
achieve high tissue concentrations of
the antibiotic during the operation.
The agents should be given as often
as necessary during the procedure to
maintain effective blood and tissue
levels as long as the organisms can
gain ready access to the tissues, but
should not be continued beyond this
time. In general, antibiotics should be
continued for no longer than 24 hours
and, as a number of authors have
suggested, it may be that a single
perioperative dose is all that is re
quired.7
H. R ic ha rd so n , m b , bs . f r c p [c ]
m d . f a c s , fr cs [ c ]

C.B. M u e l l e r ,

Division of medical microbiology and
department of surgery,
McMaster University Medical Centre,
Hamilton, Ont.
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REVIEW ARTICLE

Pros and Cons of Antimicrobial Prophylaxis in Surgery
A llan R. R onald,

Careful animal studies have de
monstrated the scientific rationale for
perioperative antimicrobial therapy in
selected operations in order to
prevent infectious complications.
Operative procedures that carry
increased risk for the patient or
in which the results of infection
are devastating, should now be
carried out concomitantly with
antimicrobial prophylaxis.
Several studies have shown that
therapy must begin before bacteria
can establish themselves in the
operative field and need not be
continued for more than 24 hours.
These principles should now be
implemented in surgical practice with
careful ongoing surveillance of
infection, incidence and antimicrobial
use to ensure their continuing efficacy.
Des etudes animates minutieuses
ont permis de demontrer les raisons
scientifiques justifiant I’emploi d'un
traitement antimicrobien peri-operatoire
dans des interventions choisies en
vue de prevenir les complications
infectieuses. Les interventions
chirurgicales comportant un risque
accru pour le patient, et cedes ou
une infection entraine des resultats
catastrophiques devraient maintenant
etre pratiquees sous le couvert d'une
medication antimicrobienne. Plusieurs
etudes ont montre que ce traitement
devraient etre institue avant que les
bacteries n’aient pu coloniser le champ
operatoire et qu'il ne devrait pas
etre poursuivi pendant plus de
24 heures. Ces principes devraient
maintenant etre mis en application
dans la pratique chirurgicale tout
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en exercant une surveillance
minutieuse continue de I’infection,
de la frequence des infections et
de I'usage des antibiotiques afin
d’assurer le maintien de leur efficacite.

What are the indications for giving
antimicrobial agents prophylactically
during operative procedures? What
drug should be selected and for how
long should it be given? What is the
risk to the patient given antimicrobial
agents? Controversy has surrounded
these questions for the past quarter
century. This paper will present briefly
the scientific rationale for preventive
antibacterial therapy during surgery.
It will also review a number of pro
spective, randomized, blind studies that
provide specific guidelines for anti
microbial prophylaxis during surgery.
Finally, the hazards of this therapy
will be weighed against the benefits.
Scientific Rationale
It has been argued that antibacterial
prophylaxis must be more rational
than antibacterial therapy. Whereas,
in the therapeutic situation, the iden
tity of the offending microbe is often
in doubt and therapy is often empiric
and urgent, prophylaxis can be
planned and the presumed targeted
microbe is known. Also, although drug
toxicity may be an acceptable risk in
the therapy of a serious disease al
ready established, it is unacceptable
when there is only the possibility that
an infection may develop.
Most infectious disease physicians
have insisted that antimicrobial pro
phylaxis should be reserved for a few
specific instances. Usually, only single
agents with a narrow spectrum di
rected against one anticipated organ
ism for a defined period of time have
been permitted. In patients scheduled
to undergo surgery, antibacterial pro
phylaxis was condemned. Excellent
studies during the past decade have
shown that these stereotyped opinions
may be in error.

In their study on surgical wounds in
the 5-year period 1967 to 1972, Cruse
and Foord1 found an overall infection
rate of 4.8%. The lowest rate was
1.8% in 18 000 clean wounds but in
patients with diabetes this rate in
creased to 10.7%, with obesity to
13.5% and with malnutrition to
16.6%. Increasing age was associated
with an increasing rate of wound in
fection as was prolonged preoperative
hospitalization. The clean-wound in
fection rate doubled with each addi
tional hour of operating. In 4100 sur
gical procedures in which the gastro
intestinal or respiratory tract was
entered without appreciable spillage
(clean-contaminated surgical wound),
the infection rate was 8.9%. In 770
contaminated wounds in which there
was acute inflammation or gross spil
lage, the infection rate was 21.5%.
This study defines some risk factors
present in surgical procedures. Conti
nuing surveillance is essential within
a hospital if prophylaxis is to be used
for patients who undergo surgery.
Green and Wenzel2 carried out a
prospective study to determine the
hospitalization costs of postoperative
wound infection. Controls were se
lected by computer for each patient
with a wound infection so that age,
sex, race, date of operation and the
operative team were matched ran
domly with no bias for length of hos
pital stay. Fifty-one postoperative
wound infections were studied. The
duration of hospital stay was almost
doubled for these patients and the
total additional hospital cost was more
than $60 000.
These and other studies have iden
tified patients at increased risk of
postoperative wound infection and
argue convincingly that such infec
tions substantially increase medical
costs. An effective strategy for pre
venting these infections would be a
significant medical advance.
The internist’s bias against anti-
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microbial prophylaxis in surgery was
substantiated by Johnstone3 who
noted, in a large uncontrolled study,
that the infection rate almost tripled in
patients treated with antibiotics. Also,
Karl and associates4 in a prospective
blind study treated surgical patients
with chloramphenicol succinate and
methicillin. These agents failed to
prevent postoperative infections. Chlo
ramphenicol succinate given intramus
cularly was ineffective because the
chloramphenicol ester was not hydro
lysed to an active drug.
Miles and colleagues,5 in their clas
sic experimental studies of wound in
fection, and more recently Burke6
have provided the scientific basis for
antibacterial prophylaxis in surgery.
They have shown that immediately
after an invading bacterium arrives
in the host tissue there is a finite
“decisive period” during which the
ultimate size of the lesion is deter
mined. Although these actions are
not understood, the host defences
appear to act immediately on t!it
bacterial population to prevent a
lesion. Although it takes almost 24
hours for the classic inflammatory le
sion to develop, its ultimate size is
determined within 4 hours. Burke6
demonstrated that blocking host de
fences increased lesion size and sup
plementing host defences eliminated
the lesion. These alterations to the
host defences were effective for only
3 hours after bacterial challenge.
From these studies, Burke6 concluded
that antibacterial supplements to nor
mal host defences must be present in
the tissues before bacterial contamina
tion occurs and that they serve no
purpose if present for more than 4
hours after the period of active bac
terial contamination has ended. In
order for antibacterial supplementa
tion of host defences to be rational,
the risk of side reactions to the drug
must be less than the risk of infection.
Prospective Controlled Clinical

Studies
Bernard and Cole7 were the first
to show that antibacterial agents given
just before and after an operative
procedure decreased wound infection
rates. In 1969, Polk and LopezMayor* reported the first prospective,
randomized, blind study of the
perioperative use of antibacterial pro
phylaxis. They gave cephaloridine,
1 g preoperatively and 5 and 12
hours postoperatively, and were able
to show a highly significant reduction
in postoperative wound infections.
Stone and associates9 extended these
114

studies and compared four regimens
of antimicrobial prophylaxis in 166
patients who underwent gastric sur
gery. Cultures taken at operation
showed that bacterial contamination
occurred in almost 60% of patients
during the operative procedure. Bac
terial contamination was markedly
less if the operation was for a com
plication of gastric hyperacidity such
as duodenal ulcer. Almost one half
of patients who had bacterial conta
mination and received no antibacterial
prophylaxis had a wound infection
postoperatively. Only 9% of prophylactically treated patients whose
wounds were colonized had an in
fection. In one of the regimens used
by Stone and colleagues antibiotics
were started after completion of
the surgical procedure. In this group,
patients were not protected from in
fection and in fact the postoperative
infection rate was similar to that of
patients who received no prophylaxis.
An earlier retrospective study of
antibacterial prophylaxis for pene
trating intra-abdominal injury also
showed that drug administration must
be started preoperatively to be effect
ive.10 Patients who received penicillin
and tetracycline before operation ul
timately had a wound infection rate
of 4%. Patients who were not started
on antibacterial prophylaxis preoper
atively had an infection rate of greater
than 30%. It is imperative in patients
with penetrating abdominal injuries or
ruptured abdominal viscus that anti
bacterial prophylaxis be started before
operation and as soon after diagnosis
as possible.
Gatehouse and colleagues11 cultured
gastric aspirates quantitatively in four
groups. Twelve healthy volunteers had
sterile cultures. Thirty-four of 49
patients with duodenal ulcer also had
sterile cultures; the remainder had
few organisms with a mean count of
3.8 x 10' organisms/ml. Fourteen
with gastric ulcers had mean bacterial
counts of 6.95 X 104 organisms/ml;
35 with gastric carcinoma had mean
counts of 1.9 X 107 organisms/ml.
Patients with counts of less than
5 X 10® organisms/ml had a post
operative wound infection rate of
16% compared with a rate of 93%
in 15 patients with more than 5 x
10“ organisms/ml in the gastric
aspirate. All but one postoperative in
fection arose from endogenous organ
isms.
For no group of patients has the
value of preoperative antibacterial
prophylaxis been more fiercely de
bated than for those who undergo
elective surgery for colonic disease.
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Surgeons have used nonabsorbable
sulfonamides, kanamycin and neo
mycin orally and a variety of other
agents and have reported enthusiastic
ally of their efficacy. However, no
objective controlled clinical trials have
been carried out. In their series from
the Mayo Clinic, Washington and as
sociates12 gave neomycin orally alone,
neomycin and tetracycline, and place
bo alone to patients in random
fashion. Whereas the administration
of neomycin alone and placebo alone
resulted in wound infection in almost
35% of patients, the combination of
neomycin and tetracycline reduced the
rate of wound infection to 5%. A
fecal fistula or wound separation
occurred in almost 10% of patients
who received neomycin or placebo
alone. There were no fecal fistulas or
wound separations in the 65 patients
who received the combination of neo
mycin and tetracycline. This study
provided convincing data on the effi
cacy of this orally administered anti
bacterial combination. Nichols and
associates13 have recently shown that
the combination of neomycin and
erythromycin given orally is effective
in preventing postoperative wound in
fections after elective colonic oper
ations.
Regimens that do not include an
aerobes in their spectrum have been
shown to be ineffective in preventing
wound infections after colonic oper
ations. Burton and associates14 were
unable to reduce the frequency of
wound infections in patients treated
with 80 mg of gentamicin intramus
cularly 1 hour before operation.
Biliary tract surgery is complicated
by infection in about 10% of patients
if the bile is infected at the time of
operation.15 The presence of common
duct stones, biliary obstruction, acute
cholecystitis and age greater than 70
years are all indicators of infected
bile and these patients should be con
sidered for prophylaxis. Unfortunately,
studies to date in this population have
been inadequate.
Kaiser and associates16 have carried
out an excellent prospective study of
antibacterial prophylaxis in 512 pa
tients who underwent major peri
pheral vascular operations. Cefazolin
was given preoperatively and every
6 hours postoperatively in a dose of
1 g for a total of four doses. Sixteen
patients who received a placebo had
wound infection; 4 of these had a
deep graft infection and 1 died. No
graft infections and only two subcu
taneous infections occurred in the 225
patients who received cefazolin. A
rash developed in two patients and two
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others had phlebitis. All four of these
patients were in the placebo group. No
untoward complications occurred in
the patients who received cefazolin.
Kaiser’s group concluded that even in
an operative procedure in which the
risk of serious infection is less than
2%, the consequences of infection are
so dangerous that prophylaxis is jus
tified.
Additional studies support perioper
ative antibacterial prophylaxis in or
thopedic surgery including total hip
replacement17 and surgical fixation of
fractured hips.18
Numerous articles have shown that
antimicrobial prophylaxis is indicated
in vaginal hysterectomy in premeno
pausal patients.11' Serious bacterial con
tamination of the operative field
occurs during operation in these pa
tients. Postoperative morbidity as
measured by febrile days, the duration
of hospital stay and the frequency of
pelvic cellulitis and pelvic abscesses
can be reduced by perioperative pro
phylaxis. Most of the cephalosporins,
penicillin combined with streptomycin
and ampicillin combined with tetracy
cline have been successful in prevent
ing infections in controlled prospect
ive studies. Indications for prophylaxis
in abdominal hysterectomy are less
well defined.20
Prophylaxis
with
antimicrobial
agents should be considered in pa
tients who are to undergo cesarean
section. Patients at increased risk of
infection because of obesity, anemia,
prolonged labour before cesarean sec
tion and general anesthesia had a
significant reduction in infection if
treated perioperatively.21
Antimicrobial prophylaxis during
urologic surgery has been reviewed
recently.22 Although it is mandatory
to treat infection within the urinary
tract before manipulation or surgical
resection, perioperative antimicrobial
therapy has not been adequately
evaluated in most operative proce
dures of the urinary tract in patients
without antecedent infection.
Careful prospective studies have
shown that antimicrobial prophylaxis
is not indicated in ambulatory patients
with minor lacerations23 and in
coronary artery bypass procedures.21
Prospective studies in patients who
undergo prosthetic valve surgery have
been inadequate. It is common prac
tice for antibacterial drugs to be given
during the procedure and a recent
study has shown that one dose of cephalothin during operation was as
effective as 20 g given prophylactically for 4 days.25
VOLUME 24, NO. 2, MARCH 1981
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Hazards versus Benefits

Despite these encouraging results,
antimicrobial prophylaxis cannot be
expected to prevent all infections re
sulting from surgery.
Prescribing errors are frequent. Pa
tients found at operation to have in
fection require a therapeutic course of
antibiotics, usually for 7 to 10 days.
Surgeons often succumb to the temp
tation to add antimicrobial agents
to an existing regimen or to replace
one agent with another. Until pro
spective, randomized, double-blind
studies have shown that a particular
agent or a combination of agents is
more effective or less toxic than what
is being used, no change in prophy
laxis should be made.
The prophylactic use of antibac
terial agents can never modify the
primary commitment to careful, pre
cise application of basic principles of
surgery and a continuing enthusiasm
for strict asepsis on the part of all
surgical staff.
Antibacterial agents will select re
sistant organisms from the mixed
population contaminating the wound.
Several studies have shown that in
fections occurring in patients after
failure of prophylaxis will be due to
more resistant infections. This is an

inevitable consequence of prophy
laxis. When starting therapy for in
fection in these patients, it is essential
that agents other than the one used
prophylactically be selected for treat
ment and that bacteria be identified
and their sensitivity to the antibac
terial drugs be determined.
Antibiotics are unique among ther
apeutic agents in their ability to have
an effect beyond the treated patient.
Resistant bacteria will appear in every
hospital unit in which antibiotics are
being used. They will develop in both
the patient’s endogenous normal flora
and that at infected sites. Spread to
other patients and hospital epidemics
are the expected consequences.26 How
ever, preliminary evidence suggests
that flora may be less disrupted by
perioperative antibacterial prophylaxis
than by prolonged administration of
antibiotics.
Many prophylactic agents are ex
pensive. Yet the cost of antibacterial
prophylaxis is much less, if used dur
ing an operative procedure, than the
cost of a more prolonged course
needed to treat patients who have in
fectious complications postoperatively.
Conclusions

Antibacterial prophylaxis should be
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used perioperatively during operative
procedures when there is risk of
serious infection. The cephalosporins
have been most thoroughly studied
and are effective in most operative
procedures. The total dose should
seldom exceed 4 g and must be begun
preoperatively. Metronidazole is ef
fective in preventing anaerobic in
fection originating in gastrointestinal
or gynecologic operations. Compara
tive studies in carefully controlled
operative procedures are essential to
define the limits of prophylaxis. Ultim
ately the potentiation of natural host
defences may make antibacterial
agents unnecessary. Infection control
programs and microbiologic surveil
lance of bacterial resistance are essen
tial if antibiotic prophylaxis is to
be widely used and to remain
effective.
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The guest lecture presented at the 3rd
annual meeting of the Canadian As
sociation of General Surgeons on June
4, 1980 will be featured in the May
1981 issue of the Journal. This lec
ture, delivered by Professor Nils
Kock, describes the evolution of ile
ostomy surgery from 1913 when
Brown reported on the construction
of an ileostomy in 10 patients to the
present use of the continent reservoir
ileostomy, designed to eliminate
many of the problems related to the
conventional type of ileostomy.
The Journal also plans to publish in
this issue some of the papers from the
33rd annual meeting of the Canadian
Cardiovascular Society held in Win
nipeg in October 1980 and part 1 of
a two-part symposium on the manage
ment of early breast cancer, which
was presented at the 1980 annual
meeting of the Royal College of Phy
sicians and Surgeons of Canada.
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Resection for Chronic Alcoholic Pancreatitis
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Nineteen patients with chronic alcoholic
pancreatitis have been followed up
for 7 to 81 months (mean 45 months)
since resection for the relief of pain.
Five had distal pancreatectomy,
three had a Whipple resection, seven
had 75% pancreatectomy and four
had total pancreatectomy.
Pain was completely relieved in all
patients after total pancreatectomy
and in four patients after 75%
pancreatectomy. Recurrent acute
pancreatitis was frequent after distal
pancreatectomy. Alcoholism recurred
in six patients.
Steatorrhea was noted grossly in
14 patients after operation. It was
corrected by enzyme replacement.
All patients had long-term weight
gain, except one who had undergone
a Whipple resection.
Diabetes developed in one patient
who underwent 75% pancreatectomy,
in one after distal pancreatectomy
and in all patients who underwent
total pancreatectomy; management of
the diabetes was complicated by
heavy alcohol consumption in one
patient who underwent total
pancreatectomy.
Dix-neuf malades souffrant de
pancreatite alcoolique chronique ont
ete surveilles pour des periodes de
7 a 81 mois (45 mois en moyenne)
apres resection pour le soulagement
de la douleur. Cinq ont subi une
pancreatectomie distale, trois une
resection de Whipple, sept une
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pancreatectomie a 75% et quatre une
pancreatectomie totale.
La douleur a ete completement
soulagee chez tous les malades qui
ont eu une pancreatectomie totale et
chez quatre patients qui ont subi
une pancreatectomie a 75%. La
pancreatite aigue a frequemment
reapparu apres la pancreatectomie
distale. II y a eu reprise de I'alcoolisme
chez six patients.
Une steatorrhee grossiere a ete
observee chez 14 patients apres
I’operation. Celle-ci se corrigea apres
recharge enzymatique. Tous les
patients, sauf un qui avait subi une
resection de Whipple, ont eu un
gain de poids qui s'est maintenu.
Un diabete est apparu chez un
patient qui avait subi une pancreatec
tomie a 75%, dans un cas apres
pancreatectomie distale et chez tous
les malades qui ont eu une pancre
atectomie totale; chez un patient
qui avait subi une pancreatectomie
totale, le traitement du diabete a ete
complique par une forte consommation
d’alcool.

The prevalence of alcoholism and
alcohol-related diseases, such as
chronic pancreatitis, is increasing in
Canada as in the rest of the world.1
Sarles and associates2,3 have defined
the changes that occur in the ducts
and acinar tissue of experimental
models and man with chronic pan
creatitis; the progressive parenchymal
disruption is related to the long-term
consumption of alcohol in association
with high fat and protein diets.2,3 Pro
gressive fibrosis with necrosis and cal
cification of the pancreas can be
recognized by roentgenography, ultra
sonography and endoscopic retrograde
pancreatography. Exocrine and en
docrine insufficiency can be recog
nized by biochemical methods.
Chronic pain and weight loss are
constant features of patients with
chronic alcoholic pancreatitis.4 Sur
gical treatment for the relief of

such pain should be selective. For
example, longitudinal pancreaticojejunostomy effectively reduces pain
when there is dilatation of the duct
of Wirsung.3 Although Leger and col
leagues6 have supported nerve inter
ruption to control pain when the pan
creatic duct is not dilated, most sur
geons consider resection when an an
astomosis is not feasible.
Alcoholism greatly complicates the
management of most patients with
chronic pancreatitis. Selection of the
appropriate pain-relieving procedure
alone may not guarantee long-term
success. Continued attention to phy
sical, metabolic and psychologic prob
lems is necessary. Because such prob
lems, particularly diabetes, are accen
tuated when an extensive resection is
complicated by recurrent alcoholism
some have suggested a conservative
approach.710
This report presents the results of
resection, of varying extent, in pa
tients who did not have dilated pan
creatic ducts. Follow-up at the time
of writing was from 7 to 81 months.
Selection of candidates for operation
was based on the potential for
physical, metabolic and, most im
portant, psychosocial rehabilitation.
Selection of each procedure was based
on the preoperative investigation and
operative findings.
Patients and Methods

Since 1973, 19 patients (15 men,
4 women) of 86 with chronic pancre
atitis were selected for resection to
relieve chronic pain. The ages of the
19 patients at operation ranged from
26 to 61 years (mean 43 years). In all
the pathogenesis of the disease was
alcohol-related. No patient had biliary
calculous disease. Selection of patients
for operation was restricted to those
abstaining from alcohol for longer
than 6 months for whom psychologic
assessment suggested that they would
continue to abstain and benefit from
rehabilitation.
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Pain was constant with superim
posed severe exacerbations in most
cases. All patients had had pain for
more than 2 years and required nar
cotic analgesics for its relief. Addic
tion was not evident in any case.
Specific investigation of the pan
creas included plain roentgenograms
to identify calcification. Abdominal
ultrasonography with grey scale and
real time was invaluable in defining
pancreatic masses, cysts and calculi.
Moreover, the biliary tract could be
assessed by this examination. En
doscopic retrograde pancreatography
(ERP) or operative pancreatography
was used in each case to define the
anatomy of the duct of Wirsung. None
of the 19 patients had dilatation of the
main duct, which is treated by longi
tudinal pancreaticojejunostomy. The
secretin stimulation test for pancreatic
function was not carried out in all
patients; this test was reserved for
patients without gross steatorrhea
when radiologic assessment was not
definitive.
Selection of the surgical procedure
was based on the preoperative results
of ultrasonography and ERP, com
bined with the findings on pancreatic
exploration.
In all cases the entire gland was
affected. Preservation of pancreatic
parenchyma to sustain endocrine func
tion was considered but was rejected
because residual diseased tissue in
creases the risk of recurrent pan
creatitis, of complications affecting
adjacent structures and of missing an
occult malignant lesion.
Distal pancreatectomy was chosen
for five patients with maximal invol
vement to that side of the portal vein,
in whom the head of the pancreas was
minimally involved and the common
bile duct and duodenum were not
compromised. The procedure included
splenectomy and extended to the
portal vein.
Whipple resection, including duodenectomy and antrectomy with vago
tomy, was selected for three patients
who had the severe inflammation in
the head of the gland with compres
sion of the second part of the duo
denum or distal common bile duct, or
both. Reconstruction included choledochojejunostomy, end-to-side pan
creaticojejunostomy and gastrojeju
nostomy.
Seven patients with severe, diffuse
involvement of the entire gland were
considered for 75% pancreatectomy.
This left-to-right resection terminated
with an oblique transection through
the head of the gland, extending in
teriorly towards the left. Superiorly,
120

the pancreaticoduodenal vessels were
divided. The common bile duct was
preserved at the upper extent of the
transection line. Interiorly, the entire
uncinate process and the inferior pan
creaticoduodenal vessels were pre
served. Circulation to the duodenum
was not compromised. No biliary tract
reconstruction was required (Fig. 1).
Total pancreatectomy and duodenectomy were indicated in two patients
who had diffuse involvement of the
entire gland and compression of the
distal bile duct and duodenum. Two
other patients required total pancrea
tectomy for persistent disease after
previous lesser resections.
All patients who underwent pan
creatic resection were assessed preoperatively and during follow-up for
the following: weight gain and de
gree of pain, and the presence of dia
betes, steatorrhea, recurrent alco
holism and recurrent pancreatitis.
Evaluation of pain was based on anal
gesic requirements. These were corre
lated with 30-mg codeine equivalents
each 24-hour period. The presence
or absence of diabetes was considered
on the basis of fasting and 2-hour p.c.
blood glucose measurements while the
patient was on a standard diet. Body
weight was recorded in kilograms.
Gross steatorrhea, inconsistent preoperatively because of minimal fat
ingestion, was recorded postoperatively
when fat intake increased. The re
sponse to enzyme replacement was
noted. Recurrent alcoholism was de
termined by patient interview and in
terview with families and referring
physicians. Recurrent pancreatitis was
documented during hospital admission.

roentgenograms in seven patients. In
the majority it was distributed dif
fusely through the parenchyma rather
than along the course of the main
duct.
Gross steatorrhea occurred preoperatively in only three patients, one of
whom had a previous distal resection.
This figure is erroneously low because
all patients ingested less than 30 mg
of fat daily. Preoperative secretin tests
demonstrated low bicarbonate con
centration and low flow rate in an
other seven patients.
Insulin-dependent
diabetes was
evident in only two patients preoperatively. Both had previously had distal
pancreatectomy (Fig. 2). Two other
patients had preoperative hypergly
cemia (blood glucose levels ranging
from 112 to 150 mg/dl [6.22 to 8.33
mmol/1]). One of these patients sub
sequently required insulin (Fig. 3).
However, he had a family history of
diabetes; one parent was insulin-dependent.
Jaundice did not accompany pan
creatitis in any case. Endoscopic re
trograde pancreatography, ultrasono
graphy and operative pancreatography
demonstrated compression of the dis
tal bile duct in six patients, four of
whom had resection of the head of the
pancreas.
The gross appearance of the
pancreas at operation confirmed the
findings of ultrasonography and ERP.
The glands were firm throughout with
asymmetric thickening affecting the
head, body or tail. The main duct of
Wirsung was compressed by obliter
ative fibrosis. No dominant retention
cysts or pseudocysts were noted.

Results

Calcification was noted by plain

I-'IG. 1— Seventy-five
createctom y.

percent
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F IG . 2— C hanges in w eight, blood glu
cose levels and analgesic re q u ire m e n ts of
fo u r patients follow ing pan createcto m y
fo r
chronic
pancreatitis.
F ollow -up
ranged fro m 7 to 51 m o n th s (m ean 31
m onths). N u m b ers opposite diabetes in
dicate units (u) o f lente insulin given
daily.
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Retropancreatic planes and the lesser
sac were obliterated by chronic peripancreatic inflammation.
Disruption of normal histology was
characterized by periacinar and peri
ductal fibrosis, acinar cell necrosis
and infiltration by mononuclear cells.
Concretions were evident in the ter
tiary duct lumen. Calcification was
evident in the interstices of lobules
and in small ducts. Islet cells were
preserved. No gross or microscopic
evidence of carcinoma was found in
any specimen.
There were no operative deaths
following pancreatic resection. Mor
bidity was related to infection and
fistula formation. Wound infections
occurred in seven patients. Peripancreatic inflammation presented as
intra-abdominal infection in four pa
tients, only one of whom required

FIG. 3—Changes in weight, blood
glucose values and analgesic require
ments of five patients who underwent
distal pancreatectomy for chronic pan
creatitis. Follow-up was from 7 to 81
months (mean 43 months). Number op
posite diabetes indicates units of lente
insulin given daily.

surgical drainage. A pancreatic fistula
occurred in two patients. Both fistulas
closed spontaneously in less than 4
weeks.
Distal Pancreatectomy (Fig. 3)
Preoperatively, these five patients
required analgesics in doses of 120 mg
to 360 mg of codeine daily. Following
resection, pain relief was complete in
only one patient, followed up for 55
months. Reduction in analgesic requi
rements was evident in the others,
observed from 9 to 81 months.
Steatorrhea did not follow distal
resection and no weight loss was
noted on long-term follow-up. Gen
erally preoperative body weight was
maintained, with a maximum gain of
7 kg in the patient who was totally
relieved of pain.
The family history was positive in
the single patient in whom insulin-dependent diabetes developed 2 months
after resection. Preoperatively, hyper
glycemia had been noted. Manage
ment of the diabetes has been smooth
and requirements at the time of
writing are less than 20 units/d of
lente insulin.
Recurrent acute pancreatitis re
quiring hospital admission has been
frequent in this group (Table I). All
patients were managed conservatively
without serious complications. The
frequency of admission to hospital
for treatment of recurrent pancrea
titis is related directly to alcoholism.
Two patients who were no longer
drinking had less frequent admissions.
Recurrence of alcoholism was

sporadic in two patients (Table II),
but was associated with other acute
gastrointestinal complications in addi
tion to pancreatitis. One patient had
evidence of alcoholic liver disease. In
neither patient did further deteriora
tion of pancreatic, endocrine or
exocrine function develop.
Whipple Resection (Fig. 4)
Three patients have been followed
up for 40 to 76 months after pancrea
ticoduodenectomy for chronic pan
creatitis maximally affecting the head
of the gland.
Preservation of the body and tail
of the pancreas prevented diabetes in
these patients. However, the increased
mass of residual disease was likely re
sponsible for the persistent pain. Anal
gesic requirements after 3 years were
greater than 120 m g/d of codeine.
In one case pain was worse than
before operation.
Steatorrhea, present in one patient
preoperatively, was evident in all
three 1 year after resection. This was
probably due to delayed stricture of
the pancreaticojejunal anastomosis, in
addition to the disease itself. Enzyme
replacement was required by all pa
tients. Weight gain was observed in
two patients, but not in the third who
had excessive pain and had lost 5 kg
by the fifth postoperative year. This
patient had six admissions in 6 years
due to recurrent acute pancreatitis,
related to recurrent alcoholism (Tables
I and II). Psychiatric problems de
veloped secondary to the alcoholism.
The two other patients who abstained

Table 1 Recurrent Pancreatitis following Pancreatic Resection
No. of patients/total

Frequency

Distal

4/5

Whipple
75%

1/3
2/7

4 admissions in 4 yr*
4 admissions in 2 y r‘
3 admissions in 7 yr
2 admissions in 5 yr
6 admissions in 6 y r*
4 admissions in 7 yr*
1 admission i n l y r

Type of resection

‘ Recurrent alcoholism.

Table II

Recurrent Alcoholism following Pancreatic Resection
No. of patients/total

Frequency

Distal

2/5

Whipple
75%
Total pancreatectomy

1/3
1/7
2/4

4 admissions in 4 yr*
4 admissions in 2 yr*
6 admissions in 6 yr*
4 admissions in 7 yr*
11 admissions in 4 yr
1 admission in 4 y r

Type of resection

FIG. 4—Changes in weight, blood glu
cose values and analgesic requirements
following Whipple resection for chronic
pancreatitis in three patients followed up
from 40 to 76 months (mean 61 months).
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*With recurrent acute pancreatitis.
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have not had recurrent pancreatitis
and are gainfully employed.
No biliary tract or gastric stomal
problems have been observed in any
of the three patients.
75% Resection (Figs. 1 and 5)

Seven patients have been followed
up after resection preserving the un
cinate process and less than half of
the head of the pancreas. Of the seven
patients in this group followed up to
79 months, pain relief has been com
plete in four who were followed up
for a mean of 36 months. The other
three patients have at least 50% re
duction in analgesic requirements.
Although all patients had steator
rhea, enzyme replacement restored
normal fat digestion. Four patients
gained more than 5 kg over pre
operative body weight. The maximum
increase in weight was 20 kg at 44
months. The remaining three patients
have maintained their weight or shown
a slight increase.
Diabetes was not present preoperatively, although one patient had bor
derline hyperglycemia. Following re
section, normal blood glucose values
were recorded in four patients fol
lowed up for 16 to 79 months. In two
patients hyperglycemia developed at
9 and 14 months, respectively. It was
controlled by diet alone. Only one
patient became diabetic, requiring 10
units of lente insulin daily. Manage
ment of the condition has been un
complicated.
Admission for recurrent acute pan
creatitis was necessary in two cases.
Following “binge drinking”, one
patient has required four admissions
in 7 years. Another patient has been
admitted with acute pancreatitis once
during the 20 months since operation.
He is not drinking (Table I).
All seven patients have returned
to work since operation.
Total Pancreatectomy (Fig. 2)

Pain relief following total pancre
atectomy was complete in these four
patients followed up for 7 to 51
months. Preoperative requirements of
codeine for analgesia had ranged from
180 mg to 300 mg/d.
Steatorrhea was evident early in
the postoperative course in all patients
and was controlled by enzyme repla
cement. Three patients have gained
from 3 to 15 kg in 7 to 49 months
since operation. After 51 months, the
weight of the fourth patient is un
changed from the preoperative body
weight.
122

Two patients were diabetic before
operation. The diabetes was related to
chronic disease which had been
treated previously by distal pancrea
tectomy. Insulin requirements did not
change in these patients following total
resection of residual parenchyma. The
other two patients require 26 units of
lente insulin daily. Control of the
diabetes was complicated in one
patient only. This patient drank heav
ily for over 3 years and during that
time required 11 admissions for con
trol of the diabetes. The patient has
also required intensive psychotherapy.
One other patient had a single admis
sion in 4 years, for diabetic control
related to an episode of “binge drink
ing" (Table II). His alcoholism has
otherwise been controlled. The re
maining patients have abstained and
have exhibited no serious complica
tions of diabetic management.
No biliary tract or gastrointestinal
complications have occurred in these
patients since the resection. Re
construction has been by choledochojejunostomy and gastrojejunostomy
with vagotomy.
The three controlled patients have
been rehabilitated to socioeconomic
stability.
Discussion

Selection plays an important role
in surgical treatment of chronic pan
creatitis. To obtain favourable results
we have stressed the importance of
assessing the patient’s psychosocial
profile before embarking on investig
ation that will help select appropriate
operative procedures. This is par
ticularly true of alcoholics. Interviews
with the patient, relatives and refer
ring physicians should be carried out
by the surgeon, social worker and
possibly psychiatrist to identify drug
and alcohol dependency and the po
tential for rehabilitation. The con
tinued support of this team on a long
term basis following operation is es
sential for a favourable outcome.
The resective procedure selected in
each case depends on the pathologic
anatomy determined preoperatively
and intraoperatively. The combina
tion of ultrasonography and ERP
provides a clear picture of the changes
affecting the ducts and the paren
chyma of the pancreas. Computerized
tomography is rarely required. Pre
operative secretin tests define exocrine
function when gross steatorrhea is not
evident; however, this test does not
aid in choice of operation. The final
selection of the procedure is made
at the time of exploration of the pan
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creas when gross derangements of the
gland and the state of adjacent struc
tures are seen and assessed.
Although the gross pathologic fea
tures were variable in the 19 patients
treated, the histopathologic picture
showed uniform changes in keeping
with that described by Sarles and
associates.2 With alcoholism, the early
lesions occur in the tertiary ducts and
adjacent acinar tissue throughout the
gland, unlike the changes noted at the
termination of the duct of Wirsung
described in juvenile pancreatitis and
some cases of biliary calculous disease.
Calcification was noted in seven of
our patients and was present in the
parenchyma, as anticipated. Clinically
there was no obstruction of the com
mon bile duct. However, compression
of the distal duct was noted radiologically in six patients. The appear
ance and frequency of this finding
were as described by Sarles and
Sahel." Gross steatorrhea was infre
quent in this series, present in only
three patients. Seven other patients
had exocrine insufficiency as shown
by secretin testing, which supports the
fact that inadequate fat intake pre
cludes gross steatorrhea in chronic
pancreatitis. Endocrine insufficiency
was infrequent in this series also; only
two patients presented preoperatively
with hyperglycemia, one with a
hereditary pattern. Insulin-dependent
diabetes was evident only in those
patients who had previously under
gone resection.
There were no operative deaths.
However, technical difficulties were
often encountered; surgery for chronic
pancreatitis requires experience as
well as knowledge of the pathologic

F IG . 5— C h an g es in w eight, blood
glucose values a n d analgesic requirem ents
of seven pa tie n ts subjected to 7 5% p a n 
c rea te c to m y fo r c hronic pancreatitis.
F o llo w -u p w as fro m 9 to 79 m o nths
(m ean 33 m onths). N u m b e r opposite
d iabetes indicates units of lente insulin
given daily.
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features of pancreatic disease. Infec
tion occurred frequently and intra-ab
dominal complications were directly
related to postoperative pancreatic in
flammation. Such complications pro
long hospitalization and the early
course following discharge is com
monly complicated by slow resolu
tion of this inflammation. This was
noted particularly following 75% pan
createctomy and Whipple resection.
Postoperative
complications
have
been noted frequently following total
pancreatectomy
and
pancreaticojej unostomy.5'9,12
No steatorrhea or malnutrition was
noted after distal pancreatectomy in
this series. Diabetes occurred in one
patient but was unrelated to resection.
The mass of residual diseased gland
preserved with distal resection con
tributes to incomplete pain relief.
Recurrent alcoholism does increase
the frequency of recurrent acute pan
creatitis. However, even without
alcohol, the rate of recurrent attacks
and degree of residual pain following
distal pancreatectomy indicate that
further resection may be required for
more effective pain relief. Continued
abstinence is mandatory before such
consideration.
Because islet cell populations are
believed to be greater in the body and
tail of the pancreas and because the
head is often found to be more dis
eased than the rest of the pancreas,
Guillemin
and
associates13 and
Warren14 favour pancreaticoduodenec
tomy as the resection of choice for
chronic pancreatitis. None of our
three patients who underwent this
procedure had evidence of diabetes.
Gross steatorrhea occurred in all cases
but was controlled by enzyme replace
ment; weight gain was recorded in
two patients but not in the third who
had recurrent alcoholism. Pain relief
in these patients was incomplete and
high-dose analgesics were required.
Concomitant vagotomy with Whipple
resection helped to prevent stomal
complications.
The greatest relief of pain followed
75% resection. Recurrent acute pan
creatitis was infrequent in this group.
One patient required four admissions
over 7 years because of recurrent
“binge drinking”. One patient had a
single admission for acute pancrea
titis which was unrelated to alcohol
intake. Gross steatorrhea occurred in
all patients but was controlled by
enzyme replacement resulting in im
pressive weight gain in most cases.
That the occurrence of diabetes was
infrequent in this group suggests that
an appreciable number of islet cell

populations exist in the uncinate
process. Only one patient required
insulin replacement (10 units of lente
insulin daily) although two others were
chemically diabetic and the condition
was controlled by diet. Correction of
fat maldigestion with enzyme therapy
allows smooth management of dia
betes when not complicated by re
current alcoholism.15
All patients who underwent total
pancreatectomy were completely re
lieved of pain, as noted by others.'1'10'12'16
Steatorrhea was also well controlled
in these patients and there was weight
gain. Selection of long-abstaining can
didates for total pancreatectomy is
likely the reason that diabetes in this
group has been managed easily. Lente
insulin dosage has remained stable
between 25 and 30 units daily. With
regular follow-up and continuing sup
portive measures, control has been
maintained in three patients without
hospital admission. One patient had
a complicated course requiring 11
admissions over 4 years because of
recurrent heavy drinking.
An alcoholic population runs a
greater risk of liver and gastrointes
tinal disease and mortality than a
comparable
nonalcoholic popula
tion. '',2 A direct relation is well recog
nized between recurrent pancreatitis
and recurrent alcoholism. Moreover,
the compounding problems of malnu
trition and diabetes are well known.
In this series of selected patients with
chronic pancreatitis recurrent al
coholism was recorded in less than
one third of patients, no greater fre
quency than the alcoholic population
at large.1 No deaths occurred from
alcoholism. Four patients had re
current acute pancreatitis; three of
these had associated liver disease, gas
trointestinal disease and psychiatric
disorders. The one patient who had
total pancreatectomy and recurrent
alcoholism has a poor prognosis
because of complications relating to
diabetes and an associated psychiatric
disturbance.
No postoperative hospital admission
was necessary in 10 patients following
operation. Of the nine requiring re
admission, six were readmitted be
cause of recurrent drinking. Four of
these patients presented with acute
pancreatic pain requiring admission,
on average, once a year. The two
patients admitted with recurrent
drinking following total pancreatec
tomy presented with diabetic com
plications. Further management of
these six patients was directed by
social workers and psychiatrists in
order to control the problems of re
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current alcoholism. No further oper
ations should be considered for pa
tients in this group. Percutaneous
celiac ganglion block (using 50%
alcohol) will relieve pain for an aver
age of 1 year. Although its effect
iveness is variable it may be helpful
as an adjunct to social rehabilitation.
Three patients required readmission
for recurrent pancreatitis in spite of
continued abstinence, two of them
following distal pancreatectomy. Based
on frequency of such attacks, degree
of residual pain and associated dis
ability, consideration should be given
to further resection in such patients.
In these cases the decision to carry
out 75% pancreatectomy or total re
section should be based on endocrine
reserve. We choose total pancreatec
tomy only for patients with insulindependent diabetes.
C onclusions

Selective pancreatic resection, in
dividualized by preoperative investiga
tion and operative pancreatic explora
tion, will reduce the pain of chronic
pancreatitis. Total freedom from pain
resulted in all patients following
total pancreatectomy,, in four of seven
after 75% resection, in only one of
five after distal pancreatectomy and
in none after Whipple resection.
Endocrine reserve is maintained
by 75% pancreatectomy, preserving
the uncinate process and half of the
head of pancreas, by distal pancrea
tectomy and by Whipple resection.
Steatorrhea may occur owing to
resection, progression of disease or
late anastomotic stricture. Enzyme
therapy will improve fat maldigestion
and contribute to weight gain and
nutritional improvement following re
section.
Recurrent pancreatitis, influenced
by recurrent alcoholism, occurs in
proportion to the amount of pan
creatic tissue preserved.
Recurrent alcoholism complicates
the management of diabetes and re
sults in recurrent pancreatitis. Post
operative abstinence is related to pa
tient selection and long-term psycho
social rehabilitation.
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Management of Duodenal Fistulas
J ack T. Sandler,

mb , ch b, frcs[c1 and

A review of records of 27 patients
with duodenal fistulas admitted to
St. Joseph's Health Centre in Toronto
since 1969, when total parenteral
nutrition (TPN) was instituted, showed
that in 19 patients the fistula formed
after gastric resection, pyloroplasty
or transduodenal sphincteroplasty.
The remaining fistulas resulted from
delayed presentation of perforated
duodenal ulcers, trauma suffered in
motor vehicle accidents and disease
in neighbouring organs.
Management included early
nasogastric suctioning, withholding
oral intake, draining the fistula
contents, protecting the skin
effectively, replacing fluid and
electrolytes and administering TPN
to suppress secretions and to
promote anabolism. In seven patients
who had associated duodenal
obstruction in this intensely inflamed
area, a gastrojejunostomy was
performed. In no instance was a
direct attack made on the fistula.
In 25 patients (92.6%) the fistula
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healed spontaneously in an average
of 21 days. Two patients (7.4% ) died
with patent fistulas.
It appears that a direct surgical
attack on duodenal fistulas is rarely
necessary. With appropriate
management, the majority will heal
spontaneously. Total parenteral
nutrition is the cornerstone
of therapy and gastrojejunostomy
is invaluable in certain cases.
La nutrition parenterale totale (NPT)
est utilisee au St Joseph's Health
Centre de Toronto depuis 1969.
L'etude des dossiers de 27 patients
hospitalises dans cette institution,
depuis cette date, pour une fistule
duodenale, a revele que chez 19
malades, la fistule est apparue apres
une resection gastrique, une pyloroplastie ou une sphincteroplastie
transduodenale. Les autres fistules
etaient la consequence tardive
d’ulceres duodenaux perfores, des
traumatismes subis iors d'accidents
automobiles ou de la maladie d'un
organe voisin.
Le traitement a compris le recours
precoce a I’aspiration gastrique par
voie nasale, I'arret de i'alimentation
orale, le drainage du contenu de la
fistule, la protection efficace de la
peau, la correction des volumes
liquidiens et des electrolytes et
I'administration de la NPT afin d'arreter
les secretions et de favoriser I'anabolisme. Chez sept malades souffrant
egalement d’une obstruction intestinale
dans cette region intensement inflammee, une gastro-jejunostomie a
ete pratiquee. Dans aucun cas on ne
s'est interesse directement a la
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fistule. Chez 25 patients (92.6%),
la fistule a gueri spontanement, apres
21 jours en moyenne. Deux malades
(7.4% ) sont decedes avec des
fistules secretrices.
II semble qu'une intervention chirurgicale directe sur les fistules
duodenales soit rarement necessaire.
La majorite guerit spontanement
avec un traitement approprie. La NPT
constitue I'element fondamental du
traitement et la gastro-jejunostomie
est particulierement precieuse dans
certains cas.

Duodenal fistula is a particularly chal
lenging problem for the surgeon.
Apart from the locally destructive
effects of the fistula itself, the loss of
gastric, pancreatic, biliary and duo
denal secretions produces major fluid,
electrolyte and protein depletion. In
the past this has resulted in a mor
tality of 70% or more.1 Various sur
gical techniques have been used to
close the fistula, such as direct sutur
ing, patching with layers of omentum
or jejunal serosa2 or Roux-en-Y drain
ing of the fistula. These operations are
formidable when there is intense local
inflammation surrounding the fistula.
Conservative methods of man
agement, including total parenteral
nutrition (TPN) for enterocutaneous
fistulas in general, have gained rapid
ly increasing acceptance.3'5 In 1970,
Dudrick and colleagues8 reported on
three patients with duodenal fistulas
resulting from trauma suffered in
automobile accidents. In each patient
the fistula closed spontaneously with
nonoperative treatment.
At
St.
Joseph’s Health Centre in Toronto
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since January 1970, 27 patients with
duodenal fistulas have been managed
conservatively. Eight of the patients
were referred to this hospital specific
ally for treatment of the fistula.
Patients

The 27 patients ranged in age from
14 to 88 years (mean 58 years). The
causes of the fistula are summarized
in Table 1. In 19 patients (70.4%)
the fistula developed as a complica
tion of an operation (Table II). In
many patients the fistula was associ
ated with other complications, includ
ing wound dehiscence, malnutrition,
cachexia or generalized sepsis, or had
followed several previous operations.
Some patients had had unsuccessful
operative closure of the fistula before
being transferred to our hospital.
Methods

The treatment used in the manage
ment of these 27 patients is set forth
in Table III. In no case was a direct
surgical attack made on the fistula. A
fine-tube jejunostomy for feeding of
an elemental diet has been valuable in
certain patients with major nutritional
depletion,7 but was not required in
any of these patients and would have
necessitated an additional operative
manipulation.
Results

In 25 (92.6%) of the 27 patients the

Table 1-C ause of Duodenal Fistulas in
27 Patients
Cause
Operative complications
Motor vehicle traum a*
Perforated duodenal ulcer
(delayed presentation)
Nephroduodenal fistula
Cholecystoduodenal fistula

No. of patients
19
3
3
1
1

’ Patients in whom fistulas developed after
suture and drainage of duodenal disruptions.

fistula healed spontaneously within 4
to 42 days (average 21 days). Two
patients (7.4%) died and in both the
fistula was patent at the time of death.
Two other patients died of multiple
complications not directly related to
the fistula, more than 30 days after
the fistula had closed.
The volume of fistula drainage
usually decreased by more than 50%
within 48 hours of commencing TPN.
Patients were forbidden to smoke
because it was noted that this in
creased the volume of drainage.8
Discussion

The conservative method of treating
duodenal fistulas is similar to that
used in treating enterocutaneous fis
tulas at other sites. In some respects
duodenal fistulas are unique and
these methods, therefore, have greater
importance.
We believe that total deprivation of
oral intake is essential to promote
healing of duodenal fistulas. This will
decrease the volume of effluent from
the fistula and prevent stimulation of
enzyme production in the stomach,
duodenum and pancreas, which would
digest the tissues about the fistulous
tract and the surrounding skin. We
have noted that administration of even
the hospital full fluid diet results in
reddened skin and profuse drainage
of fluid containing particulate matter
such as cereal particles. The use of
nasogastric suction may also be help
ful since the local inflammation at the
site of the fistula in the presence of
an adynamic duodenum produces a
functional obstruction, with resultant
drainage from the fistula and back
up of secretions into the stomach.
Cimetidine has become an important
aid in decreasing gastric secretion.*1
Because of the large volume pro
duced by duodenal fistulas, evacua
tion of the fistula contents by in
serting a sump suction drain directly
into the fistulous tract is often more
important in managing these fis
tulas than other fistulas of the gas
trointestinal tract. A variety of mate
rials are available for protecting the

Table I I — Cause of Postoperative Duodenal
Fistulas in 19 Patients
Cause
B illroth I gastrectomy anastomotic leak
B illroth II ga strec to m yduodenal stump leak
Total g a strec to m yduodenal stump leak
Pyloroplasty leak
Transduodenal sphinctero
plasty leak

Table III Treatm ent for
Duodenal Fistulas

No. of patients
4

No oral intake
Nasogastric suction, cim etidine
Tube drainage of fistula
Skin protection
Fluid and electrolyte replacement (in tra 
venous)
Total parenteral nutrition
Gastroenterostomy (7 patients)

6
1
4
4
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skin. These include aluminum paste
and karaya rings. However, we have
found that Stomahesive wafers and
Desitin cream are particularly effect
ive barriers.5'10
The vital importance of TPN has
already been mentioned. This is pro
vided by central intravenous alimen
tation. For convenience, in this insti
tution TPN solutions also provide the
vehicle for intravenous administration
of additional electrolytes and fluid
required to replace losses from the
fistula." The use of this treatment is
obviously more important than in
lower
intestinal
fistulas.
Total
parenteral nutrition permits main
tenance of satisfactory nutritional
status in spite of prolonged periods of
fasting. A favourable nitrogen balance
may be maintained, allowing the fis
tula to heal. At the same time, gastric
and pancreatic secretions are reduced
to sub-basal levels, thereby decreasing
the volume and enzyme content of the
effluent.1218 In addition, TPN dec
reases peristaltic activity,19 allowing
the duodenum greater rest.
A gastroenterostomy was used in
seven patients following development
of a fistula. Duodenal dysfunction or
obstruction as a result of local edema
and ileus at the site of the fistula was
present in several patients. In three
patients, roentgenograms demonstrated
superior mesenteric artery syndrome.
This is well recognized following loss
of retroperitoneal fat. associated with
prolonged starvation and recum
bency,20,21 and may be an important
mechanism in the production of duo
denal obstruction in some of these
patients. Such obstruction distal to a
fistula would obviously inhibit closure.
Gastroenterostomy provided an effect
ive bypass of the duodenal obstruction
in these patients, without disrupting
the intensely adherent, inflamed area
of the fistula. Vagotomies were not
performed with the gastroenterostomy
and no stomal ulcers have yet been
encountered.
We conclude that under suitable
conditions of conservative manage
ment, the majority of duodenal fis
tulas will close spontaneously. This
suggests that a direct surgical attack
on the fistula is unnecessary. Total
parenteral nutrition has been the cor
nerstone of therapy, and gastroen
terostomy is invaluable in certain
circumstances.
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“Zinacef
CEFUROXIME SODIUM INJECTION
Prescribing Information:
Indications and Clinical uses: ZINACEF may be indicated for the
treatment of the following infections when caused by susceptible
organisms: lower respiratory tract, urinary tract and soft tissue
infections.
Appropriate culture and susceptibility studies should be performed
to determ ine th e s u s c e p tib ility of the causative organism to
ZINACEF Therapy may be started while awaiting the results of these
tests, however, modification of the treatment may be required once
these results become available.
Clinical studies have shown ZINACEF to be effective against infec
tions caused by sensitive strains of:
Gram positive cocci - Staphylococcus aureus
Streptococci (excluding S. faecalis)
Gram negative rods - Hemophilus influenzae
Escherichia coli
Proteus mirabilis
Klebsiella spp.
Contraindications: Hypersensitivity to cephalosporins.
Warnings.- Before therapy with ZINACEF is instituted, careful inquiry
should be made concerning previous hypersensitivity reactions to
cephalosporins, penicillins or other drugs. ZINACEF should be given
only with caution to penicillin-sensitive patients.
There is some clin ical and laboratory evidence of partial cross
allergenicity of the cephalosporins and penicillins. Patients have
been reported to have had severe reactions (including anaphylaxis)
to both types of drugs.
Any patient who has demonstrated some form of allergy, particularly
to drugs, should receive antibiotics, including ZINACEF, with cau
tion. If an allergic reaction to ZINACEF occurs, administration of the
drug should be discontinued. Serious acute hypersensitivity reac
tions may require treatment with epinephrine and other emergency
measures.
Precautions: The safety of ZINACEF in the treatment of infections
during pregnancy has not been established. If the administration of
ZINACEF is considered to be necessary, its use requires that the po
tential benefits be weighed against possible hazards to the patient
and to the fetus. Animal studies have shown ZINACEF to affect bone
calcification in the fetus and to show maternal toxicity in the rabbit.
The safety of ZINACEF for the treatment of infections in infants,
children and nursing mothers, has not been established.
Prolonged use of ZINACEF may result in the overgrowth of nonsusceptible organisms. Careful observation of the patient is there
fore essential, and if superinfection should occur during therapy,
appropriate measures should be taken. Should an organism become
resistant during antibiotic therapy, another antibiotic should be
substituted.
Patients w ith renal or hepatic im pairm ent should be carefully
monitored during therapy w ith ZINACEF. Patients with impaired
renal fu n ctio n should be placed on the special dosage recom
mended under DOSAGE AND ADMINISTRATION, because normal
doses in these individuals are likely to produce excessive serum
concentrations.
Studies suggest that the concurrent use of potent diuretics, such as
furosemide and ethacrynic acid, may increase the risk of renal tox
icity with cephalosporins.
ZINACEF may interfere w ith Benedict's and Fehling's tests for
glycosuria. It may cause false negative reactions in the ferricyanide
test, and possibly, may cause an erroneously high reading in the
alkaline picrate test for creatinine.
Adverse reactions: The following reactions have been observed
during treatment with ZINACEF.
Hypersensitivity: rash and eosinophilia. Anaphylaxis, pruritus and
drug fever have also been observed with cephalosporin therapy.
Local reactions, thrombophlebitis, stiffness at the site of injection
and inflammatory reactions at the site of injection. Some degree of
pain, after intram uscular injections when using water as the d i
luent, has been observed.
Blood: increased erythrocyte sedimentation rate and decreased
hemoglobin. Some patients developed a positive direct Coombs test.
Renal: increases in BUN and serum creatinine.
Hepatic: transient increases in serum bilirubin, transaminases and
alkaline phosphatase.
Others: drowsiness, loose stools, faint feeling, sweating, palpita
tions and Candida intertrigo.
Symptoms and treatment of overdose: Other than general suppor
tive tre a tm e nt, no specific antidote is known. Excessive serum
levels of cefuroxime can be reduced by dialysis. For treatment of
hypersensitivity reactions, see WARNINGS

Dosage and administration: Adults: the intramuscular dose is 750
mg three times daily and the intravenous dose is 750 mg or 1,5 g
three tim es daily.
For most infections the usual recommended dosage is 750 mg every
8 hours (2.25 g/day) and may be administered either l/M or l/V.
For severe or life-threatening infections, the higher dose is sug
gested. For infections of the lower respiratory tract, caused by gram
negative organism s, the higher dose may also be required. A nti
b iotic therapy for infections caused by B-hemolytic streptococci
should be continued for at least 10 days.
There is insufficient evidence for recommending the use of ZINACEF
in children or in nursing mothers.
Dosage in adults w ith impaired renal function: ZINACEF may be
used for patients w ith impaired renal function but a reduced dosage
must be employed and serum levels of cefuroxime may need to be
monitored. The following Table shows the dosage recommendations.
Serum creatinine
(mg/mL)

Glomerular filtration rate
(m L/min)*

Dose of ZINACEF
(mg)

2.0 - 3.5
35- 60
> 6 .0

2 0 -5 0
1 0 -2 0
< 10

500 t.i.d
500 b id
500 q.d.

’ For more precise calculations, whenever possible, the glomerular
filtration rate should be used.
Patients on dialysis should receive an additional dose of 500 mg at
the end of dialysis.
Preparation of solutions: For intram uscular use Add 3.2 mL of
Water for Injection to a vial containing 750 mg of ZINACEF and
shake gently to produce an opaque suspension The total volume
obtained is approximately 3.7 mL.
For intravenous use: When a single bolus injection is prepared, 750
mg of ZINACEF is dissolved in 7 mL of Water for Injection, which pro
vides a volume of approximately 7.5 mL. Reconstitution of 1.5 g of
ZINACEF is done by adding 19 mL of Water for Injection, thereby ob
tain ing an approximate volume of 20 mL.
For short intravenous infusion, 1.5 g of ZINACEF is dissolved in
49 mL of Water for Injection, resulting in an approximate volume of
50 mL.
Administration: Intramuscular: ZINACEF should be injected into a
large m uscle mass to m inim ize pain. As the preparation is in
suspension form, a 21 gauge needle should be used.
Intravenous: ZINACEF may be administered intravenously either by
a bolus injection or by a short intravenous infusion over a period of
approximately 30 minutes.
For continuous intravenous infusions, a solution of ZINACEF (1.5 g
dissolved in 19 mL of Water for Injection) may be added to a suitable
bottle containing an appropriate intravenous infusion fluid in the
amount calculated to give the desired antibiotic dose.
Com patibility: Reconstituted primary solutions of ZINACEF may be
further diluted with Sodium Chloride Injection B.P. 0.9% w/v. 5%
w /v Dextrose Injection B.P. or Compound Sodium Lactate Injection
B.P. (Hartmanns Solution).
NOTE: The pH of 2.74% w/v Sodium Bicarbonate Injection B.P. con
siderably affects the colour of the solution, therefore, this solution is
not recommended for the dilution of ZINACEF. However, if required,
for patients receiving Sodium Bicarbonate Injection by infusion, the
ZINACEF may be introduced into the tube of the set.
NOTE: ZINACEF should not be mixed with aminoglycoside antibiotics
(e g. gentamicin sulfate, tobramycin sulfate, amikacin sulfate) be
cause of potential interaction.
Stability: The dry powder in vials should be stored below 25°C and
protected from light.
Suspensions of ZINACEF for intramuscular injection and aqueous
solutions for intravenous injection retain their potency for 6 hours if
kept below 25°C. and for 48 hours if refrigerated. More dilute solu
tions, i.e. 1.5 g in 50 mL Water for Injection, retain their potency for
at least 12 hours if kept below 25°C, and for 36 hours when re
frigerated. Some increase in the intensity of colour may occur on
storage
Dosage forms: ZINACEF is available for intramuscular or direct in
travenous injection in 18 mL vials containing cefuroxime sodium
powder equivalent to 750 mg of cefuroxime, in packs of five.
For intravenous injection, 30 mL vials contain cefuroxime sodium
powder equivalent to 1.5 g of cefuroxime, in individual packs.
For intravenous infusion. ZINACEF is available in 75 mL vials con
taining cefuroxime sodium powder equivalent to 1.5 g of cefuroxime.
in individual packs.
Product Monograph available on request.
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A
new
choice
m
firstchoicehospitalantibiotics.

Zinacef is a new third generation injectable
cephalosporin with advantages that
make it an excellent first choice antibiotic.

Unlike most penicillins and cephalosporins which
are inactivated by 5-lactamase producing pathogens,
Zinacef has a novel structure (the addition of an
o methoximino group)1which helps protect the betalactam ring against destruction.

• Lower individual dosage (750 mg) and longer half-life
(70 minutes)1than other third generation cephalosporins.
• Convenient eight-hour dosage interval for a low
usual daily dose of 2 .2 5 g.1
• Therapeutically effective levels throughout body
tissues.1
150.
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Zinacef has a broad range of activity
and excellent pharmacokinetics:
• Rapidly absorbed and not meta
bolised, yielding high levels
(91-96%) of active unchanged
antibiotic in the urine.1
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Zinacef has a high intrinsic activity against the
range of Gram-positive and Gram
negative pathogens responsible for
the vast majority of hospital
infections.1 Up to 92% of isolated
pathogens were effectively treated
by Zinacef.3

We started cephalosporin research. And we’ve never stopped.

To lower
blood pressure
during
anesthesia

Ni pride

reduces excessive
blood loss

Precautions

for controlled hypotension during anesthesia
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection.
Indications

'Nipride' is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
appropriate. Benefit-risk ratio should be carefully considered on an
individual basis.
Contraindications

In the treatment of compensatory hypertension, e.g. arteriovenous
shunt or coarctation of the aorta. It is also contraindicated in physically
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia
or hypovolemia or in those with known inadequate cerebral circulation.
In patients with liver disease, severe renal disease, Leber's optic
atrophy and disease states associated with vitamin B)2 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection. Infusion rates
greater than 8 /ig/kg/minute are virtually never required. If at this
rate an adequate reduction in blood pressure is not obtained within
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium
nitroprusside administration. One factor is common to all known
cases, namely that large amounts of nitroprusside were infused at
high rates. Since detoxification relies upon enzymatic action, the
rare possibility of deficient or atypical enzymes occurring in humans
should always be considered. Patients most apt to run into difficul
ties are those who are resistant to the hypotensive effect or those
in whom maintenance at the selected blood pressure level is difficult
or impossible.
Constant attention to the patient’s dose-response characteristics
is mandatory. If infusion rates are in excess of 8 jig/kg/minute deter
mine the nature of the response (effective constant response at
higher dose; tachyphylactic; resistant - none or less than expected).
As soon as either tachyphylaxis or resistance is determined the infu
sion of ‘Nipride’ should be discontinued immediately. In abnormal
responders it has been noted that metabolic acidosis may occur
at higher doses.

Caution should be exercised in using ‘Nipride’ in patients with hypo
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 mg/100 ml, it is
probably safe to continue with the infusion. Peritoneal dialysis can
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concomitant antihypertensive medications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of ‘Nipride’ should
be adjusted downward accordingly.
The following Warnings apply to the use of ‘Nipride’ for controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin
ished. If possible, preexisting anemia and hypovolemia should be
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipment and personnel should be available
for frequent and vigilant monitoring of blood pressure. When the infu
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clinical situation, stress induced by pain or manipulation
is reduced or eliminated during ‘Nipride’ infusion, the patient could
experience a greater than expected reduction in blood pressure
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the
infusion bottle should be wrapped with aluminum foil or other opaque
material. Solutions of ‘Nipride’ should not be kept or used longer
than four hours. ‘Nipride’ in aqueous solution yields the nitroprusside
ion, which reacts with even minute quantities of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction products (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions

Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle twitching, retrosternal discomfort and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and somnolence have been noted with too
rapid reduction in blood pressure. These symptoms rapidly disap
peared with slowing of the rate of infusion or temporary discontinua
tion of infusion and did not reappear with continued slower rate
of administration.
Irritation of the injection site may occur. Methemoglobinemia and
one case of hypothyroidism following prolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
‘Nipride’ should be discontinued immediately. (See Warnings).

The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml
of sterile dextrose in water without preservatives. No other diluent
should be used. Depending on the desired concentration, all of the
prepared stock solution should be diluted in 500 or 1000 ml of 5 per
cent sterile dextrose in water and promptly wrapped in aluminum
foil or other opaque material. Both stock solution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution for infusion has a very faint brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than four hours from
initial reconstitution. The infusion fluid used for the administration
of ‘Nipride’ should not be employed as a vehicle for simultaneous
administration of any other drug.
‘Nipride’ dosage varies considerably from patient to patient, hence
the need for individual titration. The infusion should be started at
the lower dosage range, 0.5 jtg/kg/minute and increased by
0.2 fig/kg/minute every 5 minutes until the desired reduction in
blood pressure is obtained. The blood pressure usually starts to drop
immediately or at least within a few minutes. Continuous monitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to drop at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
Infusion rates greater than 8 /jg/kg/minute should rarely be used.
The maximum recommended dose is 800 fig/minute.
‘Nipride’ should be administered by an infusion pump, micro-drip
regulator or any similar device that will allow precise measurement
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effect, as determined by frequent
blood pressure determinations.
For the use of ‘Nipride’ in the treatment of hypertensive crises please
refer to the Product Monograph.
Supply

‘Nipride’ is supplied in 5 ml amber-coloured vials containing the
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
* Reg. Trade Mark for sodium nitroprusside ‘Roche’
®Reg. Trdde Mark

Can.8042

(sodium nitroprusside)

Usage in pregnancy

The safety of ‘Nipride’ in women who are or who may become preg
nant has not been established; hence, it should be given only when
the potential benefits have been weighed against possible hazard
to mother and fetus.
Usage in children

The safety of ‘Nipride’ in children has not been established. Clinical
experience is limited.

Hoffm ann-La Roche Limited
Vaudreuil, Quebec
J7V6B3
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Reversal by Protamine of the Prolonged
Response to Intrapulmonary Heparin
C h a r l e s J. W r i g h t , m b , ch b , m sc , f r c s [ c ], f r c s ( e d i n ),*
J aYSEN M aHADOO, PH Df AND LOUIS B. JAQUES, PH D, D SCf

A single large dose of heparin
(2000 units/kg) was administered to
dogs by intratracheal instillation.
Whole blood clotting times and
plasma heparin concentrations were
measured at intervals. At each
interval the calculated dose of
protamine required to neutralize the
circulating heparin was given
intravenously and the measurement
of plasma heparin concentration
repeated. The authors found that the
whole blood clotting time was
prolonged for 24 to 48 hours and there
was a detectable concentration of
heparin in the plasma for 96 hours.
On each occasion the protamine
eliminated the circulating heparin,
but more heparin continued to enter
the circulation. It is hypothesized
that after rapid absorption from the
lung, heparin is stored temporarily
in a cellular pool throughout the body
and then released into the circulation.
At any given time the anticoagulant
effect can be reversed by intravenously
administered protamine sulfate if this
should become necessary, but
repeated administration would be
required. Intrapulmonary heparin
may have useful clinical applications
but further clinical and laboratory
investigations are required.
Chez le chien, une seule dose elevee
d'heparine (2000 unites/kg) a ete
administree par instillation dans la
trachee. Les temps de coagulation du
sang entier et les concentrations
plasmatiques d’heparine ont ete
mesures a divers intervalles. Pour
chaque intervalle, la dose calculee
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de protamine necessaire pour neu
traliser I’heparine circulante a ete
administree par la voie intraveineuse
et la mesure de la concentration
plasmatique en heparine a ete
repetee. Les auteurs ont trouve que
le temps de coagulation du sang entier
etait prolonge pour une periode de
24 a 48 heures et qu’une concentration
mesurable d’heparine etait presente
dans le plasma pendant 96 heures.
A chaque occasion, la protamine a
permis d'eliminer I’heparine circulante,
mais d'autre heparine a continue de
penetrer dans la circulation. On
suppose qu'apres une absorption
pulmonaire rapide, I'heparine est
emmagasinee temporairement dans
un pool cellulaire reparti a travers
I'organisme, puis liberee dans la
circulation. En tout temps, I'effet
anticoagulant peut etre inverse par
('administration intraveineuse de
sulfate de protamine si cela devient
necessaire, mais une administration
repetee est necessaire. L’administration intrapulmonaire d'heparine peut
trouver des applications cliniques
utiles mais d’autres etudes cliniques
et de laboratoire sont requises.

effective and convenient method of
administration. It may also be valu
able for long-term anticoagulation in
patients with cardiac prostheses or
chronic venous problems. This study
was designed to answer the following
question. After a single large loading
dose of heparin has been given via
the lung, how can the anticoagulant
effect be reversed at any time if this
should become necessary?
Methods
Heparin Administration

Heparin (2000 units/kg) was given
by intratracheal instillation to five
dogs (body weight 22.5 ± 3.1 kg,
mean ± 1 standard deviation). The
sodium heparin used was from pig
intestinal mucosa, with an activity of
168.6 units/mg (United States Phar
macopoeia) (Lot LP080178, Cohelfred
Laboratories Inc., Chicago, 111.). Each
dog was lightly anesthetized with
sodium pentobarbital (25 mg/kg
body weight) and placed on a table
inclined at a 20° angle with the head
uppermost. An endotracheal tube was
inserted and a soft rubber catheter
passed through the tube into the
Until the report of Jacques and col lower trachea. The heparin was given
leagues was published in 1976,1 in a volume of 2 to 3 ml and the
it was believed that the lung did not catheter was flushed with an addi
absorb heparin. It had been shown tional 3 ml of saline. The dog was
that heparin given by the intrapul ventilated for 5 minutes and then the
monary route, in doses similar to those endotracheal tube was removed. No
usually given intravenously, caused no respiratory difficulties were encoun
significant change in coagulation.2'5 tered and none of the solution instilled
Jaques and colleagues1 demonstrated was returned.
in dogs, rats, mice and human volun
The whole blood clotting time was
teers that a single large dose (1500 measured by a standard modification
to 2000 units/kg) of heparin into the of the Lee and White10 technique.
lung caused a moderate but prolonged Blood (1 ml) is placed in each of
hypocoagulable state lasting from 2 three glass tubes of internal diameter
days in dogs to 10 days in humans. 8 mm in a water bath at 37°C. The
This has been confirmed in many first tube is gently tilted at 30-secohd
experiments from this laboratory.°'9 intervals until the blood fails to flow
Mahadoo7 has shown that the heparin up the side. The second and third
is rapidly absorbed from the lung and tubes are sequentially handled in the
has suggested that it may exert its same manner, and the end-point is
prolonged effect by slow release from when clotting occurs in the third tube.
temporary storage in a cellular pool
Plasma heparin concentration was
throughout the body.
measured by the thrombin clotting
The prophylactic regimen of low- time assay described by Penner.11
dose heparin is now widely used and
Experimental Procedure
preliminary studies suggest that the
intrapulmonary route may offer an
Venous blood samples were taken
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before the heparin was given anti at
2, 4, 6, 24, 48, 72 and 96 hours after.
At each time interval, the whole blood
clotting time and the plasma heparin
concentration were measured. The
amount of protamine required to neu
tralize the circulating heparin was
calculated from the body weight, the
hematocrit and the plasma heparin
concentration, assuming that the dog’s
blood volume is 8.5% of body weight
and that 1 mg protamine is required
for 100 units of heparin. The cal
culated protamine dose was given by
intravenous bolus injection as pro
tamine sulfate, and 3 to 5 minutes
later the plasma heparin concentra
tion was again measured.
Results

The changes in the whole blood
clotting time are shown in Fig. 1; a
peak of almost three times the control
time was reached 6 hours after the
intrapulmonary administration of he
parin and at 24 hours a small anti
coagulant effect was still present.
There was a significantly positive cor
relation (P < 0.01, linear regression
analysis) between the whole blood
clotting time and the plasma heparin
concentration (Fig. 2). The plasma
heparin concentration and the prota
mine dose injected at each time in
terval are listed in Table I. There was
a measurable concentration of heparin
in the plasma for 96 hours following
the single intrapulmonary dose of
heparin, with a peak level of 0.7 ±
0.45 units/ml at 6 hours. On each
occasion, intravenous injection of the
calculated dose of protamine reduced
the plasma anticoagulant activity to a
very low level. This effect was only
transitory as more heparin continued
to enter the circulation. These data are
illustrated in Fig. 3.
Discussion

Our study confirms that heparin is
present in the circulation for a pro

longed period after a single large intra
pulmonary dose, although the level is
high enough to cause substantial
elevation of the whole blood clotting
time only during the first 24 hours.
The prolonged anticoagulant effect
of intrapulmonary heparin may be
explained by uptake into, and subse
quent release from, a cellular pool.
Mahadoo7 found that in rats given tritiated heparin by intratracheal instilla
tion, 40% of the administered dose
left the lung in W i hours and 90%
was absorbed at 24 hours. The heparin
was found to be taken up by the lym
phatic vessels of the lung, the capillary
vessels and alveolar macrophages. A
marked arteriovenous difference in
plasma heparin concentration has also
been demonstrated, as vascular endo
thelium takes up heparin against a
huge concentration gradient.12 This
work led to the hypothesis that
heparin is distributed throughout the
body from the lung and is then slowly
released back into the circulation from
this cellular pool to cause the moder
ate hypocoagulable state that is ob
served. This hypothesis is currently
under critical investigation.
The subcutaneous low-dose heparin
regimen requires twice daily injections
for 5 to 7 days. A single intrapul
monary injection may provide the

FIG. 1— Whole blood clotting time at
intervals after intratracheal instillation
of 2000 units/kg of heparin. Mean values
± 1 standard deviation. WBCT = whole
blood clotting time.

moderately hypocoagulable state for
the time required for the prophylaxis
of thromboembolic disease. This tech
nique is also potentially useful for
long-term anticoagulant therapy in
patients with vascular prostheses or
with severe recurrent venous throm
bosis. It has already been shown that
intrapulmonary
administration
of
heparin does not cause any changes
in lung function or microscopic ap
pearance,8 and no toxic effects have
been observed either clinically or
radiologically in human volunteers. In
experimental
surgery immediately
after a large dose of heparin was given
into the lung, operations with minimal
tissue dissection proceeded unevent
fully, but in procedures requiring
major tissue dissection there was in
creased postoperative blood loss.9 This
is a well known risk with any prophy
lactic anticoagulant regimen.1315
If intrapulmonary administration of
heparin becomes clinically useful, it
would obviously be desirable to know
how to reverse the anticoagulant effect
at any time if this should be required.
The usual titration schedule for pro
tamine after intravenous administra
tion of heparin is quite well under
stood,18 but there are concerns that
after a large intrapulmonary dose the

FIG. 2— Linear regression analysis of
whole blood clotting time and plasma
heparin concentration (y = 16.7x -|- 4.7,
r = 0.97). There is significant positive
correlation (P < 0.01). PHC = plasma
heparin concentration.

Table 1— Plasma Heparin Concentration and Protam ine Dose at Intervals
afte r Intrapulmonary Instillation of H eparin*

Time
interval, h
Control
2
4
6
24
48
72
96

Plasma heparin
concentration, units/m l
0.16
0.35
0.70
0.26
0.04
0.05
0.08

0
±
±
±
±
±
±
±

Protamine injected, mg

Plasma heparin
concentration after
protamine, units/m l

_
0.09
0.31
0.45
0.20
0.02
0.01
0.02

2.16
4.38
9.10
3.18
0.49
0.70
1.09

‘ Values given as mean ± 1 standard deviation.
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±
±
±
±
±
±
±

_
1.33
3.69
6.85
2.23
0.28
0.26
0.38

0.05
0.08
0.05
0.01
0.04
0.05
0.03

±
±
±
±
±
±
±

0.03
0.05
0.06
0.01
0.03
0.01
0.01

FIG. 3— Plasma heparin concentra
tion at intervals after intratracheal
instillation of 2000 units/kg of heparin,
before and after intravenous administra
tion of calculated dose of protamine.
White bars = PHC, shaded bars = PHC
after protamine was given.
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same schedule would not be appro
priate. The results of this study show
that the anticoagulant effect of he
parin actually in the circulation can
be neutralized effectively at any time
by the usual formula; 1 mg of pro
tamine is required for each 100 units
of heparin. At each time interval
studied, however, the plasma heparin
concentration had risen again (Table
I, Fig. 3), suggesting that more heparin
had entered the circulation after the
previous dose of protamine. It would
probably be necessary to give prota
mine on a titrated basis at hourly in
tervals to neutralize the anticoagulant
effect of the intrapulmonary heparin.
It should be noted, however, that
the dosage of heparin in these experi
ments was equivalent to 140 000 units
in a man weighing 70 kg. Such a
high dose would not be necessary for
the prophylaxis of thromboembolic
disease. A clinical dose-response study

of intrapulmonary heparin in patients
who undergo surgery is now in pro
gress and further experimental studies
are under way to elucidate the ab
sorption and storage of heparin after
administration into the lung.
The expert technical assistance of Mr.
Ed Weber and Miss Judy Klassen is
greatly appreciated.

7.
8.
9.

10.
11.
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SESAP III Question
Items 453-454

After several days of conservative treatment and eight blood transfusions, a 47-year-old Chinese man
with a bleeding duodenal ulcer was treated by vagotomy and antrectomy with Billroth II reconstruction.
On the fifth postoperative day a duodenal fistula became apparent. The wound was placed on sump
drainage, and total parenteral nutrition (TPN) was initiated through a central venous catheter. A stand
ard TPN solution (3000 ml) containing 4.25% amino acids and 20% dextrose was administered daily.
A sump drain placed near the fistula drained 1100 ml, 1240 ml and 980 ml in the next three
days. Urinary tract output was >1000 ml day; glucose and acetone were not detected.
On the eighth postoperative day, plasma electrolytes, which had been within normal ranges on
day 5, were as follows: sodium, 123 mEq/liter; potassium, 3.8 mEq/liter; chloride, 97 mEq/liter;
and total carbon dioxide, 16 mEq/liter. Blood glucose was 180 m g/100 ml.
453. The most probable cause of these findings is

(A)
(B)
(C)
(D)
(E)

elevated blood glucose with expansion of extracellular fluid
under-replacement of abnormal salt loss
water intoxication
third-space shift into the peritoneal cavity
adrenal insufficiency

454. The hemoglobin level decreased from 11.5 gm/100 ml to 9.5 gm/100 ml over a ten-day period and
the patient was transfused with packed red blood cells. Because the cell mixture did not flow well
through a peripheral vein, the transfusion was given through the central venous catheter used for TPN.
After two hours of infusion of packed cells, the patient complained of feeling anxious and jittery,
began to sweat profusely, and became mentally confused.
The most probable cause is

(A)
(B)
(C)
(D)
(E)

air embolism
contaminated blood transfusion
ABO mismatch
hypoglycemia
leukocyte sensitivity reaction

For the two incomplete statements above select for each item the one answer that is best of the five
given.
For the critique of Items 453-454 see page 175 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self-assessment Program
No. 3. For enrolment in the Surgical Education and Self-assessment Program No. 3, please apply to the
American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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a significant advance in

Increased activ ity.
Decreased risk.
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Rapidly bactericidal against sensitive organisms
□

Usually more active against Klebsiella sp, and
Enterobacter sp.

Particularly active against aminoglycosideresistant strains

n e t r o m y c in

□

Active against the majority of strains resistant to
tobramycin and gentamicin
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Active against some amikacin resistant strains
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injectable

netilmicin sulk
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management
Excellent clinical results in a therapeutically
challenging patient population
□

37 studies show 90% clinical cure/improvement.
including some compromised host conditions

□

unusually high rate of pathogen elimination or marked
reduction

□

favorable response even in gentamicin failures

□

excellent results in children, including infants and neonates

90% favorable clinical response (713 of 789 infection sites] in adults and children1

Infection site
Urinary tract
(410)
Respiratory tract
(94)

Resolution
320

Marked
51

Clinical response—
Improvement
Moderate
16

Slight
12

Failure
11

94%

35

36

5

4

14

81%

Septicemia
(104)

65

13

7

1

18

82 h

Skin, soft tissue, bone
(181)

100

50

15

2

14

520

150

19

57

43
________ 1

90%

713/789(90%)

Published studies document effectiveness

Y

"The over-all cure rate of 84,8 per cent as well as the 100 per cent cure rate in the septicemia
K • group compare favorably with study results in patients with similar infections treated with other
aminoglycosides."2
"Nearly all the infections were cured, although the underlying diseases were serious in many of the
patients. In the four instances where other antibiotics were used in conjunction with netilmicin,
synergy was either demonstrated or expected."3

Increased activity.
Decreased risk.
;i si& nifieant advan

netilm icin sulfate

Decreased risk
Rigorous clinical trials bear out safety expectations
demonstrated in 890 courses of therapy,1

Auditory effects probably NETROMYClN-relatedb

4
0.4%

□

no losses exceeded 25 db

□

predisposing factors included old age, neurologic
disorders, prolonged exposure to loud noise

□

pretreatment hearing loss in some patients

□

no case of total deafness recorded

^When adm inistered as recommended. One additional case recorded with 43 days therapy was
c la ssifie d as "not c linic a lly sig nific a nt by investigator."

Rena! effects probably NETROMYCIN-related0
□

pretreafment renal function abnormal or
borderline

□

four age 65 or older

□

one treated with other aminoglycoside
immediately prior to NETROMYCIN

□

multiple host-risk factors present

□

no report of renal failure

cWhen adm inistered as recommended. Three additional cases recorded. Two treated 38 and 57
days. One excessive dosage. One previous am inoglycoside therapy.

MINIMAL ADVERSE REACTIONS IN CHILDREN Clinical studies with pediatric patients also underscore the«
absence of drug related side effects, In a special analysis of 360 courses of therapy in children, infants ^
and neonates, only one patient experienced a reaction considered probably related to NETROMYCIN, *
which was reversed when the dose was lowered to recommended levels.

Increased activity.
Decreased risk.
... a significant advance in amineglycoside therapy

netilmicin sulfate

Twice daily dosage for most infections.

4

PHARMACOKINETICS AND SAFETY PERMIT LESS FREQUENT
DOSAGE in patients with normal renal function, p ea k
serum concentrations (mcg/ml) are usually u p to 3 1/z
times the single IM dose (mg/kg); effective le v e ls persist
for 8 to 12 hours.
NETROMYCIN Serum Concentrations

Systemic or urinary tract infections: The recom
mended dosage of NETROMYCIN Injection for
patients with urinary tract a systemic infections with
normal renai function is 4,0 to 6.0 m g/kg/day given
in three equal doses every eight hours or two equal
doses every twelve hours. In general, within this dose
range, lower dosage will be used for urinary
infections and higher dosage for systemic infections.
For both uses, dosage should be adjusted
depending on severity of infection and patient

condition.

Systemic infections
Twice
daily

150 mg
to
200 mg

150 mg
to
200 mg

Three
times
daily

100 mg
to
150 mg

100 mg
to
150 mg

Urinary tract
infections
150 mg

100 m g"
to
150 mg

150 mg

/

For the average adult (50-80 kg ), depending on 1he severity of infection,
the usual dose is 100 mg to 150 mg administered every 8 hours a 150 mg

to 200 mg every 12 hours for 7 to 14 days.
F a fu ll prescribing information please consult the product monograph.
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Preventing Anaerobic Infection in Surgery of the Colon
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(groupe 2). Bacteroides fragilis et
Escherichia coli ont tous deux ete

A randomized prospective study of
antibiotic prophylaxis was carried out
in patients who underwent elective
surgery of the colon. The wound
infection rate in 70 patients who
received cephradine intravenously
in the perioperative period (group 1)
was 25%, compared with 8% in
60 patients who received metronidazole
and erythromycin base orally before
operation (group 2). Both
Bacteroides fragilis and Escherichia
coli were cultured from the majority
of wound infections in group 1, but
B. fragilis was not found in any group
2 patient. Wound contamination
indicated by wound class or by culture
of the subcutaneous tissue of the
wound before closure was the best
predictor of subsequent wound
infections. These results suggest
a dominant role for intestinal
anaerobes in the genesis of wound
infections after colonic surgery and
show that antibiotics specifically
directed against these organisms
can substantially reduce the rate of
wound infection.

cultives dans la majorite des infections
de plaies du groupe 1 mais 8. fragilis
n'a ete retrouve chez aucun des
patients du groupe 2. Une contamina
tion de plaie indiquee par la
classification de la plaie ou par
culture du tissu sous-cutane de la
plaie avant la fermeture a ete le
meilleur indicateur d'une infection
de plaie subsequente. Ces resultats
indiquent un role dominant des
bacteries anaerobies abdominales dans
I'origine des infections de plaies et
montre que les antibiotiques specifiquement diriges contre ces organismes
peuvent reduire de fagon marquee
le taux d’infection de plaie.

Ten years ago Polk and Lopez-Mayor1
reported the first study of antibiotic
prophylaxis in surgery that was ran
domized, prospective, blind and con
trolled. Among patients having
colonic or rectal surgery, wound in
fection developed in only 4 of 54 who
received cephaloridine perioperatively
compared with 15 of 50 patients who
received a placebo. This clinical study
and others since2’3 have confirmed the
importance of starting antibiotic pro
phylaxis before operation “in the de
cisive period of defence against bac
terial invasion”4,5 and seemed to
establish a role for parenterally ad
ministered cephalosporins in prevent
ing infection resulting from colonic
operations.
More recently, repeated failures of
cephalosporins given prophylactically
in colonic surgery have been noted.8'7
They have been attributed to the fail

Une etude prospective randomisee
sur I'emploi prophylactique des
antibiotiques a ete pratiquee chez
des malades qui ont subi une inter
vention chirurgicale non urgente du
colon. Le taux d’infection de plaie
chez 70 patients qui ont regu de la
cephradine intraveineuse dans la
periode peri-operatoire (groupe 1) fut
de 25% comparativement a 8% chez
60 malades qui ont regu du metro
nidazole et de I’erythromycine base
par voie orale avant I’operation
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ure of cephalosporins to protect
against infection by intestinal an
aerobes.7’8 In fact, some9’10 have sug
gested that prophylaxis need be
directed only against intestinal an
aerobes. In infections following
colonic operations, both intestinal
aerobic and anaerobic bacteria are
found on culture. Which of these
groups is dominant in producing post
operative infection? We recently
examined this question in a prospect
ive randomized study of colonic oper
ations in which two prophylactic anti
biotic regimens were compared, one
effective only against major intestinal
aerobes and the other effective only
against major intestinal anaerobes.
Patients and Methods

Starting in May 1977 all patients
scheduled for elective colonic proce
dures at the Queen Elizabeth Hospital
in Montreal were considered candi
dates for a new antibiotic protocol.
Patients allergic to penicillin and those
who were to undergo operation on a
segment of bowel previously excluded
from the fecal stream by proximal
colostomy were excluded from the
study.
All patients received a standard
mechanical bowel preparation (Table
I) and were then randomized by the
last digit of the year of birth (even
year— group 1, odd year— group 2) to
receive oral or parenteral antibiotic
prophylaxis. Group 1 patients received
1 g cephradine intravenously 1 hour
before operation, 1 g in the recovery
room and 1 g 6 hours after the oper
ation. The patients in group 2 re
ceived metronidazole orally, 750 mg
three times daily for 2 days before
operation and erythromycin base
orally, 1 g three times on the final pre
operative day. At operation swabs for
culture were obtained from the lumen
of the colon and from the subcuta
neous tissue of the wound before
closure; the wound was classified
according to the degree of contamin
ation.11
Wounds were examined on days 5
and 7 after operation, and thereafter
as necessary for up to 1 month.
Wound infection was diagnosed when
pus drained from the wound. A
sample of the pus was then taken for
culture. Mild erythema or induration
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of the wound was observed until it
resolved spontaneously or the wound
drained pus. The age, weight and
height of the patients were noted, as
were the duration of preoperative and
postoperative stay, the duration of
operation “from skin to skin”, the
operative diagnosis and site of oper
ation. The actual body weight was
compared with the patient’s ideal body
weight for height, as determined from
standard tables.12 A risk index of post
operative infection was calculated for
each patient, as recommended by
Davidson and colleagues12 from the
patient’s age, the potential and actual
degree of wound contamination and
from the duration of operation. The
preoperative blood lymphocyte count
was determined for each patient as
the product of the leukocyte count
and the percentage of lymphocytes in
the differential leukocyte count.14 Sta
tistical analysis of the differences be
tween the two groups was by Student’s
7-test and y2 analysis where applicable.
Results

In all, 130 patients were studied, 70
in group 1 (cephradine) and 60 in
group 2 (metronidazole-erythromy
cin). The two groups were evenly
matched with respect to patient age,
body weight, Davidson risk index,
preoperative blood lymphocyte count,
operative diagnosis and site and the
potential degree of contamination of
wounds (Table II). Postoperative sur
gical infections are noted in Table III.
Postoperative pneumonia and urinary
tract infections were seen in 18 pa
tients in group 1 and in 16 patients in
group 2 (P = 0.97).
Most of the 18 wound infections in
group 1 yielded both Bacteroides fra
gilis and Escherichia coli on culture.
B. fragilis was cultured from 14 of
the 18 wounds, 2 yielding a pure
culture; E. coli was cultured from 15
wounds, 1 giving a pure isolate. In
group 2 there were five wound in
fections, none of which were due to
B. fragilis; E. coli was cultured in all
and group D streptococci in one of
the five (Table IV). In two group 1
patients and one group 2 patient,
E. coli cultured from the infected
wounds was resistant to cephradine.
Cultures obtained from the lumen
of the colon yielded an average of
three organism types per patient in
group 1 and two types in group 2. In
group 1 E. coli was isolated from 49
of 54 specimens, other coliforms from
12, B. fragilis from 29 and other an
aerobic bacteria (Clostridium, Peptococcus, Peptostreptococcus and diph
140

theroids) from 14 of the 54 specimens.
In group 2, the organisms isolated
were E. coli in 23 of 41 specimens and
group D streptococci in 10, but B.
fragilis and other intestinal anaerobes
were not isolated from a single spe
cimen in group 2.
The best predictor of the develop
ment of postoperative infection was
the degree of potential or actual
wound contamination during operation
(P < 0.0001 and P < 0.01, respect
ively) (Table V). The mean preoper
ative blood lymphocyte count in those
patients who had infection postoperatively was similar to that in the
patients whose wounds remained un
infected (Table V).
Discussion

Meticulous attention to technique
to avoid gross contamination is the
best way to prevent wound infection
after colonic surgery. We have shown
once again that even in patients given
antibiotics, intraoperative contamina
tion results in an increased rate of
infection
postoperatively.
Unfor
tunately, in certain procedures, such
as difficult abdominoperineal resec
tion, low anterior resection, closure or
creation of a colostomy, some conta
mination may occur and one must use

antibiotic prophylaxis to decrease the
risk of wound infection. Which anti
biotic should be used and how should
it be given?
Our results suggest a predominant
role for intestinal anaerobic bacteria
in the development of sepsis after
colonic surgery. This is clearly ,indicated by the following:
• Wound infections were caused
by intestinal bacteria.
• Infection rate increased with
intraoperative contamination.
• Enteric bacteria were grown in
cultures from the wounds.
• When anaerobes persisted in the
bowel lumen after preparation, a high
rate of wound infection followed.
• Anaerobes were implicated in
the majority of wound infections.
• When anaerobes were eliminated
from the lumen of the bowel, the
wound infection rate decreased
markedly and anaerobic bacteria were
not grown from any infected wound.
• Aerobic gram-negative bacteria
remaining in the bowel lumen were
then only infrequently the cause of
postoperative infection.
• An antibiotic combination ef
fective against anaerobic bacteria
alone reduced the infection rate after
colonic surgery.

Table I I — Comparison of Patient Groups

Factor
Age, yr*
Weight (ac tu al/id ea l), % *
Risk index*
No. of clean-contaminated wounds
Preoperative lymphocyte count, X10!'/l *
Diagnosis and procedure, no. of
wound infections/no. of cases
Carcinoma
Inflammation
Resection of right colon
Resection of left colon or rectum
Resection of transverse colon
Other

Group 1,
cephradine
(n = 70)

Group 2,
metronidazole erythromycin
(n = 60)

66.6 ± 1.4
113.3 ± 2
25.4 ± 3
51
1.931 ± 0.104

65.7 ± 1.9
109.7 ± 2.5
30.1 ± 0.8
47
1.867 ± 0.102

15/60
3/10
4/14
8/37
5/15
1/4

3/47
2/13
1/18
3/34
1/4
0/4

♦Mean ± standard error of mean.

Table III

Incidence of Postoperative Surgical Infection

Type of infection
Wound
Other surgical
Anastomotic leaks
Intra-abdom inal-intrapelvic
Drain site
Bacteremia
Total surgical

Group 1
(n = 70)

Group 2
(n = 60)

18
8*
3
5
0
2
25f

5
1
0
0
1
0
6

P value
<0.01
<0.03

<0.0007

♦Bacteremia in 1 patient w ith a subphrenic abscess and in 1 patient with an anastomotic leak.
tSubphrenic abscess and bacteremia in 1 patient with a wound infection.
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than in peritonitis. Kelly18 has shown
that synergy between subinfective
doses of E. coli and B. fragilis may
result in wound infections in guinea
pigs; this may explain the clinical suc
cess in preventing infection in colonic
surgery of cephaloridine1’3 and cefa
zolin,2 which kill E. coli but not B.
fragilis. If this is correct, the success
of metronidazole-erythromycin and
failure of cephradine in the present
study suggest that anaerobes are more
important than aerobic bacteria in
producing postoperative infection.
But cephradine may have failed in
our study because of pharmacody
namic factors rather than the in
adequacy of its spectrum. Moreover,
it may be difficult to differentiate the
two causes. Thus Keighley and
associates19 attributed the failure of
orally as opposed to parenterally ad
ministered metronidazole and kanamycin to lack of efficacy of oral me
tronidazole in colonic surgery. But
when their results are compared to
those of Richards and associates,20
which showed that orally and parent
erally administered metronidazole
were equally successful in prophylaxis,
it is clear that Keighley’s failures with
metronidazole were due to inadequate
serum levels reached with the dosage
selected for oral administration.
We did not measure serum anti
biotic levels. However, our oral metro
nidazole regimen was the same as
that of Richards whose subjects
reached a mean serum metronidazole
level at the time of operation of 15.2
u.g/ml; our intravenous cephradine
regimen was similar to that used more
successfully by Finch and colleagues21
and Vaughan.22 Neither of these
authors reported serum cephradine
levels, but the expected serum levels
in our study 1 and 2 hours after ad
ministration, would be approximately
10 y.g/ml and 4 ag/ml, respectively23
—just adequate for killing coliform
organisms.24 Since the rate of sepsis
did not differ between operations last
ing less than 1 hour or more than 1

Onderdonk and associates15 have
recently suggested that metronidazole
metabolites inhibit or destroy E. coli
in vitro and in vivo. However, in the
present study some infections due to
aerobic gram-negative organisms oc
curred despite metronidazole prophy
laxis. Indeed, the results of this study
raise serious questions as to how best
to prevent these infections, for sys
temic cephradine administered perioperatively also failed to prevent
them.
The striking variance in results be
tween the two treatment groups in our
study may be due to the difference
in spectrum of antibiotics selected for
prophylaxis or to pharmacodynamic
factors that reduce the effectiveness of
the antibiotics chosen. The antibiotic
spectrum is obviously important but
still controversial. Which bacteria pro
duce abscesses and which antibiotics
best prevent abscess formation? In
experimentally induced peritonitis
Onderdonk and associates15 found that
gram-negative aerobic bacteria of the
colon caused toxic infection and death
whereas anaerobic bacteria such as B.
fragilis, when associated with aerobic
bacteria, produced abscesses in sur
viving animals. At the same time,
Weinstein and associates17 found that
to prevent abscess formation an anti
biotic specifically effective against
anaerobic bacteria was required. How
ever, this finding may not apply to
antibiotic prophylaxis of wound in
fection, where the number of infect
ing bacteria may be much smaller

Table ll/~B acteriology of Wound Infections

Organism

Escherichia coli
Bacteroides fragilis
Group D streptococci

Staphylococcus
Pseudomonas
Proteus

Group 1
(n = 18)

Group 2
(n = 5)

14
15

5
0
1
0
0
0

3
1
1
3

Table V
Predictor
Wound classification
Contaminated
Clean-contaminated
Culture of subcutaneous tissue
Positive culture
No growth
Mean preoperative blood
lymphocyte count, X108/ l *

hour, it is likely that our cephradine
regimen was at least marginally ade
quate, pharmacodynamically. After a
similar failure of cephalothin pro
phylaxis in colonic surgery, Burdon
and coworkers6 doubled the dose of
cephalothin but saw no improvement
in the high postoperative infection
rate. These results are, however, at
variance with the findings of Louie
and associates23 in experimental peri
tonitis, where high doses of cephalo
thin were more successful than low
doses in preventing abscess forma
tion.
Since our results with systemically
administered cephradine prophylaxis
in this study differ from our own
previous results3 with cephaloridine
and from those of Polk and LopezMayor1 and because serum antibiotic
levels of cephradine are generally
lower and of shorter duration than
those of cephaloridine or cefazolin,23
we are now repeating the study, meas
uring serum antibiotic levels and using
high-dose systemic prophylaxis with
cefazolin.
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Because “biphasic infection”
threatens to complicate surgery
of the large bowel...

control sepsis with
an antibiotic to arrest primary
gram-negative aerobic infection
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DalacinC

Phosphate S.S

(Clindamycin Phosphate Injection N.F.)

to treat or prevent
secondary abscess formation
k Rupture of the large bowel can result in contam i
nation of surrounding tissues with gram-negative
pathogens initiating primary aerobic infection. While
the primary infection often responds to a gram-negative
, antibiotic, e.g. gentamicin, secondary anaerobic
invaders may persist and produce abscess formation.
T his“biphasic infection” process increases morbidity
and delays recovery.
k Dalacin C Phosphate IV during and following surgery to
► control anaerobes such as Bacteroides frag iIis, along with
appropriate antibiotic therapy to control gram-negative
aerobic pathogens, can prevent abscess formation,
reduce m orbidity and speed recovery.
THE UPJOHN COMPANY OF CANADA
865 YORK MILLS ROAD / DON MILLS, ONTARIO
CE 1905.1
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Indications: Oalacin C Phosphate (clindam ycin phosphate in jection N.F.) Dalacin C Phosphate Sterile Solution is indicated for the treatmerit of in fe c tio n s where the oral route is not indicated or feasible.
Clindam ycin phosphate is in dicated in the treatm ent of serious in fe c tio n s due to sensitive anaerobic bacteria, such as Bacteroides
species, pep tostre pto coccus, anaerobic streptococci, C lostridium species and m icro-aerophilic streptococci.
Clindam ycin phosphate is also indicated in serious in fe c tio n s due to sensitive Gram positive organism s staphylococci (including p e n ic il
linase-producing staphylococci), stre p to c o c c i and pneum ococci when the patient is intolerant of, or the organism resistant to, other
appropriate a ntib iotics.
Contraindications: The use o f Dalacin C Phosphate is contraind icated in patients previously found to be hypersensitive to this com pound
the parent com pound, clindam ycin , or clindam ycin palm itate. A lth ough cross-se nsitizatio n w ith Lincocin (lincom ycin) has not been
dem onstrated, it is recom m ended that Dalacin C Phosphate not be used in patients who have dem onstrated lincom ycin sensitivity. Until
further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (infants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhoea have been reported during or after therapy w ith Dalacin C Phosphate. This
diarrhoea has been occasionally associated w ith blood and mucus in the s to o ls and has at tim es resulted in acute colitis . When endoscopy
has been perform ed, som e of these cases have shown pseudom em brane form ation.
If sig n ifica n t diarrhoea occurs during therapy, this drug should be d iscontinued or, if necessary, continued only w ith close observation.
S ignificant diarrhoea oc curring up to several weeks post-therapy should be managed as if antibiotic-associated.
If c o litis is suspected, pnd oscopy is recommended. M ild cases show ing m inim al m ucosal changes may respond to sim ple drug dis 
continuance. Moderate to severe cases, including those show ing ulceration or pseudom em brane form ation, should be managed w ith fluid,
electrolyte, and protein supp lem entation as indicated. C o rticoid retention enemas and system ic c orticoid s may be of help in persistent
cases. An tic h o lin e rg ic s and a n tip e ris ta ltic agents may worsen the c ond ition. Other causes of c o litis should be considered.
Precautions: Dalacin C Phosphate, like any drug, should be prescribed w ith caution in atopic individuals.
The use of a n tib io tic s occasionally results in over-growth of non susceptible organism s - particularly yeasts. Should superinfections occur
appropriate m easures-should be taken as dictated by the c linica l situation.
Since abnorm alities of liver fu n c tio n te s ts have been noted occasionally in anim als and man, periodic liver function tests should be per
form ed during prolonged therapy. Blood coun ts should also be m onitored during extended therapy.
As w ith all antib io tics, perform cultu re and sensitivity studies in c o n ju n c tio n w ith drug therapy.
Clindam ycin phosphate may be used in anuretic patients and patients w ith im paired liver function. The serum half-life o f clindam ycin
phosphate in patients w ith m arkedly reduced renal fu n c tio n is greater than that of the half-life of the com pound in normal patients. The
dose of clindam ycin phosphate should, therefore, be appropriately decreased. Haem odialysis and peritoneal dialysis are not effective
means of rem oving the com pound from the blood. Periodic serum levels of clindam ycin should be determ ined in patients w ith severe renal
insufficiency.
Adverse Reactions: Local.
(a) Intram uscular Inje ctio n s: Of 404 p atie nts treated w ith clindam ycin phosphate intram uscularly (with a solution containing 150 m g/m l),
six (1.5%) dem onstrated local reactions as follows: Two com plained of pain at the in jection site, tw o dem onstrated induration at the in je c
tion site and tw o developed sterile abscesses.
(b) Intravenous Infusion: Of 192 p atie nts treated w ith clindam ycin phosphate by intravenous infusion, 14 (7.3%) dem onstrated local
reactions. Eleven patie nts developed supe rficial thro m bo phleb itis and one patient developed both superficial and deep throm bophlebitis.
The m ajority of these cases developed in conjunction w ith the use of in dw elling IV catheters and it is d iffic u lt to know how much the drug
contributed to the irrita tio n . Two p atie nts developed localized erythem a, sw elling and pain at the site o f the infusion.
Systemic Side Effects: Tw enty-eight p atie nts of 596 treated w ith c lindam ycin phosphate by either the intram uscular or intravenous routes
developed system ic side effe c ts as follow s:
Number o f Patients
Ra s h .......................................................................................................... 7
U rtica ria .....................................................................................................1
P ru ritis .......................................................................................................1
Fever, L e u c o c y to s is ............................................................................... 1
Nausea, w ith or w ith o u t v o m itin g ........................................................1
Diarrhoea (See also under “ W arnings” ) ............................................ 4

Num ber o f Patients
H yp ote nsion................................................................................................ 1
H y p e rte n s io n .............................................................................................. 1
Shortness of B re a th .................................................................................. 1
S u p e rin fe c tio n *..........................................................................................4
C ardiac arrest* * ...................................................................................... 1
Bad or b itter taste in m o u th ...................................................................... 5

'S u p e rin fe ctio n is a com p lic a tio n of a n tib io tic therapy in general and is not necessarily a true side effe c t of clindam ycin phosphate.
* * Due to underlying m yocarditis in th is patient.
Clinical and Laboratory Findings: P atients treated during clinica l trials of clindam ycin phosphate were followed w ith clin ic a l laboratory
tests, including com plete haematology, urinalysis and liver and kidney fu n c tio n tests. Some of these tests were abnormal in itia lly and
returned to norm al during therapy w ith clindam ycin phosphate, w hile others were norm al in itia lly and became abnormal during therapy.
Overall evaluation of c lin ic a l laboratory values in these patients does not indicate that clindam ycin phosphate therapy has a toxic effect on
the haem atopoietic, hepatic or renal system s. Transient elevations of serum transam inases have occurred in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not show n any tendency to increase and there have been no clin ic a l signs of
drug-induced hepatic toxicity.
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No sp e cific antidote is known. Doses as high as
1200 mg every six hours (4800 mg/day) by infusion for five days have been given w ith out adverse effect.
DOSAGE AND ADMINISTRATION
Adults
Intram uscular Injectio n: 600 m g /d a y in tw o equal doses.
M oderately severe in fe c tio n s : 600 to 1200 m g/day in tw o or three equal doses.
Severe in fe c tio n s : 1200 to 2400 m g /d a y in two. three or fo u r equal doses. Intram uscular in je c tio n s of more than 600 mg in to a single site
are not recom mended.
Intravenous A d m in is tra tio n : Dalacin C Phosphate m ust be diluted prior to IV adm in istratio n to a d ilution of 300 mg in 50 ml of diluent
(6 m g /m l) or more, and infused in not less than 10 m inutes. A d m inistra tion o f m ore than 1200 mg in a single one-hour infusion is not recom 
mended. Dalacin C Phosphate should not be injected intravenously und ilu ted as a bolus.
M oderately severe in fe c tio n s : 900 to 1800 m g/day by contin uous drip or in tw o or three equal doses, each infused over 20 m inutes or longer.
Severe in fe c tio n s 1800 to 2700 m g /d a y by continuous drip or in three or four equal doses, each infused over 20 m inutes or longer. In lifethreatening in fectio ns, doses of 2700 to 4800 m g/day by continuous drip or in three or four equal doses each infused over 20 m inutes or
longer may be given.
Children: (Over one m onth o f age)
Intram uscular Injectio n: 10 to 1 5 m g /k g /d a y in two, three or four equal doses.
M oderately severe in fe c tio n s : 15 to 20 m g /k g /d a y in three or four equal doses.
Severe in fe c tio n s : 20 to 30 m g /k g /d a y in three or four equal doses.
Intravenous Administration:
M oderately severe in fe c tio n s : 15 to 25 m g /k g /d a y by contin uous drip or in three or fo u r equal doses, each infused over 20 m inutes or
longer. In severe in fe ctio n s, it is recom m ended that children be given not less than 300 m g /d a y regardless of body weight. (Dilute Dalacin C
Phosphate Sterile S o lution in the same manner as for adults.)
AVAILABILITY:
Oalacin C Phosphate Sterile Solution - Each ml contains clindam ycin phosphate equivalent to clindam ycin base 150 mg in 2 ml ampoules.
Product M onograph available upon request.
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The Palliative Value of Surgical Resection
for Carcinoma of the Esophagus
J.D. Cooper ,

md , frcs [c],

W.R.E. J amieson ,
R. I lves, md, frcs [c]

The authors review their experience
with primary resection for carcinoma
of the esophagus and compare the
palliative results with those of a
recently reported series of similar
patients treated with radiotherapy
alone. Between 1971 and 1977,
104 patients with carcinoma of the
esophagus underwent resection as
the primary therapy. The operative
mortality was 7.7% (1.7% in the latter
half of the series). At least 80%
of the 104 patients had complete,
continuing palliation of their dysphagia.
Radiotherapy in a similar group of
patients reported resulted in an 8%
mortality from complications of
the treatment and there was local
recurrence of the tumour, usually
associated with dysphagia, in 80%.
The authors conclude that the
palliation achieved with surgical
resection is substantially better than
that achieved with radical radiotherapy
applied to a similarly staged group
of patients with carcinoma of the
esophagus.
Les auteurs passent en revue les
resultats qu’ils ont obtenus par
la resection primaire du cancer de
I'oesophage et comparent les resultats
palliatifs avec ceux qui ont ete decrits
recemment dans un groupe de patients
similaires traites par radiotherapie
uniquement. Entre 1971 et 1977,
104 malades souffrant d'un cancer de
I'oesophage en ont subi la resection
comme mode primaire de traitement.
La mortalite operatoire fut de 7.7%
(1.7% dans la seconde moitie de la
serie). Au moins 80% des 104
patients ont beneficie d'un soulagement
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continu et complet de leur dysphagie.
On a signale dans un groupe similaire
de malades traites par radiotherapie,
une mortalite de 8% resultant des
complications du traitement, et une
recidive locale de la tumeur,
habituellement associee a une
dysphagie, dans 80% des cas. Les
auteurs concluent que ['amelioration
obtenue par resection chirurgicale est
nettement superieure a celle qui
suit une radiotherapie radicaie chez
des groupes de patients aux memes
stades clinique du cancer de
I'oesophage.

Carcinoma of the esophagus, in most
symptomatic patients, is already in
curable when the diagnosis is made.
Treatment will be palliative for more
than 90% of such patients. These
tumours frequently result in disabling
esophageal obstruction and weight
loss. While the outlook is discour
aging, the achievement of worthwhile
palliation is an important and chal
lenging problem for thoracic surgeons.
The surgical treatment of carcinoma
of the esophagus is therefore aimed
primarily at producing the best pal
liation, specifically the restoration of
normal swallowing as quickly as pos
sible for as long as possible.
Surgical therapy for carcinoma of
the esophagus is based upon several
assumptions:
• A one-stage procedure, com
bining resection of the tumour with
restoration of gastrointestinal conti
nuity, offers the best palliation.
• Most resections are clearly pal
liative in nature. Frequently this is
apparent at the time of operation
when lymphatic spread is found. Even
in apparently favourable cases, the
rate of tumour recurrence is high.
• Operation must therefore be
accomplished with a minimum of mor
bidity and postoperative hospital stay.
• In a small number of patients
resection does result in a long-term
cure which may be viewed as an un
predictable bonus.
Radical radiotherapy offers an al
ternative means by which palliation
can be attempted. The goals of radio
therapy and surgery in the treatment
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of carcinoma of the esophagus are
much the same.
In the view of most surgeons
experienced in treating cancer of the
esophagus, surgical resection produces
a quality and duration of palliation
which is sufficiently superior to that
produced by radiotherapy to justify
the nature and magnitude of the oper
ation required.
Patients and Methods

The opportunity to compare the
palliative results of surgery with those
obtained by radical radiotherapy was
afforded by a recent, well documented
report from the Princess Margaret
Hospital in Toronto.1 That report
presented a complete follow-up of 146
patients with localized carcinoma of
the esophagus, who were treated by
radical radiotherapy alone, between
1969 and 1975. An additional 168
patients in the series, treated palliatively by radiotherapy for more ad
vanced carcinoma, are excluded from
the following analysis. Using this
report as a model, we analysed the
results in 104 patients with carcinoma
of the esophagus who underwent
resection at the Toronto General
Hospital between January 1971 and
July 1977. Follow-up is complete as
of July 1979 (minimum of 2 years).
In both the radiotherapy and re
section groups, the criterion for in
clusion in the series was the same—the
tumour must be localized without
evidence of local or distant spread at
the time of treatment. In both series,
carcinomas of the hypopharynx and
postcricoid regions were excluded
from the analysis.
The patients who received radical
radiotherapy in the Princess Marg&ret
series were considered potentially
curable. Approximately 95% of pa
tients had squamous cell carcinoma
and 5% had adenocarcinoma. They
received between 4000 and 6000 rad
over 3 to 5 weeks.
The patients who underwent resec
tion were similarly considered poten
tially curable on the basis of the pre
operative investigations. At the time of
operation, of course, many patients
clearly had incurable disease but re-
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section was none the less performed
as a palliative procedure.
Two types of surgical procedure
were used predominantly. For tumour
of the lower esophagus or cardia,
the distal esophagus and proximal
stomach were resected through a left
thoracoabdominal incision, and an
astomosis between the residual eso
phagus and stomach was carried out
in the chest. For tumours of the upper
or middle esophagus and, in recent
years, for tumours of the lower eso
phagus as well, total esophagectomy
was performed. The stomach was
mobilized through a midline ab
dominal incision, the esophagectomy
was performed through an anterior
right fourth interspace thoracotomy,
and the stomach anastomosed to the
cervical esophagus through a separate
cervical incision.
The surgical series consisted of
equal numbers of squamous cell car
cinoma and adenocarcinoma and the
results were analysed for the whole
group and for each cell type separ
ately. We attempted to analyse the
results of operation in terms of pal
liative benefit, as did the previously
noted report of radiotherapy. Both
series suffer from being retrospective
studies without the detailed and ac
curate documentation of the relief
from dysphagia that a prospective
study would provide. Nevertheless,
from the number of cases of local
tumour recurrence and of persistent
or recurrent malignant or nonmalignant stricture, the quality of palliation
can be surmised.
The survival figures were calculated
using the actuarial method as was used
in the radiotherapy series. Deaths
occurring within 30 days of operation
were considered as operative deaths.
Data on recurrence of benign or
malignant strictures were obtained
from the patients' hospital files,
records from physicians’ offices,
autopsy reports and telephone inter
views with the patients or their fam
ilies.

the 104 patients was 18 months (in
cluding the operative deaths). The 17
surviving patients have lived a mean
of 18 months while the patients
who died had an average postoperative
survival of 16 months (including the
operative deaths). The actuarial sur
vival rates for all patients is shown
in Table I which also shows the results
following radical radiotherapy as re
ported from the Princess Margaret
Hospital.
Palliation

In the absence of a prospective
evaluation of the quality of swallow
ing function, the results of resection
were compared with the results of
radiotherapy from the standpoint of
persistent or recurrent tumour in the
esophagus, or persistent or recurrent
stricture formation. Of the patients
who underwent resection, 17 (16%)
had a proven or suspected local recur
rence and 6 (6%) patients had an
apparently benign stricture. This often
responded to a single dilatation.
Discussion

In the series of potentially curable
patients treated with radical radio
therapy at the Princess Margaret Hos
pital, 8% of patients died of eso
phageal hemorrhage, 7% had radiol
ogic evidence of pulmonary fibrosis
and 25% required subsequent opera
tion for palliation of severe dysphagia
(7 esophageal intubation, 7 gastro
stomy, 11 esophageal bypass, 6 pal
liative resection).
Apparently the overall morbidity
and mortality rates following surgical
resection do not exceed those resulting
from radical radiotherapy for car
cinoma of the esophagus. In recent
years, the operative mortality for
resection of carcinoma of the eso
phagus at our institution as well as at
other centres has dropped to less
than 5% .2-3
The actuarial survival in the sur

gical series (including operative mor
tality) was somewhat better than that
achieved with radical radiotherapy.
However, for the treatment of squa
mous cell carcinoma alone, the sur
vival rates were comparable.
Analysis of the radiotherapy results
from the Princess Margaret Hospital
indicated an estimated local recur
rence rate of 80% compared with
20% for the patients in our series,
who
underwent
resection
with
long-term survival. Not all of our
patients with local recurrence had
dysphagia, but for the purposes of
comparison, it is fair to conclude that
at least 80% of our patients had satis
factory relief of dysphagia. This is
consistent with reports from other
centres2-4 indicating that 90% of
patients had unobstructed swallowing
following surgical resection for car
cinoma of the esophagus. Further
more, following surgical resection
there is generally prompt and com
plete relief of dysphagia. Dysphagia
in the radiotherapy group, however,
usually resolved slowly or not at all.
As a result of this retrospective
study, it is apparent that a more de
tailed, prospective evaluation of the
quality of palliation is necessary for
a true assessment of results following
various treatments for carcinoma of
the esophagus.
The combination of preoperative
radiotherapy and surgical resection
has been advocated by many treat
ment centres.510 The dose of radiation
generally varies between 2000 and
6000 rad. The postoperative mortality
in these series is high, averaging
approximately 20%. It is probable
that preoperative radiotherapy has
contributed to this increased mor
tality, though an operative mortality
of 20% has been reported in some
series in the absence of adjuvant radio
therapy.
The palliation achieved with sur
gical resection appears more predict
able, more complete and more durable
than that achieved with radical radio-

Results
Table I— Actuarial Survival following Treatm ent for Carcinoma of the Esophagus

Morbidity and Mortality

There were eight (7.7%) operative
deaths in our series. There were 15
anastomotic leaks (14%), 2 of which
were responsible for operative death.
It is of note that between Jan. 1, 1974
and June 30, 1977 there were 58
resections with only one (1.7%) death
and three (5%) anastomotic leaks.
Survival

Survival

(% )

following

Surgical resection
Length of
survival, yr

Squamous
carcinoma

Adenocarcinoma

Overall

Radical radiotherapy

1
2
3
4

37.3
24.5
14.7
11.8

42.3
28.5
24.1
9.0

39.8
26.4
19.5
10.5

39
20
10
Not given

♦From B eatty and colleagues.1

The average length of survival for
146
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therapy applied to a similarly staged
group of patients with carcinoma of
the esophagus. The value of adjuvant
radiotherapy or chemotherapy requires
continuing reassessment because of the
overall poor prognosis still associated
with all stages of this condition.
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Tolerance of the Liver to Ischemia:
an Experimental Study
C.M. F ein d el ,

md,

R. H arper ,

The experiments described in this
study challenge the 20th century belief
that the liver is particularly vulnerable
to deprivation of its blood supply for
appreciable periods of time. The
authors studied the effects of
60 minutes of normothermic hepatic
ischemia on 10 pigs. The hepatic
artery and its collateral vessels were
occluded and portal blood was
diverted by a portojugular shunt.
This produced a 90% reduction in
liver blood flow as determined by
xenon-127 washout. None of the
animals died of liver failure.
The ischemic insult did not produce
jaundice in any of the animals and
only minimal transient changes in liver
enzymes occurred. The results
suggest that the liver is capable
of withstanding prolonged periods
of ischemia.
Les experiences decrites dans cette
etude defient cette croyance du
20° siecle voulant que le foie soit
particulierement vulnerable a une
insuffisance de I’apport sanguin
pendant une periode appreciable de
temps. Les auteurs ont etudie les
effets d’un ischemie hepatique de
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60 minutes a temperature normale
chez 10 pores. L'artere hepatique et
ses vaisseaux collateraux ont ete
obtures et le sang porte a ete
derive par une anastomose portejugulaire. Ceci entraina une reduction
de 90% du debit sanguin hepatique
determinee par I’epreuve d'epuration
du xenon 127. Aucun des animaux
n’est mort d'insuffisance hepatique.
L'ischemie n'a provoque d'ictere
chez aucun des animaux et seuls des
changements transitoires minimes
des enzymes hepatiques sont survenus.
Ces resultats indiquent que le foie
est capable de supporter des
periodes d'ischemie prolongees.

Since Pringle' at the beginning of this
century described the maneuver of
portal compression to arrest hemor
rhage of the liver, it has generally
been accepted that interruption of
blood supply to the liver for periods
of longer than 15 minutes is unsafe
and may cause massive hepatic
necrosis.2 The concept has been sup
ported by experiments in dogs in
which death followed ligation of the
hepatic artery or temporary occlusion
of portal and arterial flow for periods
as short as 30 to 40 minutes.3'5 Al
though these observations were cor
rect, two unique physiologic proper
ties of the dog make any analogy to
liver ischemia in man tenuous. First,
portal vein blood in the dog contains
clostridial organisms. After ligation
of the hepatic artery death occurs
from clostridial necrosis of the liver
rather than from hepatic ischemia.6
Second, liver ischemia stimulates con
traction of canine hepatic vein sphinc
ters which produce “outflow block”,7'9

W.J. W all ,
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causing hepatic and splanchnic engor
gement,
progressive
hypotension,
acidosis and death. In spite of these
differences between dog and man, the
concept of the liver’s susceptibility to
ischemic injury persists.
The pig does not have the draw
backs of the dog and Battersby and
associates10 have shown that the pig
will tolerate 30 minutes of normother
mic hepatic ischemia with minimal
damage to the liver. We report herein
our experiments in pigs with 60
minutes of hepatic ischemia.
Animals and Methods

Ten Yorkshire pigs (weight ap
proximately 15 kg) were fed a regular
diet until the day of operation. On
the day of operation the animals were
sedated with Alfathesin, intubated and
ventilated with a mixture of oxygen,
room air and halothane. Blood pres
sure, pulse rate, the electrocardiogram
and rectal temperature were moni
tored continuously during the oper
ation.
The liver was exposed through a
midline incision and its ligamentous
attachments to the diaphragm and
posterior abdominal wall were divided.
The portal vein, hepatic artery and
common bile duct were isolated. Fol
lowing heparinization (2 mg/ kg) the
hepatic artery and its collateral vessels,
including the gastroduodenal artery,
were occluded (Fig. 1). The portal
vein was clamped and the common
bile duct occluded. To decompress the
portal system an opening was made
in the portal vein and a cannula in
serted for diverting the total portal
flow to the jugular vein through an
external Silastic shunt.
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After 60 minutes of vascular occlu
sion the arterial clamps were released,
the portojugular shunt was removed
and the opening in the portal vein
was repaired with running 5-0 Prolene
sutures. Restoration of pulses in the
hepatic artery was verified in each
case. The action of the heparin was
reversed with protamine sulfate (10
mg) and the incisions were closed.
Body temperature was maintained
above 37°C and systolic blood pres
sure remained above 80 mm Hg
during operation. Light anesthesia was
used and each animal received 1000
ml of normal saline during the proce
dure. The animals were fed a stand
ard diet from the first postoperative
day onwards and no additional sup
portive measures were given.
In five of the animals liver blood
flow was determined immediately
before and during the period of vas
cular occlusion by the clearance of an
intraparenchymal injection of xenon127 (Brookhaven National Labora
tories, Upton, NY) (100 u.Ci dissolved
in 0.1 ml saline). Radioactivity was
recorded with a sodium iodide scin
tillation crystal placed over the liver.
The signals were passed through a
pulse-height analyser and recorded
(Picker analyser and linear instru
ments
recorder; Picker
Corp.,
Cleveland, Ohio). Blood flow was
calculated from the clearance curves
by the following formula:

clinically, biochemically or histologic
ally. The rest of the pigs ate and
behaved normally in the postoperative
period and none of the animals, in
cluding the one that died, had
jaundice.
Liver blood flow, measured in five
of the animals, was reduced from a
control value (± standard deviation)
of 46 ± 14 m l/100 mg each minute
to 4.5 ± 0.6 ml/100 mg each minute
during ischemia (Fig. 2). This repre
sents a reduction in liver blood flow
of more than 90%. (Subsequent
experiments in 20 animals have con
firmed these results.)
The tests of liver function are
shown in Figs. 3 to 5. The mean

SGOT increased significantly (P <
0.05) 60 minutes after restoring blood
flow. It had returned to normal values
by the second postoperative day. A
smaller increase in the SGPT occurred
at 60 minutes and on the first day
after blood flow was restored (Fig. 4)
but this was not statistically signif
icant.
Gross examination of the livers
after the animals were killed showed
no abnormalities and few were seen
histologically. There were no archi
tectural disturbances and no areas of
parenchymal necrosis (Fig. 6). Occa
sional mitoses were seen in the liver

FIG. 3—Mean (± SD) serum glutamic
oxaloacetic transaminase values in 10
animals. PRE = preischemia and min
utes and days denote time after blood
flow was restored to liver. Increase at
60 minutes following restoration is sig
nificant (P < 0.05).

flow = 161 X Dml/100 g/min,
where D is the fraction of one decade
the slope decrease in 1 minute.11
A blood-tissue partition coefficient of
0.7 was used.12
Venous blood samples from an
indwelling superior vena caval catheter
were taken before inducing ischemia,
at 1, 5, 10 and 60 minutes following
restoration of flow and on days 1,
2 and 3 postoperatively for the follow
ing serum determinations: glutamic
oxaloacetic transaminase (SGOT), glu
tamic pyruvic transaminase (SGPT)
and bilirubin. Statistical analysis was
performed using the paired Student’s
/-test.
Survival for 10 days after operation
was considered a successful outcome
at which time the animals were killed
and the livers were examined grossly
and microscopically.

FIG. 1—Model for liver ischemia.
Hepatic artery (HA), gastroduodenal ar
tery (GD) and collateral branches are
occluded. Portal vein (PV) blood is
diverted to jugular vein (JV) through
shunt (ST).

FIG. 4—Increase in mean (± SD)
serum glutamic pyruvic transaminase
values at 60 minutes and on postoperative
day 1 was not significant.

Results

Nine of the 10 pigs survived for the
10-day period. One animal died 6
days after operation from protracted
vomiting and dehydration. It showed
no evidence of acute liver necrosis
148

FIG. 2—Liver blood flow measure
ments (± standard deviation) before and
during ischemia in five animals showing
average 90% reduction in flow.
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FIG. 5—No significant change in
mean (± SD) serum bilirubin value in
10 pigs.
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organ, are an ideal energy source dur
ing hypoxia.22 The pigs in this experi
ment were fed until the day of oper
ation and therefore the liver cells
would have been rich in glycogen.
• The liver is unsurpassed in its
functional reserve and regenerative
capacity. It can sustain massive injury
from toxins and viruses and yet re
cover normal function. There is no
reason to believe that the same should
not be true following an ischemic
injury.
• Free radicals may be responsible
for the cell damage that occurs fol
lowing an ischemic insult.23 The liver
contains large amounts of free radical
scavenger
enzymes
which
may
protect it.24
The experimental results reported
here and clinical case reports suggest
that the liver can tolerate prolonged
periods of ischemia. Clamping the
portal triad can help to control bleed
ing either from liver injuries or during
difficult hepatic resections. Surgeons
should not be reluctant to perform
this maneuver for periods of up to 1
hour when circumstances warrant it.

F IG . 6— Liver from pig killed 10 days
after operation. N o necrosis or significant
cell abnorm alities are seen. Occasional
mitoses are present (arrows). Appearance
does not differ appreciably from that of
norm al liver (hematoxylin and eosin,
reduced by 55% from X350).

tension was very important imme
diately after liver blood flow was
restored, otherwise a low blood pres
sure would have produced more he
patic ischemia than was intended. Un
like man, the pig (and many other
species) cannot tolerate acute portal
occlusion because of the lack of porto
systemic connections.10 Using a shunt
to bypass the occluded portal vein was
mandatory. Heparinization prevented
microthrombi from forming in the
hepatic vasculature during the period
of ischemia and ensured patency of
the shunt.
A very important and somewhat
surprising feature of the model de
scribed was that on average 10% of
the control blood flow persisted dur
ing the period of ischemia. A sub
stantial number of lymph nodes is
present around the posterior part of
the portal structures in the pig. Small
arterioles
and
venules coursing
through the lymphatics were not
divided in these experiments. We
believe they were the source of the
persistent blood flow. A backwash of
venous blood in and out of the hepatic
veins was the only other possible
source. The fraction of blood flow
remaining may have been crucial for
survival of the organ. Because the
liver >is capable of extremely high
oxygen extraction ratios,17’18 the re
maining 10% blood flow may have
provided the minimum oxygen requi
rements to prevent cell death. It still
remains, however, that the liver can
manage on a small fraction of its
normal flow for at least 1 hour. The
extensive collateral arterial flow and
variations in arterial supply that exist
in man make it difficult to render the
human liver entirely avascular.19’20
Under clinical situations of clamping
the porta hepatis it is very likely that
important residual flow to the liver is
maintained through these collateral
pathways and accessory vessels.
The liver has the largest blood flow
of all solid organs and it has a high
metabolic rate. It does not necessarily
follow that it is ill-equipped to with
stand periods of prolonged ischemia.
Several aspects of hepatic physiology
may protect the liver from ischemic
injury.
• The liver uses energy to process
portal blood. In the absence of portal
flow the metabolic demands on the
liver and thus its oxygen requirements
are reduced.21
• The liver switches to anaerobic
metabolism when deprived of oxygen.
Its intracellular stores of glycogen, up
to 8% of the total weight of the
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of the animal that died 6 days after
operation but there were no necrotic
cells.
D iscussion

Madding and Kennedy2 stated
“most authors agree that 10 to 15
minutes of afferent vascular occlusion
is the maximum that can be safely
tolerated at one period”. A few case
reports in man of liver inflow occlu
sion for periods of 1 hour or more
with survival exist.13'15 Recently,
Pachter and Spencer16 reported a
series of 22 patients who required
hepatic inflow occlusion for the man
agement of liver injuries. Ten of the
patients had inflow occlusion for
periods of 30 to 60 minutes and sur
vived. Although moderate degrees of
hypothermia and medications may
have had a protective effect in some
of these patients, a reappraisal of the
safe period of liver ischemia seems
warranted.
Our experiments demonstrate that
a 90% reduction in liver blood flow
for 60 minutes at normal body tem
perature in the pig produced only
moderate, transient disturbances in
liver enzymes and minimal histologic
changes and no liver necrosis. We
believe that meticulous attention to
several technical details in the experi
ments contributed to our success.
Minimal handling of the liver and
other intra-abdominal organs was
practised. Care was taken not to dis
turb liver blood flow during the in
itial stages of the dissection when the
portal structures were being isolated.
We avoided systemic hypotension and
splanchnic engorgement by using light
anesthesia and adequate portal de
compression. The avoidance of hypo-
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Successful closure...
but the bleed won’t stop

AMICAR
[AMINOCAPROIC ACID)

The Clot Stabilizer
• Inhibits excessive activity of plasmin
and plasminogen activators
• Prevents excessive breakdown of
fibrin and fibrinogen
• Stops bleeding because clots are
stabilized
• infusion of whole blood, fibrinogen,
and other measures may be used
concomitantly
• Available in 3 formsIntravenous (5 gm/20 ml);
Tablets (500 mg); Syrup (250 mg/ml)

A M IC A R '
Aminocaproic Acid

T h e ra p e u tic C la ss ifica tio n — Antifibrinolytic
Agent.

In dica tio ns— Treatment of excessive bleeding
resulting from systemic hyperfibrinolysis and uri
nary fibrinolysis.
Contraindications— Active intravascular clotting.
Th e effects on foetal development are unknown. Do
not use during the first and second trimester of
pregnancy unless potential benefits outweigh
possible hazards.
Precautions— The drug should not be adminis
tered without a definite diagnosis and/or laboratory
findings indicative of hyperfibrinolysis. Rapid I.V.

administration should be avoided as it may induce
hypotension, bradycardia and/or arrhythm ia.
Caution should be used treating patients with car
diac, hepatic or renal diseases.
A d v e rs e R e a c t i o n s — O cca s io n a lly nausea,
cramps, diarrhea, dizziness, tinnitus, malaise,
conjunctival suffusion, nasal stuffiness, headache,
skin rash have been reported but rarely has it been
necessary to reduce or discontinue medication be
cause of one or more of these side effects. As with
all I.V. medication, thrombophlebitis should be
guarded against.
D o sa g e - Oral tablets, syrup, I.V.— Initial dose 5 gm$
followed by 1 -1 K gms hourly until bleeding is con
trolled. Administration of more than 30 gms in any

24 hour period is not recommended. Intravenous
administration should be by infusion over one hour.
Rapid I.V. injection of undiluted A M IC A R is not

A v a ila b ility - I n t r a v e n o u s -20 ml vial, 5 gms/
20 cc. Raspberry flavour syru p — 500m l bottle,
2S0 mg/ml. Oral tabs, 500 mg.

F u ll prescribing Inform ation available on
request.
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Recurrent Hiatal Hernia: Management by
Thoracoabdominal Total Fundoplication Gastroplasty
R.D. H enderson, m b , frcs[ c ], facs and G. M a r r y a t t , rna

Recurrent hiatal hernia presents
a difficult diagnostic and therapeutic
challenge. The authors present a series
of 121 patients in whom recurrent
hiatal hernia was investigated by
history, radiology, endoscopy and
manometry and acid perfusion
testing before surgical correction
by thoracoabdominal total fundoplica
tion gastroplasty. The preoperative
findings were compared with those of
238 patients who had undergone
primary repair.
Roentgenography was found to be
less accurate in the diagnosis of
anatomic recurrence than of the
original hernia. Manometry and
endoscopy increased the diagnostic
accuracy of recurrent hernia.
The thoracoabdominal approach was
used to allow direct vision dissection
both above and below the diaphragm.
Gastroplasty minimized the risk of
anatomic recurrence and allowed
reflux control even in patients
with an irreducible hiatal hernia.
Total fundoplication, added to
gastroplasty, is the most effective
method of preventing reflux.
There were no anatomic recurrences
and no evidence of reflux in the

121 patients who had secondary repair.
Two patients have required further
surgery to modify the total
fundoplication gastroplasty. With
a 96.7% follow-up, 94.2% of the
patients are considered to have
excellent results.

reparation secondaire. Deux malades
ont eu besoin d’une nouvelle chirurgie
afin de modifier la gastroplastie avec
fundoplicature totale. Avec une
verification de controle chez 96.7%
des patients, on considere avoir
obtenu d’excellents resultats dans
94.2% des cas.

Reprint requests to: Dr. R.D. Henderson,
Chief, Department of surgery,
Women’s College Hospital,
76 Grenville St., Toronto, Ont.
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La hernie hiatale recidivante presente
un defi diagnostique et therapeutique
difficile. Les auteurs decrivent une
serie de 121 malades chez qui la
hernie hiatale recidivante a ete etudiee
au moyen du dossier medical, par
radiologie, endoscopie et manometrie,
et epreuve de perfusion d’acide avant
de proceder a une correction chirurgicale de gastroplastie par voie
thoraco-abdominale avec fundoplicature
totale. Les observations preoperatoires
ont ete comparees avec celles de
238 patients qui avaient subi une
reparation primaire.
La radiographie s'e st averee moins
precise pour diagnostiquer une
recidive anatomique que pour la
hernie originale. La manometrie et
I’endoscopie augmentait la precision
diagnostique pour la hernie recidivante.
L'abord thoraco-abdominal a ete
employe afin de permettre une
dissection sous observation visuelle
directe au-dessus et au-dessous du
diaphragme. La gastroplastie a minimise
le risque de recidive anatomique et
permis de maitriser le reflux, meme
chez les malades ayant une hernie
hiatale irreductible. La fundoplicature
totale, ajoute a la gastroplastie, est
la methode la plus efficace de
prevenir le reflux.
II n’y a eu aucune recidive
anatomique et aucun signe de reflux
chez les 121 patients qui ont eu une
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Recurrent gastroesophageal reflux or
anatomic recurrence after hiatal her
nia repair'-2 is difficult to diagnose and
treat. Diagnosis is difficult because
the symptoms and investigative find
ings may be altered by the previous
operation and surgical correction o f
the recurrent reflux is complicated hy
the presence o f scar tissue.
In this study, the preoperative in
vestigative findings o f patients re
quiring secondary repair are compared
with those in patients presenting for
primary repair. Total fundoplication
gastroplasty for recurrent reflux will
be described in detail because the
technique differs from that used for
primary repair. Postoperative evalua
tion is used to confirm the effect
iveness o f the surgical approach in
preventing anatomic recurrence or re
flux.
Patients and M ethods
Total fundoplication gastroplasty
was carried out in 359 patients to cor
rect gastroesophageal reflux. O f these,
121 (33.7% ) had already had a hiatal
hernia repair and form the study
group. There were 41 men and 80
women. The age range was 17 to 75
years (mean 48.6 years).
Evaluation o f the 121 patients was
by history, roentgenography, endo151

scopy, manometry and acid perfusion
testing. Using a prepared format we
questioned each patient regarding
heartburn, its duration, location and
precipitating and relieving factors, and
regarding the presence of reflux,
aspiration, eructation, hiccough, water
brash, nausea, vomiting, respiratory
symptoms, weight loss and crico
pharyngeal
and
gastroesophageal
dysphagia.
Manometric studies were conducted
with an ultraviolet Honeywell 1508
visicorder (Honeywell Inc., Denver,
Col.) with a Harvard pump (Harvard
Apparatus Corp., Millis, Mass.) and
constant water infusion. Polyethylene
catheters with side holes (PE 190)
were passed into the stomach and
recordings obtained during staged
withdrawal.
Esophagogastroduodenoscopy with
a fiberoptic endoscope was carried
out on all patients. Rigid esophagoscopy was also used to evaluate and
dilate strictures.
All patients underwent standard
roentgenographic studies of the eso
phagus, stomach and duodenum.
Of the 121 patients, 48 required
other procedures in addition to total
fundoplication gastroplasty. In 29 a
pyloromyotomy was added to im
prove gastric drainage because of
vagal injury or vagal encasement in
scar tissue from a previous operation.
Eight required splenectomy because
of splenic damage caused during dis
section of scar tissue. The other oper
ative additions were a planned part
of the procedure. They included
vagotomy and pyloroplasty in three,
an enteroenterostomy in five patients
who had previously undergone Billroth
II gastrectomy and a cholecystectomy
in one. Two patients who had under

gone inappropriate esophageal myo
tomy had the defect repaired at the
time of total fundoplication gastro
plasty.

good mobility despite the increased
risk of cholelithiasis when these
branches are divided.3
The lesser sac is now entered later
ally and four or five short gastric
vessels are divided. The upper margin
Operative Details
of the lesser sac and small arterial
Thoracoabdominal total fundoplica branches from the diaphragm are
tion gastroplasty was the operation divided to expose fully and mobil
used in all 121 patients. The patient ize the left crus. The esophagus and
is placed in a 75° left lateral position stomach are now dissected from the
and an incision 18 cm long is made hiatus to give extensive mobilization
from the linea alba through the costal and if the esophagus is not shortened
margin and into the chest. This inci by intrinsic scar, complete anatomic
sion can be extended if necessary, reduction can be achieved without
using the interspace immediately tension. During the dissection, great
below the xyphoid to improve the care must be taken to preserve the
abdominal or thoracic exposure. A left gastric artery.
1-cm segment of the costal margin is
No. 1 silk sutures are placed post
resected. The diaphragm is taken eriorly under direct vision to include
down circumferentially, preserving the peritoneal coverings of the crura
the phrenic nerve and leaving a 1-cm for very loose crural approximation
cuff on the chest wall for suture following repair. The esophagogastric
closure.
fat pad is excised. Vagal fibres are
Initial dissection is begun in the identified and inspected to ensure that
chest by retracting the diaphragm in they are intact and not damaged by
teriorly and freeing the inferior pul scar or previous sutures. If vagal func
monary ligament. The esophagus is tion is in doubt, then the duodenum
mobilized under direct vision to the is kocherized, and a pyloromyotomy
aortic arch medially and to the in performed. With this thoracoab
ferior pulmonary vein laterally. The dominal approach the pylorus is read
vagi can be preserved and there is ily accessible.
little risk to the esophageal wall. Early
A no. 60 French Maloney bougie is
dissection of the anterior hiatus is passed into the stomach. Right angled
completed.
DeBakey clamps are placed close to
The diaphragm is now sewn to the the bougie taking care that the
upper wound margin giving excellent stomach incision will start immediately
exposure of the gastric fundus and below the phrenoesophageal ligament.
distal esophagus. Medial dissection A 5-cm gastroplasty tube is now cut
frees the stomach from liver adhesions in continuity with the lesser curvature
and the left lobe of the liver is also so that the left gastric artery is at the
dissected from the diaphragm. The base of the tube. This tube is closed in
right crus is mobilized and its peri two layers with 2-0 chromic and 3-0
toneal coverings are carefully pre continuous silk suture (Fig. 1).
served. Vagal branches to the liver
The newly created gastric fundus
are almost always sacrificed to obtain
is now rotated clockwise from left to

Left Gastric Artery

F IG . t — P re p a ra tio n o f g a stro p la sty tu b e a t esophagogastric
ju n c tio n below d iap h ra g m . S to m ac h a n d esophagus a re fully
m obilized, four sh o rt g astric vessels divided and left gastric
a rte ry and vagal nerves p reserved. N o . 60 F rench M aloney
bougie has been passed into sto m ac h a n d D eBakey v ascular
cla m p s applied b e fo re incision o f sto m ac h and creation of
g a stro p la sty tube.
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F IG . 2— G a stro p lasty tube has been com pleted and new
fu n d u s passed posterio rly . S tom ach and gastroplasty tube are
a p p ro x im a te d along left lateral m argin fo r firm fixation.
F u n d o p lica tio n is com pleted over distance of 2 to 2.5 cm with
th ree in te rru p te d 2-0 silk m attress sutures. P osterio r crural
su tu re s are tied.
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right and behind the esophagus and
gastroplasty tube, then it is carefully
positioned as it will lie following com
pletion of the fundoplication.
The first suture placed is to ap
proximate the fundic wrap to distal
esophagus just below the diaphragm.
Four or five 2-0 silk mattress sutures
are now used to provide firm fixation
along the lateral aspect of esophagus
and gastroplasty incorporating the
gastroplasty suture line (Fig. 2). This
fixation is entirely separate from the
completion fundoplication suturing.
The fundus is now rotated forwards
and the fundoplication completed with
three mattress sutures. One last stitch
is placed along the medial aspect of
the esophagus fixing the upper margin
of the fundoplication. Very firm fixa
tion is achieved between the fundo
plication and the gastroplasty tube;
however, the fundoplication itself is
extremely loose to avoid any risk of
anatomic narrowing. One finger can
easily be slipped between the fundo
plication and gastroplasty tube.
Reflux is controlled by the fundo
plication and competence is altered
by increasing or decreasing the length
of the total wrap. The length of the
gastroplasty, of incorporated esopha
gus and of total fundoplication are
all carefully measured. The gastro
plasty tube is 5 cm long, a 3-cm por
tion of distal esophagus is incor
porated and the completion wrap
never exceeds 2.5 cm. The gastro
plasty tube can be extended if there
is esophageal shortening. In patients

with scleroderma or excessive disor
dered motor activity (greater than
70% in the distal esophagus) or who
have previously undergone esophageal
myotomy or radical gastrectomy (80%
or greater), the length of the com
pletion wrap is reduced to 0.5 cm.
This reduction effectively prevents
reflux and avoids dysphagia.
Following completion of the gas
troplasty, the posterior crural sutures
are tied taking care not to restrict the
diaphragm. The wound is closed in
a standard fashion and the chest
drained.
Results

Follow-up of the 121 patients is 1
to 4.5 years (average 2.5 years).
Preoperative Evaluation
The characteristic history of reflux
was very similar to that obtained in
patients requiring primary hiatal her
nia repair (Table I). In those who
had previously undergone operation
the original symptoms were also
evaluated as this was helpful in assess
ing the patient's presenting problem.
In eight patients (6.6%) dysphagia was
a new and dominant symptom. It oc
curred immediately after the initial
operation and was shown at the sub
sequent operation to be due to a
tight diaphragm, a tight fundoplication
or too long a fundoplication. In four
other patients (3.3%) severe and pro
gressive dysphagia developed 3 to 12
months after standard Nissen fundo

Table I— Comparison of Symptoms in Patients Who Had
Prim ary and Secondary Repair
Group, %
Symptom

Primary (n = 238)

Secondary (n = 121)

100.0
92.4
94.1
41.5
3.4
9.3

100.0
91.3
86.7
42.3
14.9
0

96.6
97.5
72.0
15.3
14.4
79.7
50.0
13.6
77.1
32.2
28.0
78.8
33.9

98.3
95.0
73.9
14.5
19.1
86.3
36.5
10.8
67.6
25.3
21.6
65.5
34.4

45.0
53.0
6.8

42.3
56.0
7.5

Heartburn causing pain
Epigastric
Retrosternal
Back
Arms
Ears
Pain precipitated by ingestion of food
Quality
Quantity
Posture
Exercise
Hunger
Reflux
Aspiration (n igh t)
Respiratory
Eructation
Hiccough
Water brash
Nausea
Vomiting
Motor dysphagia
Cricopharyngeal
Gastroesophageal
Mechanical dysphagia
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plication and was due to intussus
ception. These factors are of critical
importance in assessing the individual
patient.4,5
Radiologically the presence of a
recurrent hiatal hernia was more dif
ficult to demonstrate than in patients
with primary repair (Table II). This
difficulty is related to the anatomic
defect created by previous repair.
Manometric evaluation preoperatively using the diagnostic criteria
described by Code and associates6 in
dicated the presence of a hiatal hernia
in 67.8% of patients. By using a
modification of these diagnostic cri
teria and adding disordered motor ac
tivity, a totally negative high pressure
zone and cricopharyngeal incoordina
tion in the assessment, we increased
the diagnostic accuracy of manometry
to 80.9% in 115 of the 121 patients
with secondary repair whose studies
were of sufficiently high quality for
this assessment (Table III).
The tone of the high pressure zone
and lower esophageal disordered
motor activity are also important in
patient assessment but will be pre
sented in comparison to postoperative
data to illustrate the effect of reflux
control.
Endoscopy
performed
preoperatively is mandatory in all patients.
The percentage of patients with eso
phageal ulceration, stricture, gastric
and duodenal lesions is shown in
Table IV.
Results of Operation
Follow-up was available in 96.7%
of patients, 96.7% by history, 86%
radiologically and 65.3% manometrically.
There were no operative deaths.
The major postoperative complica
tions (5%) were fistulas (2.5%), bowel
obstruction (1.7%) and wound infec
tion (0.8%).
Symptomatically 94.2% had ex
cellent results, with minimal or absent
residual symptoms; 4.1% had mild
residual symptoms but were improved;
1.7% (two patients) had significant
dysphagia. These two patients with

Table II

Radiologic Evaluation
Group, %

Finding
H iatal hernia
Reflux
Normal
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Primary
(n = 238)

Secondary
(n = 121)

71.8
11.7
16.5

53.5
17.5
29.0
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In intra-abdominal and pelvic infections, MEFOXIN*
— an effective single agent — provides bactericidal activity against
many mixed aerobic/anaerobic organisms including B. fragilis.
In many cases MEFOXIN* may eliminate the need for combination
antibiotic therapy which could include potentially more toxic agents.
MEFOXIN* is generally w ell tolerated ... Data from
108 studies conducted world-wide on 2277 patients with infections at
various sites, 1924 of whom received MEFOXIN* revealed the drug to be
well tolerated by more than 90% of patients.1
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bactericidal action of MEFOXIN*, a cephamycin
derived from cephamycin C, results from the inhibition of bacterial cell wall synthesis.
Evidence suggests that the methoxy group in the lo t position is responsible for the
resistance of MEFOXIN* to degradation by bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
The treatment of the following infections when due to susceptible organisms:
1 — Intra-abdominal infections such as peritonitis and intra-abdominal abscess
Z —■Gynecological infections such as endometritis and pelvic cellulitis
3 — Septicemia.
4 — Urinary tract infections.
5 — Lower respiratory tract infections.
6 — Bone and joint infections caused by Staphylococcus aureus.
7 Soft tissue infections such as cellulitis, abscesses and wound infections.
Appropriate culture and susceptibility studies should be performed to determine the
susceptibility of the causative organism(s) to MEFOXIN*. Therapy may be started while
awaiting the results of these tests, however, modification of the treatment may be
required once these results become available.
’
Organisms particularly appropriate for therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and non-producing.
Streptococci excluding enterococci.
Gram negative: (beta-lactamase producing and non-producing strains)
E. Coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Hemophilus influenzae
Providencia species
Anaerobes
Bacteroides Iragilis
MEFOXIN* may also be appropriate for the treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that MEFOXIN* can be administered to patients
Tl ON¥ an d A D ^fm s f RATION f ,ll,n ’ 9entamicin' tobramYcin' or amikacin (see PRECAUIntravenous Administration
The intravenous route is preferable for patients with bacteremia, bacterial septicemia, or
other severe or life-threatening infections, or for patients who may be poor risks because
of lowered resistance resulting from such debilitating conditions as malnutrition trau
ma, surgery, diabetes, heart failure, or malignancy, particularly if shock is present or
impending.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who have shown hypersensitivity to cefoxitin or
to the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted, careful inquiry should be made to determine
whether the patient has had previous hypersensitivity reactions to MEFOXIN*, cephalo
sporins, penicillins or other drugs. MEFOXIN* should be given with caution to penicillinsensitive patients.
There is some clinical and laboratory evidence of partial cross-allergenicity between
cephamycins and the other beta-lactam antibiotics, penicillins and cephalosporins
bevere reactions (including anaphylaxis) have been reported with most beta-lactam
antibiotics.
Any patient who has demonstrated some form of allergy, particularly to druqs should
receive antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs, administration of the drug should be
discontinued. Serious hypersensitivity reactions may require treatment with epinephrine
and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced when MEFOXIN* is administered to patients
™ h transient or persistent reduction of urinary output due to renal insufficiency (see
UOSAGE and ADMINISTRATION) because high and prolonged serum antibiotic concen
trations can occur from usual doses.
In patients treated with MEFOXIN* a false-positive reaction to glucose in the urine may
occur with Benedict’s or Fehling’s solutions but not with the use of specific qlucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine values in serum may occur if serum
C9Ji.c « ? ™ lons of ce,ox',in exceed 100 mcg/mL. Serum samples from patients treated
with MEFOXIN* should not be analyzed for creatinine if withdrawn within two hours of
drug administration.
Increased nephrotoxicity has been reported following concomitant administration of
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN* in the treatment of infections during pregnancy has not been
established. If the administration of MEFOXIN* to pregnant patients is considered
necessary, its use requires that the anticipated benefits be weighed against possible
hazards to the fetus. Reproductive and teratogenic studies have been performed in mice
and rats and have revealed no evidence of impaired fertility or harm to the fetus due to
MEFOXIN*.
Cefoxitin has been observed in the milk of nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the overgrowth of non-susceptible organisms.
Repeated evaluation of the patient’s condition is essential and if super-infection occurs
during therapy, appropriate measures should be taken. Should an organism become
resistant during an antibiotic therapy, another antibiotic should be substituted.
The safety and efficacy of MEFOXIN* for the treatment of infections in infants and
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ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse reactions rarely required cessation of
treatment and usually have been mild and transient.
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Thrombophlebitis has occurred with intravenous administration. Some degree of pain
and tenderness is usually experienced after intramuscular injections using water Indu
ration has occasionally been reported.
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Maculopapular rash, urticaria, pruritus, eosinophilia, fever and other allergic reactions
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Gastrointestinal
Diarrhea has been reported rarely.
Blood
Transient leukopenia and neutropenia have been reported. Some individuals may develop
positive direct Coombs tests during therapy with MEFOXIN*
Liver Function
Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood urea nitrogen levels have been observed. The
role ot MEFOXIN in changes in renal function tests is difficult to assess, since factors
predisposing to prerenal azotemia or to impaired renal function have often been present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no specific antidote is known MEFOXIN* can
be eliminated by dialysis in patients with renal insufficiency.

DOSAGE AND ADMINISTRATION
MEFOXiN* may be administered intravenously or intramuscularly when required (See
monograph for reconstitution directions for each route.)
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'
Adult Dosage
The usual adult dosage is 1 g or 2 g of MEFOXIN* every 6 to 8 hours. Dosage and route of
administration should be determined by severity of infection, susceptibility of the
causative organisms, and condition of the patient. The usual adult dosages are shown in
tne table below.
Type ol Infection
Uncomplicated forms* of
infections such as
pneumonia, urinary tract
infection, soft tissue infection
Moderately severe or
severe infections

Usual Adult Dosage
Daily Dotage
3-4 grams

Frequency end Route
1 gram every 6-8 hours
IV or IM

6-8 grams

1 gram every 4 hours
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2 grams every 6-8 hours IV
infections commonly
12 grams
2 grams every 4 hours
needing antibiotics in
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higher dosage (e.g.
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'
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’
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should be employed and it is advisable to monitor serum levels in patients with severe
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In adults with renal insufficiency, an initial loading dose of 1 g to 2 g should be given.
After a loading dose, the following recommendations for maintenance dosage may be
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RENAL
FUNCTION

CREATININE
CLEARANCE
DOSE
FREQUENCY
mL/min
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1- 2 g
every 8-12 hrs
Moderate impairment
2 9 -1 0
1- 2 g
every 12-24 hrs
Severe Impairment
9 -5
0 5 -1 g
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Essentially no function
<5
o.5 —1 g
every 24-48 hrs
In the patient undergoing hemodialysis, the loading dose of 1-2 g should be given after
each hemodialysis, and the maintenance dose should be given as indicated in the table
above.
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containing cefoxitin sodium as follows:
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signed to minimize the risk of further
anatomic recurrence and to provide
effective control of reflux.7'9 These
121 patients had had a total of 157
operations on the esophagus and in
addition 27 had had gastric oper
ations, including 11 with previous
Billroth II gastrectomy. The presence
of bile gastritis appreciably increases
the difficulty of obtaining symp
tomatic relief.
The thoracoabdominal approach
was chosen to minimize operative
damage to the esophagus and stomach
by allowing direct visual dissection of
these organs. In the authors' experi
ence this allows dissection with much
less damage to esophagus and
stomach. Fistulas occurred in 2.5%
of patients. This is a much higher
proportion than in patients having
primary repair (1.4%) and is directly
related to the difficulty of dissection.
The other complication related to the
operation is splenic injury. The spleen
is much more vulnerable with this
approach as it is densely adherent to
stomach and hiatus in many instances.
In this study, there were no an

previous radical gastrectomy were
operated on earlier in the study before
the necessity of shortening the fundoplication in these circumstances was
fully appreciated.
Inability to belch was present in
15% of patients but none had serious
gaseous bloating.
Radiologically, no patients had
reflux hy water syphon testing and
none had anatomic recurrence.
Manometrically there was increased
tone in the high pressure zone and a
decreased percentage of patients with
disordered motor activity of the lower
esophagus (Table V). These findings
are considered to represent esophageal
healing following control of reflux.
Four of the 121 patients have re
quired further operation. Two pa
tients with severe dysphagia have had
the gastroplasty modified to decrease
the length of the total fundoplication,
with good relief of symptoms.
Two patients with persistent crico
pharyngeal dysphagia have had a cri
copharyngeal myotomy with good re
sults. The persistent cricopharyngeal
dysphagia is unrelated to the method
of repair and will occur in about 2%
of patients with severe damage to
the cricopharyngeal muscle caused by
reflux.

atomic recurrences and no reflux after
the second repair as demonstrated
radiologically. Anatomic recurrence
is very rare in patients who undergo
gastroplasty, probably because of fixa
tion of the gastroplasty tube to the
left gastric artery. With this proce
dure a normal anatomic structure is
used to tether the fundoplication
below the diaphragm. In patients with
total fundoplication, reflux does not
occur unless the fundoplication dis
rupts. The strength of the suture line
when a gastroplasty tube is used is
substantially greater than can be
achieved with normal esophagus
alone.1011
Using a gastroplasty with total fun
doplication, the greatest risk is to
overcorrect reflux by making the
total fundoplication too long. By
measuring and tailoring the fundo
plication to fit the patient’s needs,
the problem of dysphagia can be much
reduced.11
In this group of patients, many of
whom had had more than one eso
phageal or gastric operation, a high
degree of patient satisfaction has been
achieved using thoracoabdominal total
fundoplication gastroplasty.

Table V— Comparison of Preoperative and
Postoperative Manometry
Tone of high Disordered
motor
pressure zone,
activity, % t
cm H20*

Discussion
All patients in this study had had a
previous esophageal operation fol
lowed by anatomic hiatal hernia re
currence, reflux or severe dysphagia
because of a tight initial repair. There
fore, an operative approach was de

Preoperative
Postoperative

46
30

12.2
17.0

"Increase 39.3%.
tDecrease 35%.
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Iatrogenic False Aneurysms
R a y C.J. C h iu , m d , ph d , f r c s [ c ], O. R u fu s A y e n i , m d , Joan S t e t s , m d , P e t e r E. B l u n d e l l , m d , f r c s [ c ],
D avid S. M u l d e r , m d , f r c s [ c ] and H e n r y J. Sc o t t , m d , f r c s [ c ]

Of 270 patients operated upon for
aneurysm, 25 patients underwent repair
for 28 iatrogenic false aneurysms. Of
these, 67.9% were complications of
vascular reconstructive surgery and
64.3% occurred at the groin. Iatrogenic
false aneurysm was associated with
various prosthetic and suture
materials and in many the attenuation
of host arterial wall appeared
to play an important role. Newer
invasive procedures, such as arterial
infusion of chemotherapeutic agents,
also lead to formation of iatrogenic
false aneurysm. Infection, present in
50% of the authors' series, and
intra-abdominal iatrogenic false
aneurysm, with abdominal viscera
forming part of the aneurysmal wall,
posed a technical challenge. Iatrogenic
false aneurysm is a potentially grave
complication since the mortality and
limb loss were each 8 % in this series.
D'un nombre de 270 malades qui ont
ete operes pour une anevrisme, 25
patients ont subi une chirurgie
correctrice pour 28 faux anevrismes
iatrogenes; 67.9% de ceux-ci etaient
des complications d'une chirurgie de
reconstruction vasculaire et 64.3%
etaient localisees a I'aine. Les faux
anevrismes iatrogenes etaient relies a
divers materiels de prothese et de
suture, et chez plusieurs, I'amincissement de la paroi vasculaire de
I'hote a semble jouer un role important.
From the division of cardiovascular and
thoracic surgery, M cGill University
and the Montreal General Hospital,
M ontreal, PQ
Presented at the 2nd annual meeting
o f the Canadian Society for Vascular
Surgery, Ottawa, Ont., June 4, 1980
A ccepted for publication Oct. 14, 1980
Reprint requests to: Dr. Ray C.J. Chiu,
Rm. 961, The Montreal General Hospital,
1650 Cedar Are., Montreal, PQ
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Les nouveaux procedes envahissants,
tels que la perfusion intra-arterielle
d’agents de chimiotherapie, ont aussi
entraine la formation de faux
anevrismes iatrogenes. L'infection,
presente dans 50% des cas etudies
par les auteurs, et les faux anevrismes
iatrogenes intra-abdominaux avec
adherence des visceres abdominaux
a la paroi de I'anevrisme ont pose
un defi technique. Le faux anevrisme
iatrogene est une complication
possiblement grave puisque les taux
de mortality et de perte d'un membre
ont tous deux ete de 8% dans
la presente serie.
The frequency with which iatrogenic
false aneurysm occurs may increase
as the number o f reconstructive vas
cular and other invasive procedures
increases.1 The causes o f anastomotic
failure leading to false aneurysm
formation after vascular grafting may
also change with the introduction o f
new prosthetic graft and suture ma
terials. W e therefore reviewed our
recent experience with iatrogenic false
aneurysms in the following retrospect
ive study.

Patients and Methods
The hospital records o f patients
operated on for false aneurysms at
the Montreal General Hospital be
tween Jan. 1, 1974 and Dec. 31, 1979
were reviewed. O f 270 patients
who
underwent
operation
for
aneurysms during this period, 25
(9.3% ) had iatrogenic false aneu
rysms. False aneurysms due to trauma,
such as penetrating injuries and frac
tures, were not included. As indicated
by the term “ iatrogenic” , all the false
aneurysms reviewed here were caused
by previous medical and surgical in
terventions. Three o f the 25 patients
experienced recurrence o f false aneu
rysms, which required repair, thus
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giving a total o f 28 false aneurysms
for review.

Results
The false aneurysms appeared pre
ponderantly at the groin, involving the
iliofemoral artery in 18 (64.3% ). All
but one (from femoral artery puncture
for cardiac catheterization) o f the
femoral false aneurysms followed
previous
vascular
graft
surgery.
Another two (7 .1 % ) false aneu
rysms involved graft anastomotic sites
other than the groin area. Eight other
false aneurysms (2 8 .6 % ) o f unusual
type are listed in Table I. The first
patient was a young woman who had
had an aortic valve repaired 4 years
previously. A false aneurysm arising
from the dorsal aspect o f the aortic
arch, opposite the site o f aortic cannulation for cardiopulmonary bypass,
extended around the trachea causing
severe airway obstruction. In two
other patients false aneurysms de
veloped in the axillary arteries where
indwelling catheters had been inserted
for continuous chemotherapeutic in
fusion through the hepatic arteries.
Both were in the terminal stage of
cancer and had hepatic metastases.
The axillary arterial laceration that
led to the formation o f false aneu
rysms was extensive; in one case more
than 5 cm o f arterial wall had disin
tegrated.
The interval between previous surT a b le 1— U n u s u a l I a t r o g e n i c F a ls e
A n e u rysm s

T yp e (c a u se )
A o r t i c a r c h ( c a r d ia c s u r g e r y )
A x illa r y a rte ry (c h e m o th e ra p y )
B r a c h i a l a r t e r y ( h e m o d ia l y s i s )
R a d ia l a r t e r y
( p u n c t u r e s f o r b lo o d g a s
e s t im a t io n )

Num ber
1
2
4

1
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gical intervention, such as vascular
grafting and punctures, and the time
the iatrogenic false aneurysm was
operated upon, ranged from less than
1 month to 8 years (Fig. 1). At the
time of presentation the majority of
patients had a palpable pulsating mass
(Table II). Fever and other signs of
sepsis were noted in patients with in
fected false aneurysms. This occurred
in 14 instances. Table III lists the
graft and suture materials used in the
20 patients with anastomotic false
aneurysms. As can be seen, informa
tion was not available in a number
of cases, but our data clearly indicate
that false aneurysms occurred with a
variety of graft and suture materials.
Table IV shows the surgical repair
performed on the false aneurysms.
The choice of repair technique was
governed mostly by the lesion en
countered. For example, vein graft and
extra-anatomic prosthetic bypass grafts
were preferred for infected false
aneurysms and simple suture repair
was carried out for false aneurysms
arising from needle punctures.
There were two major operative
complications in this series of patients.
Intestinal tear with contamination in
the presence of a prosthetic graft was
a grave complication in three patients
(11%). One of the patients eventually
died of sepsis. This occurred in our
patients whose false aneurysms in
volved the anastomotic line in the
intra-abdominal aorta, with the in
testine forming part of the wall of the
false aneurysm. Often extensive ad
hesions due to previous operations
and infection exist, and meticulous
dissections were required before ade
quate proximal and distal control
could be obtained. Excessive hemor
rhage (requiring transfusion of more
than 2 units of blood) may occur when
the lumen of the false aneurysm is en
tered before obtaining such control.

This happened in seven patients
(25%). In one patient with an ab
dominal aortic false aneurysm, tear
of the inferior vena cava, which
formed the wall of the false aneurysm,
resulted in considerable blood loss
before it was repaired. Therapeutic
failures including the two amputations
and one of the two postoperative
deaths, were directly attributable to
the false aneurysms. The results of
operation for iatrogenic false aneu
rysm in our 25 patients are shown in
Table V.
Discussion

By definition, a false aneurysm is
one that arises from a tear in an artery
in which the perivascular hematoma is
walled off by the surrounding tissue
and later by a fibrous capsule. This
should be differentiated from the true
aneurysm which has a wall consisting
of all layers of the blood vessel, al
though true and false aneurysms may
coexist at the anastomotic site. In
several of our patients who had aneu
rysms involving the femoral artery,
such a differentiation was found to
be difficult.
False aneurysms due to arterial
trauma probably have existed since
prehistoric times. However, Spratt and
associates' in 1967 pointed out that
the increasing frequency of surgical
reconstruction of arteries and other
invasive procedures has made iatro
Table I I — Presenting Symptoms and
Signs in Patients w ith Iatrogenic
False Aneurysms

Symptom/sign

genic false aneurysms more common.
New monitoring and therapeutic
methods, such as the intra-arterial in
fusion of anticancer agents, inevitably
introduce complications such as the
false aneurysms reported here. With
increasing numbers of cardiac oper
ations, false aneurysms arising at cannulation sites are not uncommon.
However, a false aneurysm arising
from a tear at the aortic wall opposite
the cannulation site as reported here
is unique and was not diagnosed until
exploratory thoracotomy was carried
out.
By far the most common cause of
iatrogenic false aneurysm is previous
vascular grafting and anastomosis.
Such anastomotic aneurysms appear
to be more common when a prosthetic
graft is anastomosed to an artery but
may also occur between two segments
of prosthetic graft and autologous
tissue, such as a vein to artery an
astomosis. Stoney and associates2 in
1965 reported a frequency of an
astomotic false aneurysm in the groin
region as high as 23.7%. The overall
incidence of false aneurysm in arterial
grafting was reported by Haimovici3
to be 2.9% in a collective series of
2700 patients. It is recognized that
anastomosis is more prone to disrup
tion at the groin than elsewhere.
Sawyers and associates4 reported that
false aneurysm developed in more
than 10% of their patients with groin
anastomosis. Moore and colleagues5
in 1968 and Moore and Hall" in 1970
reviewed their experience. They be
lieved that disruption of the an
astomosis when silk was used was the

No. of cases of
false aneurysm (% )

Pulsatile mass
Pain
Fever
Paralysis
Embolism
R espiratoryfailure

24
18
6
3
1
1

(86)
(64)
(21)
(11)
(4)
(4)

Table IV — Repairs Done for
Iatrogenic False Aneurysms

Repair

No. of cases of
false aneurysm ( %

Bypass graft
Vein
Prosthesis
Ligation
Suture

22
4
18
2
4

)

(78)
(14)
(64)
(7 )
(14)

Table II I — Graft and Suture Materials
Used in 20 Patients
M aterial

FIG. 1— Interval between previous
vascular procedures and repair of false
aneurysms (range 1 month to 8 years).
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Grafts
Teflon
Dacron
Polytetrafluoroethylene
Nylon
Mandril
Vein
Sutures
Silk
Prolene
Polydek

Table V— Results in 25 Patients

No. of cases
2
11
1
1
1
3
5
2
4

No. of
patients (% )

Result
Recurrence
(1 mo to 3 y r )
Am putation
Hem orrhage
Sepsis
Death
Sepsis
Myocardial infarction
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3 (12)
2 (8 )
1
1
2 (8 )
1
1
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major cause of false aneurysm. More feeding vessels may also be helpful.
recent review by Thompson and as False aneurysm involving arteries
sociates7 and by us indicate that the within the peritoneal cavity could be
use of both braided and monofilamen- technically challenging since the ab
tous plastic sutures such as Tevdek, dominal viscera may form part of the
Polydek and Prolene did not com wall of the false aneurysm. To avoid
pletely prevent the formation of false septic complications associated with
aneurysms.
intestinal tearing, preoperative bowel
Infection continues to be important, preparation may be advisable if it is
not only because it causes many false not complicated by conditions that
aneurysms, but also because it makes necessitate emergency surgery, such
the repair much more difficult. Re as aortoenteric fistula. Iatrogenic false
moval of the prosthetic materials from aneurysm thus remains a potentially
the infected area and autologous or grave complication and continued
extra-anatomic prosthetic bypass graft efforts should be made for its pre
ing may be required for limb salvage. vention.
In our series sepsis was the cause of
Conclusions
limb loss in one case and of death in
another. A number of other causes
The frequency of iatrogenic false
for anastomotic aneurysm have been aneurysm remains high in spite of
postulated (Table VI). Our recent ob recent advances in the number and
servations and those of Thompson and quality of biomaterials available for
associates7 that both the graft and
reconstructive vascular surgery. A
sutures were often intact but pulled pulsatile mass at the site of previous
out of the attenuated arterial wall tend invasive vascular intervention, either
to incriminate the weakened arterial for diagnosis or for therapy, is sug
wall. The much greater distensibility gestive of an iatrogenic false aneu
of the arterial wall (15 times more rysm, which can be confirmed either
than the prosthetic graft) also tends by arteriography or ultrasonography.
to weaken the host artery. Pulsatile
Most false aneurysms continue to
flow, turbulence and vibration at such be associated with arterial operations.
a site may also play a role.8 The Infection and the pulling out of
higher frequency of false aneurysm at sutures from an attenuated arterial
the groin may be apparent because it wall at the anastomotic site appear to
is easier to diagnose there, but it may be the most common causes. Preven
also be related to tension at the an tion of these complications therefore
astomosis from hyperextension of the should be directed at avoiding infec
hip joint. Infection is also more com tion and at meticulous surgical tech
mon, presumably due partly to poorer nique. Patch grafting and dilation of
tissue coverage. We agree with the arterial lumen can be carried out,
Thompson and associates7 that avoid if necessary, to avoid excessive end
ing infection, extensive endarterec arterectomy which may further weak
tomy and undue graft tension and en the already attenuated arterial wall
well placed plastic sutures should keep at the site of anastomosis.
the frequency of anastomotic false
Bowel preparation may be indicated
aneurysm to a minimum.
when the false aneurysm involves the
In repairing false aneurysms, ade intra-abdominal arterial segment, since
quate control of proximal and distal in such cases the gastrointestinal tract
feeding vessels is essential to avoid may actually form part of the wall of
excessive hemorrhage. Arteriography the pseudoaneurysm. In infected cases,
performed preoperatively to delineate either autogenous vein or extra-an
the anatomy and, in difficult cases, atomic prosthetic bypass grafting,
transluminal balloon occlusion of the
avoiding the site of infection, may be
necessary for limb salvage.
Table VI—Causes of Iatrogenic False
Aneurysm after Vascular Grafting
Material failure
Graft weakness
Suture weakness
Arterial wall weakness
Graft-artery distensibility ratio
Technical failure
Faulty sutures
Graft angle and calibre match
Tension at suture line
Infection
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ROYAL COLLEGE — CAGS SYMPOSIUM

Symposium on Carcinoma of the Pancreas
1. Introduction
This year more than 2200 Canadians
will die of cancer of the pancreas.
There has been a conspicuous increase
in the incidence of pancreatic cancer
over the last few decades. The disease
has been documented since 1905 and
most countries in the world have re
ported increases in the real incidence
varying from 150% to 300% since
1952.1,2 Despite improved diagnostic
techniques and surgical skills, and
other sophisticated methods of treat

ment, there has been no appreciable
improvement in the cure rate which
still stands at 1% (5-year survival).
There is evidence, however, that we
have increased the duration of sur
vival by several months.
It is beyond the scope of this sym
posium to speculate on the causes of
this increasing incidence. Our task is
to examine the ways of diagnosing and
treating those who have the disease.
To this end we have gathered a panel

of experts to give you their views and
to answer your questions.
J.E.

M u l l e n s , m s , m d , f r c s [c ]

Chief, division of general surgery,
Ottawa Civic Hospital.
Ottawa, Ont.
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2. Diagnosis of Carcinoma of the Pancreas
C hia-Sing H o ,

The emergence of new diagnostic
techniques has been of great value in
pancreatic carcinoma. These tech
niques include ultrasonography,
computerized axial tomography,
endoscopic retrograde cholangio
pancreatography, percutaneous transhepatic cholangiography and fine-needle
aspiration biopsy. In spite of these
advances in diagnosis, the prognosis
of the disease remains poor and
most patients still present at a
late stage.
Used intelligently, these technologic
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advances can reduce the number of
investigations for pancreatic malignant
lesions and yet maintain a high
degree of diagnostic accuracy. A
schema of investigations based on
clinical symptoms and a patient's
ability to undergo surgery is presented.
The author believes this approach
obviates the need for diagnostic
laparotomy in many and palliative
surgery for obstructive jaundice
in some.
Dans le cancer du pancreas, I'arrivee
de nouvelles techniques de diagnostic
represente une importante contribution.
Ces techniques comprennent
lechographie ultrasonique, la tomographie transverse axiale avec
ordinateur, la cholangiopancreatographie par endoscopie retrograde,
la cholangiographie trans-hepatique
percutanee et la ponction biopsie a
I 'aiguille fine. En depit de ces
ameliorations dans le diagnostic, le
pronostic de la maladie demeure
sombre et la plupart des malades
sont vus a un stade avance.
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Utilisees avec intelligence, ces
ameliorations technologiques peuvent
reduire le nombre d’examens requis
pour le diagnostic des tumeurs
malignes du pancreas tout en
conservant un haut degre de precision.
On decrit un schema des examens
a pratiquer selon les symptomes
cliniques et la capacite du malade
de subir une operation. L’auteur croit
que cet abord elimine la necessity
d'une laparotomie diagnostique dans
plusieurs cas et celle d'une chirurgie
palliative dans certains cas d'ictere
par retention.

Carcinoma of the pancreas is the
fourth commonest form of cancer
causing death in the United States1
and its incidence is increasing. Since
1930 in the US the incidence has in
creased threefold and in the last 25
years it has increased twofold in Nor
way and fourfold in Japan.2 The prog
nosis of the disease remains poor. Less
than 1% of patients survive 5 years
from the time of diagnosis, the aver
age being only 6 months.3
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To improve the survival, an effect
ive screening program is required for
early detection of tumour in asymp
tomatic patients. For symptomatic
patients efficient evaluation for de
finitive diagnosis and operability is
desirable. My presentation will touch
briefly on the difficult task of screen
ing and will centre on efficient diag
nosis.
Screening

The search for a tumour marker
for cancer of the pancreas has so far
been disappointing. Any effective
screening test should be inexpensive,
accurate and highly specific as well as
reasonably sensitive. A test with 98%
specificity may appear encouraging
but when applied to a population of
100 000 this means unnecessary in
vestigation for 2000 persons without
the disease. To be acceptable, the
false-positive rate must be in the
order of 0.02%.4 Such a test is un
available at present.
Of the tumour antigens, carcinoem-

FIG . 1— Endoscopic retrograde cho
langiopancreatography shows segmental
narrowing of main pancreatic duct
(arrow) in head of pancreas due to car
cinoma. T here is minim al dilatation of
main duct in body and tail.

bryonic antigen (CEA) is most widely
studied. The relative frequency of
false-positive elevated CEA values in
benign disease ranges from 20% in
normal smokers with a low pulmonary
capacity to 50% of patients with
benign hepatobiliary diseases.4 This is
unsuitable for screening purposes.
Pancreatic oncofetal antigen was first
identified and reported in 1974 by
Banwo and colleagues.5 It was subse
quently found to be sensitive in only
two thirds of patients with carcinoma
of the pancreas but can be used in a
negative sense because it has a spe
cificity of 94% .6 The a-fetoprotein
level is infrequently elevated in pan
creatic carcinoma and the isolation of
isoamylase has not been fruitful.
Evaluation of Symptoms

Assessment of clinical symptoms is
still the key to efficient diagnosis of
pancreatic malignant lesions. Ab
dominal pain, weight loss and jaundice
are the cardinal symptoms. When
jaundice occurs, only 20% of patients
remain painless throughout the course
of the disease. The majority of patients
(50% to 80%) present with ab
dominal pain. Some suffer from severe
depression. In a small percentage,
pancreatitis may be the presenting
complaint.
In Gambill’s series7 4% of patients
presented with pancreatitis and diag
nosis of the underlying malignant
tumour at surgery was difficult and
often delayed. In a recent review
(Connon JJ, Bluestein P: Personal
communication, 1980) 50 patients
with carcinoma of the pancreas were
studied by endoscopic retrograde
cholangiopancreatography (ERCP) at
the Toronto General Hospital. Seven

of them had presented with pancre
atitis of unknown cause. I believe
that ERCP is the preferred method of
investigation for such patients. The
following is an example of such a
case.
A 56-year-old man was admitted to
the hospital with acute pancreatitis. He
had no history of alcoholism and no gall
stones were found on ultrasonography
and oral cholecystography. His serum
lipid levels were normal. On ERCP a
short (0.5 cm) stricture was noted in the
main duct in the head of the pancreas
(Fig. 1). The preoperative diagnosis of
carcinoma of the pancreas was confirmed
at laparotomy which also revealed me
tastasis to the liver.
Newer Diagnostic Modalities

There are numerous diagnostic tests
for pancreatic carcinoma. In general,
roentgenography with barium, radio
active selenium scanning and sec
retin tests have lost favour as the
initial tests. Ultrasonography or com
puterized axial tomography (CAT), or
both, together with ERCP are used
extensively. Each of these three meth
ods has a tumour detection rate
ranging from 70% to 90%. Angio
graphy is sometimes used to deter
mine the nature of the lesion but most
frequently is used to assess its oper
ability. Isotope liver scanning, in ad
dition to ultrasonography or CAT is
another means of detecting liver metastases. Percutaneous transhepatic
cholangiography (PTC) not only will
diagnose accurately the site and nature
of bile duct obstruction, but may also
be modified to provide drainage for
the obstruction (Fig. 2).8 The resur
gence of the fine-needle aspiration
biopsy technique allows cytologic
proof of pancreatic carcinoma and

Fig. 2a

Fig. 2b

FIG . 2— (a) Percutaneous transhepatic cholangiography showing obstruction of com m on bile d uct by pancreatic carci
nom a. N ote gross dilatation of intra- and extrahepatic bile ducts, (b) Percutaneous transhepatic cath eter inserted fo r bile drainage
through obstruction into duodenum.
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liver metastases without operation.910
I cannot overemphasize that the
diagnostic accuracy of these newer
modalities varies immensely depending
upon the expertise of the investigator
and the type of equipment available.
This explains why one technique is
found to be superior in one paper and
not in another.
Time does not allow me to give a
detailed analysis of the merits and the
disadvantages of these different diag-_
nostic methods. I shall briefly sum
marize our experience with angio
graphy and percutaneous fine-needle
aspiration biopsy applied to the pan
creas and the liver. The biopsy tech
nique has an accuracy rate of 70%
in pancreatic lesions9 and 95% in
malignant hepatic lesions.10
In fine-needle aspiration of the liver
we use isotopic liver scanning for
guidance. A 22G spinal needle (0.7
mm diameter) is used for multiple
passes under fluoroscopy. Compared
with conventional methods, it is far
more accurate. Our complications in
cluded one death following pancreatic
biopsy, a mortality rate of 1%.U Four

patients had exacerbation of pre-exist
ing pancreatitis. Minor bleeding oc
curred in 1 of 40 patients who under
went aspiration biopsy of the liver.
(The success of this method depends
on the expertise of the cytopathologist.) Angiographic assessment of a
nonresectable pancreatic mass was re
markably accurate. In a recent review
at our hospital, 29 patients with car
cinoma of the pancreas had abdominal
angiography. Angiography indicated
that 17 patients had inoperable disease
and this was confirmed at surgery in
all 17. The remainder were considered
to have resectable disease but at oper
ation resection was possible in only
5 of the 12.

Group 1: Nonjaundiced,
Nonsurgical (Table I)
In this group ultrasonography or
CAT is used to find out if the patient
has a pancreatic mass. If so, cytologic
proof of malignancy may then be ob
tained by percutaneous biopsy. If no
mass is demonstrated, ERCP may be
performed together with cytologic an
alysis of pancreatic juice. If all these
tests are negative, pancreatic car
cinoma may be excluded.
A 72-year-old man with abdominal
pain and weight loss underwent CAT
which revealed a large mass in the pan
creas (Fig. 3). Percutaneous fine-needle
aspiration biopsy defined the mass as an
adenocarcinoma of the pancreas. No fur
ther diagnostic investigation was neces
sary.
Selection of Tests
Group 2: Nonjaundiced,
An efficient diagnostic program
Surgical (Table II)
should reduce the number of tests to
the minimum while maintaining a
Any pancreatic mass shown by ul
maximal degree of certainty in diag trasonography or CAT and any ab
nosis. This can be accomplished in normality revealed by ERCP suggest
most cases by classifying patients into ing a malignant condition are assessed
four groups according to their clinical for operability by angiography and
presentation and their ability to un
dergo surgery as follows.
Table II— Investigations for Group
2 Patients
Table 1 Investigations for Group
1 Patients
U Itrasonography/CAT
Ultrasonography/computerized axial
tomography (C AT)

Mass
±ERCP

No mass
I

T

FIG, 3—Computerized axial tomo
gram of pancreas shows gross enlarge
ment of body (small arrow) and tail
(large arrow) of pancreas due to car
cinoma.

Mass

No mass

|

f

i

Biopsy

▼
Endoscopic retrograde
cholangiopancreatography
(ERCP) with cytology

ERCP
Angiography
Isotope liver
scanning

1

I

Inoperable
Positive biopsy

Laparotomy

FIG. 4— (a) Computerized axial tomogram of pancreas shows mass in tail of pancreas (arrows), (b) Several areas of
decreased density in left of liver suggestive of secondary lesions seen in same cut set at narrower window width.
16 6
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isotope liver scanning. If conditions
are favourable the patient undergoes
laparotomy. In the patients whose
mass is inoperable, cytologic proof of
malignancy may be provided by per
cutaneous fine-needle aspiration biop
sy of the pancreas or the liver.
At splenectomy performed on a 52year-old man with traumatic rupture of
the spleen, a mass was fo\ind in the tail
of the pancreas. He was referred to the
Toronto General Hospital for evaluation.
Computerized axial tomography (Fig. 4)
revealed both the pancreatic mass and
areas of decreased density in the liver
suggestive of metastases. Percutaneous
fine-needle biopsy confirmed that adeno
carcinoma was present in both organs.
Subsequent operation was rendered un
necessary.
Group 3: Jaundiced,
Surgical (Table III)
Bile duct size and level of obstruc
tion are determined by either ultra
sonography or CAT. For those with
normal bile ducts or obstruction at the
lower end, ERCP is the method of
choice for further investigation. Oper
ability is assessed angiographically and
by isotope liver scanning. Patients in
this group usually undergo laparotomy

Ultrasonography/CAT

(

High
obstruction

Percutaneous transhepatic
cholangiography (PTC)
with drainage
Positive bopsy
Isotope liver
scanning
Angiography

Group 4: Jaundiced,
Nonsurgical (Table IV)
Percutaneous cholangiography and
drainage is chosen for patients with
dilated ducts that require decompres
sion. Further assessment with percu
taneous biopsy may follow. For pa
tients in whom normal-sized ducts are
demonstrated
by
ultrasonography,
ERCP is performed. This is followed
by endoscopic papillotomy, if com
mon bile duct stones are present, or
liver biopsy if no obstruction is de
monstrated.
Finally, I would like to present one
more illustrative case history.
This 60-year-old woman had obstruct
ive jaundice. Endoscopic retrograde cho
langiopancreatography showed obstruc
tion of the pancreatic duct at its head,
clearly suggesting carcinoma. The bile
ducts were not opacified. Her surgeon
had planned a laparotomy to bypass the
obstruction. While still in hospital, upper
respiratory tract infection developed,
delaying the operation. Her jaundice pro
gressed and PTC with catheter biliary
drainage was planned.

Table III— Investigations for Group
3 Patients

Low
obstruction
(normal
ducts)
ERCP

with surgical resection or bypass. Ob
struction of the bile duct at a high
level, shown by noninvasive tests, is
preferably followed by PTC incor
porated with a catheter drainage pro
cedure. If the lesion is subsequently
found by angiography or liver scan
ning to be inoperable, biopsy is re
quired for further proof. When a
positive biopsy is obtained, further in
vestigations and treatment may be
unnecessary because the obstruction is
already relieved by catheter drainage.

Inoperable

X
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3. The Pathological Features of Carcinoma
of the Pancreas
A lt H. Q izilbash ,

The frequency of cancer of the
pancreas is increasing and has
surpassed that of cancer of the
stomach. Lesions are more common
in the head of the gland than in the
body and tail. Smaller tumours tend
to be localized and are associated with
a better prognosis. The majority of
tumours are hard and demonstrate a
prominent desmoplastic reaction.
They present as ill-defined masses
which makes their differentiation
from chronic pancreatitis difficult.
Duct cell adenocarcinomas constitute
75% of all cancers of the pancreas.
Some of the uncommon types include
giant cell carcinoma, adenosquamous
carcinoma, mucinous cystadenocarcinoma and acinar cell carcinoma.
The role of open biopsy in diagnosing
cancer of the pancreas remains
controversial. Percutaneous fine-needle
aspiration cytology appears promising.
The technique is safe and inexpensive
but needs an experienced cytopathologist to interpret the results
accurately.
La frequence du cancer du pancreas
est en augmentation et depasse
maintenant celle du cancer de
I’estomac. Les lesions de la tete de la
glande sont plus courantes que celles
du corps ou de la queue. Les petites
tumeurs ont tendance a etre localisees
et sont rattachees a un meilleur
pronostic. La majorite des tumeurs
sont dures et demontrent une
importante reaction desmoplastique.
Elies se presentent sous forme de
masses mal definies, ce qui rend
difficile leur differenciation d’une
pancreatite chronique. Les adenocarcinomes des cellules secretrices
constituent 75% de tous les cancers
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du pancreas. Ouelques uns des types
rares incluent le carcinome gigantocellulaire, le carcinome adenosquameux,
le cystadenocarcinome mucineux et
le cancer des cellules acineuses.
Dans le diagnostic de ces cancers,
le role de la biopsie a ciel ouvert
demeure controversy. La cytologie
par aspiration percutanee parait
prometteuse. Cette technique est sure
et peu couteuse mais demande la
presence d’un cytopathologiste
experiments pour interpreter les
resultats avec precision.

The frequency of cancer of the pan
creas is increasing. In the United
States the incidence is estimated to
have increased threefold since 1930.'
Carcinoma of the pancreas is now the
second most common malignant tu
mour of the gastrointestinal tract2 and
is the fifth commonest cause of death
from cancer in the US. Approximately
21 000 patients in the US die of this
disease each year.2 Only cancers of
the lung, colorectum, breast and
prostate cause a greater number of
deaths. Despite advances in diagnostic
and therapeutic techniques the overall
survival rate for patients with the dis
ease remains low. Most patients die
within 6 months of diagnosis.3
In any discussion of cancer of the
pancreas, care should be taken to
separate tumours arising in the head
from those of the ampullary and peri
ampullary regions. I shall confine my
discussion to pancreatic cancer but
for completeness will briefly refer to
these other tumours.
Carcinoma of the second part of
the duodenum may cause obstructive
jaundice and mimic cancer of the
head of the pancreas. Such tumours
may be papillary or scirrhous and the
scirrhous ones may be difficult to
separate from carcinoma of the head
once the lesion is advanced.
Carcinoma of the ampulla of Vater
tends to be papillary and in the early
stages its origin from the ampullary
epithelium can be demonstrated.
Both duodenal and ampullary carcino
mas, which are associated with a 35%
to 40% 5-year survival, have a much
more favourable prognosis than car
cinoma of the pancreas.
Carcinoma of the terminal bile duct
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is the third lesion that must be dis
tinguished from cancer of the head.
This tumour produces symptoms early,
may be scirrhous or papillary and is
associated with a 5-year survival of
20% to 25%.
Pathological Features

Cancer of the pancreas appears to
arise more commonly in the head than
in the rest of the organ. Miller and
associates4 in an autopsy study of 202
cases found 71% of the cancers in the
head and 29% in the body and tail.
Cubilla and Fitzgerald5 found cancer
in the head of the pancreas in ap
proximately 60% of their cases.
Locating the site of origin of these
lesions is complicated by the fact that
in approximately 19% of these cases
multicentric lesions are present.3 In the
series of Cubilla and Fitzgerald7 clinic
al staging of 333 patients at the time
of diagnosis showed that 14% had
stage I disease, 21% stage II and 65%
stage III. Median survival in stage I
disease was 11 months, in stage II 5
months and in stage III 3 months.
More than 75% of tumours in the
body and tail of the pancreas are stage
III lesions compared with 40% for
cancer of the head. There is fairly
good correlation between tumour size
and stage of disease. Tumours less
than 3 cm in size are usually localized.
The majority of pancreatic cancers
are hard and ill defined. They cut
with a gritty sensation, revealing a
pale cut surface lacking the lobular
markings usually seen in normal pan
creas. The majority of the hard tu
mours are of ductal origin and as
sociated with a prominent desmoplas
tic response. This poses a problem in
differentiating them from chronic pan
creatitis. Obstruction and dilatation of
the main pancreatic and common bile
ducts are present in the majority of
patients with cancer of the head of
the pancreas. Focal areas of hemor
rhage and necrosis are not uncommon.
Histologically a wide variety of subtypes have been described. Based on
a study of 508 patients, Cubilla and
Fitzgerald7 classified cancer of the
pancreas into three subtypes: those of
duct cell origin, of acinar cell origin
and those of uncertain histogenesis
(Table I).
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Duct cell adenocarcinoma makes up
75% of all cancers of the pancreas.
These tumours arise from the ductal
epithelium and like adenocarcinomas
found elsewhere in the body are com
posed of glandular acini of varying
size and shape (Fig. 1). Varying de
grees of differentiation are present
from glands lined by tall columnar
cells to cells showing poorly differen
tiated and anaplastic features. Precancerous lesions and in-situ carci
noma are present in about 25% of
cases in ducts adjacent to the tumour.
This supports the duct cell as the
probable cell of origin for this type
of cancer.
Perineural involvement is common
in pancreatic cancer and signifies a
poor prognosis. Approximately 90%
of cases show perineural involvement.
Venous involvement is seen in 50%
of the cases. Lymph-node metastases
are common and when carefully
sought can be found in about 85%
of cases of carcinoma of the head of
the pancreas.7 Cancer of the pancreas
involves many groups of lymph
nodes. Metastases are commonly
present in lymph nodes of the superior
head, superior body, inferior body and
posterior pancreaticoduodenal groups.
Local and distant metastases may be
a presenting feature. In one study,7
8% of cancer of the head and 36%
of cancer involving the body and tail
of the pancreas presented as me
tastases from an unknown primary
tumour.7 Pancreatic cancer spreads
intra-abdominally
to
duodenum,
stomach, spleen, left adrenal and left
kidney. Liver is the most common site
of metastases and contains tumour
deposits at the time of laparotomy in
about 40% of cases and at autopsy
in about 80% of cases.7 Other sites
of metastases include peritoneum,

lungs, pleura,
kidneys.

adrenals,

bone and

U ncom m on Types of Pancreatic
Carcinoma

Table I includes the uncommon
types of pancreatic cancer. Com
pared with adenocarcinoma the ma
jority of these tumours tend to be
larger when first diagnosed and,
though histologically distinctive, have
a similar pattern of local and distant
spread and are associated with a sim
ilar survival rate. Mucinous cystadenocarcinoma is different, having a much
better prognosis than other malignant
tumours of the pancreas. The mean
interval between diagnosis and death
was 30 months in one study.8
Acinar cell carcinomas are well
recognized. Miller and associates4 de
scribed 27 examples of this distinctive
tumour in a study of 202 cancers of
the pancreas. Recently Webb9 reported
12 cases of acinar cell tumour in a
study of 105 carcinomas of the pan
creas. These tumours are composed of
round, columnar or polyhedral cells,
arranged in acinar or alveolar groups,
solid clumps or cords. The cytoplasm
contains coarse granules in the apical
portion of the cell. The nucleus is
located basally. By electron micro
scopy the tumour cells have features
of pancreatic acinar cells. Character
istic homogeneous electron-dense zy
mogen granules up to 250 nm in dia
meter are present in the cytoplasm of
tumour cells.
A few pancreatic carcinomas have
features best described as undifferen
tiated. These tumours consist of large
and small anaplastic cells growing in
solid sheets making a more precise
diagnosis and differentiation from
lymphoma and other small cell tu
mours difficult.

T a b le 1— T y p e s o f N o n e n d o c r in e C a r c in o m a o f t h e
P a n c re a s *

Type
D u c t c e ll o r ig in
A d e n o c a r c in o m a
G ia n t c e ll c a r c in o m a
A d e n o s q u a m o u s c a r c in o m a
M ic r o a d e n o c a r c in o m a
M u c in o u s c a r c in o m a
C y s ta d e n o c a r c in o m a
A c i n a r c e ll o r ig in
A c i n a r c e ll c a r c in o m a
U n c e r t a in h is t o g e n e s is
P a n c r e a t ic o b la s t o m a
M ix e d t y p e : a c in a r , d u c t a n d i s l e t c e ll c a r c in o m a
U n c la s s if ie d c a r c in o m a
T o ta l
* F r o m C u b illa a n d F i t z g e r a ld . 7
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Two distinctive pancreatic tumours
of uncertain histogenesis deserve brief
mention. Pancreaticoblastoma10 is a
rare infantile carcinoma composed of
small cells showing acinar differen
tiation. The majority of these tumours
behave in a malignant fashion with
death occurring within 1 year of diag
nosis. Survival of up to 16 years, how
ever, has been reported.10 Papillary
cystic carcinoma11 is the other rare
tumour of low malignancy. It is com
posed of small round cells lining papil
lary processes. The tumours may be
hemorrhagic and angiomatous in
places.
T he Role o f Biopsy in
Diagnosing Pancreatic Cancer

Biopsy of the pancreas has been
both advocated and condemned. The
main reasons for condemning the pro
cedure are the risk of hemorrhage, of
fistula formation, abscess and pancre
atitis.12 Difficulty in securing adequate
pancreatic tissue and errors of pathol
ogical interpretation are also cited.12'14
Those who advocate the procedure
argue that a radical operation should
not be performed in the absence of a
definite histologic diagnosis and report
a lack” or low frequency10 of com
plications. Both needle and wedge
biopsies have been used. In an attempt
to reduce complications, transduodenal needle biopsies have been ad
vocated. Biopsy should be reserved
for resectable lesions or cases in which
the diagnosis of cancer is not obvious.
When metastases are present it is
preferable to carry out a biopsy of
the tumour nodule and not the pan
creas itself. Wedge biopsies from the
surface are notoriously unreliable and
for a mass within the head a needle
biopsy is preferable. A negative biopsy
does not exclude carcinoma and mul
tiple biopsies are recommended in
such cases.
Open biopsy of the pancreas can be
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FIG. 1—Well differentiated adenocar
cinoma with w ell formed glands and
desmoplastic reaction (hematoxylin and
eosin, reduced by 50% from X 125).
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a dangerous procedure but if per
formed carefully may be accomplished
without complications. George and
associates15 in a review of 47 wedge
biopsies of the pancreas had no com
plications directly attributable to the
procedure. On the other hand Schultz
and Sanders12 reported a 9.5% com
plication rate after biopsy and a mor
tality of 3.8%. Isaacson and col
leagues16 reporting their experience
with biopsy in 527 patients found that
in patients who underwent laparotomy
and biopsy alone the complication rate
was 6.2% with no deaths. When a
major pancreatic or biliary tract pro
cedure was performed in addition to
the operative biopsy, the complica
tion rate was 4.1% and the mortality
1.9%. The results of biopsy in cancer
of the pancreas are variable. Cote and
associates14 reported a positive diag
nosis of cancer in 46% of wedge
and 68% of needle biopsies. In the
experience of Spjut and Ramos17 the
diagnosis was positive in 88% of cases
when wedge biopsy was used. Wise
and associates,18 using transduodenal
needle biopsy, obtained a positive
diagnosis in 84% of patients. Isaacson
and colleagues16 found the procedure
extremely useful, achieving a diag
nostic accuracy of 97%. A positive
diagnosis was obtained in 326 (97%)
of the 335 patients with pancreatic
carcinoma. False-negative results were
obtained only in nine patients (3%).
False-positive results are extremely
rare.
As in small biopsies elsewhere
in the body the main sources of error
are those of interpretation and sam
pling. Interpretation errors are un
common. Isaacson and associates16 in
reviewing their experience with 527
patients found no cases of false-posi
tive diagnosis and only in one case
was the diagnosis of benign disease,
made on frozen section, corrected to
adenocarcinoma on subsequent per
manent section. Sampling errors, how
ever, are not uncommon. Carcinoma
of the pancreas is usually surrounded
by a zone of chronic pancreatitis and
if the biopsy is not deep enough false
negative diagnoses will result. In such
cases needle biopsy yields better re
sults because tissue is obtained from
the centre of the lesion. In one study14
needle biopsy was positive for cancer
in 68% of cases whereas the super
ficial wedge biopsy yielded a positive
diagnosis in only 46%.
Because of the complications and
morbidity associated with conven
tional biopsies, fine-needle aspiration
pancreatic biopsy performed preoperatively has gained favour over the
170

past decade. The procedure is simple.
A thin needle is inserted into the
lesion and material is aspirated and
smeared on glass slides for cytologic
evaluation. Results from various cen
tres attest to the high accuracy of the
technique and lack of complications.
The diagnostic accuracy varies from
89% to 100%.1921
Endoscopic fine-needle aspiration
biopsy has been reported by Tsuchiya
and associates.22 A 21-gauge needle
is passed into the pancreas from in
side the duodenum or stomach using
duodenal or gastric fiberscopes. The
cellular material so collected is
smeared on glass slides, stained by the
Papanicolaou technique and examined
for malignant cells. A positive diag
nosis was made in 21 (84%) of the
25 proven cases of carcinoma of the
pancreas. Carcinoma has also been
diagnosed by fine-needle aspiration of
fluid from the pancreatic duct at
laparotomy.23 Cytologic diagnosis was
positive in 82% of cancers of the
head and in 40% of cancers of the
body and tail of the pancreas. Endo
and colleagues24 reported on aspira
tion cytology using a duodenal fiberscope for the diagnosis of cancer of
the duodenum and head of the
pancreas. Fluid was aspirated through
the fiberscope from the duodenum,
ampulla and pancreatic duct. A
positive diagnosis was made in 22
(79%) of the 29 proven cases of pan
creatic carcinoma.
Endoscopic retrograde cholangio
pancreatography (ERCP) combined
with brush cytology25 or pancreatic
juice cytology26 has also been success
fully used in the preoperative diag
nosis of carcinoma of the pancreas.
Combined ERCP and pancreatic juice
cytology26 achieve a positive diagnosis
in 90% of cases.
Percutaneous fine-needle aspiration
biopsy of the pancreas is now being
reported from various centres.27'29

Needle aspiration is done through the
abdominal wall. Angiography, ultra
sonography, computed tomography
and ERCP have been used in local
izing the lesion before aspiration
biopsy. The technique has many
advantages over conventional biopsy
methods. The risk to the patient is
negligible, it takes only a few minutes
to perform and avoids laparotomy in
patients too sick to undergo an oper
ation or with metastatic disease. The
technique is reliable and has a high
degree of accuracy. The major disad
vantage is the need for a highly skilled
and competent cytopathologist. The
full potential of percutaneous needle
aspiration biopsy can therefore be
realized only in large centres where
an experienced cytopathologist is
available to interpret the results.
In fine-needle aspiration biopsy
the aspirate consists only of the epi
thelial component of the tumour. The
stroma is not present and diagnosis is
based on the cytologic alterations of
the epithelial cells. The malignant cells
in aspiration biopsy material are ar
ranged singly or in small clusters
showing lack of cohesion. Variation in
cell and nuclear size is common. The
cytoplasm may be vacuolated with
thickened nuclear membranes and
prominent nucleoli (Fig. 2). In con
trast benign pancreatic cells are usual
ly exfoliated in sheets with uniform
bland nuclei surrounded by ample
cytoplasm.
With technical advances the ac
curacy of diagnosis has considerably
improved. Clinical diagnosis, however,
is still being made when cancer is ad
vanced. The mortality from the dis
ease has not appreciably decreased.
For better results patients with pan
creatic carcinoma will have to be
identified before signs and symp
toms appear. We await the discovery
of a tumour marker, at a stage when
the tumour is small and asymptomatic,
to offer some hope in an otherwise
gloomy situation.
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FIG. 2— Specimen obtained by percu
taneous needle aspiration showing group
of malignant glandular cells with pro
minent nucleoli (Papanicolaou stain, re
duced by 50% from X500).
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SESAP III Critique
ITEMS 453-454
453— The patient was maintained on a standard total parenteral nutrition (TPN) solution, which contained
sodium, 40 mEq/liter; potassium, 30 mEq/liter; and chloride, 50 mEq,/liter. Fluid from the duodenal
sump is always underestimated because the air bubbling through the sump drain removes part of the
water. For this patient, probable fistula losses ranged from 1200 to 1500 ml/day and could be ex
pected to contain sodium, 110 to 120 mEq/liter; chloride, 80 to 100 mEq/liter; and potassium, about
10 mEq/liter. Fluid volume replacement was adequate and the urine output remained at a satisfac
tory level. The abnormal loss of sodium and chloride resulted in falling concentrations of both of these
ions in the plasma.
Elevated blood glucose of 180 mg/100 ml may have caused a slight but inconsequential shift of in
tracellular water to the extracellular fluid space with dilution of sodium. The data do not support the
diagnosis of water intoxication because the patient did not have any significant excess of water intake.
A third-space shift should have been manifested by hypovolemia with a sharp decrease in the urine
volume as well as fever and hypotension. Adrenal insufficiency is also less of a possibility. Acute
adrenal insufficiency is manifested by hyponatremia, often hyperkalemia, and a lactic acidosis that sub
stantially depresses total carbon dioxide.

HI

454— When the patient was given a red-cell transfusion, an initial mistake was giving the blood through
the central venous catheter used for TPN. In order to minimize the risk of infection, it is preferable and
much safer to use such catheters only for TPN solutions and not for medications or for blood.
The patient had an episode of acute hypoglycemia. He had been receiving 125 m l/hour of a
solution containing 20% dextrose (25 gm dextrose/'hour). This results in a sustained high level of in
sulin in the bloodstream. When the TPN line was used for blood, this input of glucose was suddenly
stopped and the high level of insulin in the blood produced the episode of acute hypoglycemia.
Air embolism is a possibility, but unless the transfusion was being given under positive pressure
in a noncollapsible container or glass bottle, such an accident would be highly unlikely.
Contaminated blood transfusion would be more likely to produce signs of acute sepsis with a shaking
chill and fever followed by hypotension. Contamination reaction and an ABO mismatch are both likely
to occur early during transfusion, and signs would not usually be delayed until two hours after the
transfusion had been started.
A leukocyte sensitivity reaction is also a possibility, particularly because the protocol did not
specify that the cell mixture was of washed red cells. However, the white-cell content and residue
in packed cells is markedly diminished. Urticaria and itching and perhaps a chill would be more
likely symptoms than sweating and anxiety.

m
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4. Surgery of Carcinoma of the Pancreas
Lord Smith of M arlow ,kbe,ms ,frcs*
The surgical treatment of pancreatic
cancer depends upon the site and
extent of the tumour and in particular
the experience of the surgeon, as
pancreatic resection performed outside
specialized centres carries a high
risk. Within the specialized unit the
Whipple operation is the treatment
of choice for periampullary carcinomas,
but the results of resection for more
extensive tumours of the pancreatic
head are disappointing even with
adjuvant chemotherapy and radio
therapy. Resection, however, provides
the only prospect of cure and may be
the best palliative procedure. The
place of total and “regional”
pancreatectomy is undecided. The
choice of palliative operations to
relieve malignant biliary, duodenal and
pancreatic duct obstruction should be
carefully considered to avoid early
recurrence of symptoms. The
prognosis for patients with cancer
of the body of the pancreas
remains poor.

tomie totale ou “regionale" est
incertaine. Afin d'eviter la recidive
precoce des symptomes, il y a lieu
de choisir avec soin I'operation
palliative appropriee pour soulager
I’obstruction maligne des voies
biliaires, duodenales et pancreatiques.
Le pronostic des malades souffrant
d'un cancer du corps du pancreas
demeure sombre.

Until the 1930s few attempts had been
made to resect a malignant pancreatic
tumour. Those that had had usually
ended in spectacular failure. As a
result of the work of Dam in the mid1930s on the properties of vitamin K,
it became much safer to operate upon
patients with a deepening obstructive
jaundice. This paved the way for the
pioneer work of Alan Whipple, in the
latter half of the decade, on the prob
lem posed by cancers arising in the
head of the pancreas or periampullary
region and obstructing the terminal
bile duct. For the first time, surgeons
began to treat these cancers by a block
excision comparable to that employed
Le traitement chirurgical du cancer
for other cancers of the alimentary
du pancreas depend du siege et de
tract.
I'etendue de la tumeur, et en particulier
The original Whipple operation was
de I'experience du chirurgien car une
carried out in two stages, but it was
resection pancreatique pratiquee hors
not long before many surgeons real
des centres specialises comporte
ized that this had disadvantages, and
un risque elevee. A I’interieur d'un
within a few years a multiplicity of
service specialise, I’operation de
“improvements” had been described.
Whipple est consideree comme le
In particular many of these modifica
traitement de premier choix dans
tions included a pancreatojejunal an
les cas de cancer peri-ampullaire;
astomosis instead of a mere ligation
cependant, les resultats de la
of the pancreatic duct and closure of
resection dans les tumeurs plus
the neck of the pancreas by suture.
etendues de la tete du pancreas
The years immediately before and
sont desappointants, meme avec
after World War II saw a great con
une chimiotherapie et une radiothecentration of effort upon the purely
rapie d'appoint. La resection toutefois
technical question: How should we
assure la seule possibility de guerison
be performing this operation? It was
et peut etre la meilleure intervention
tacitly assumed by many that results
palliative. La place de la pancreatecwould necessarily improve and that a
reasonable proportion of surgical cures
::Former President (1978 to 1980) of
would be obtained.
the R oyal Society of Medicine,
Today I believe we should ask our
London, England
selves a series of quite different ques
Presented at the 49th annual meeting
tions and I put these to you as follows:
of the Royal College of Physicians
1. Has the Whipple operation be
and Surgeons of Canada by the
come as safe as had been anticipated,
Royal College in cooperation with the
Canadian Association of General
not just in the hands of the expert
Surgeons, Ottawa, Ont., June 4, 1980
with a particular interest in pancreatic
surgery, but as performed by the
Accepted for publication Oct. 31, 1980
average,
competent, general surgeon?
Reprint requests to: Lord Smith of
2.
Do
the long-term results justify
Marlow, KBE, 149 Harley St., London,
its use and, in particular, are they
England W IN 2DE
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significantly better than those obtained
after purely palliative surgery?
3. Are the results improved by the
use of adjuvant chemotherapy or
radiotherapy, or both?
4. If the general picture is disap
pointing, how can it be improved?
Should we become more conservative
or more radical? Should we now
abandon the Whipple operation and
replace it, where resection appears
worthwhile, by total pancreatectomy
or by regional pancreatectomy?
In any assessment of results, the
first necessity is to realize that the
original concept of the Whipple oper
ation was that of grouping together
tumours presenting in a roughly sim
ilar clinical fashion in which four
quite distinct types can be recognized:
(a) primary carcinoma of the duo
denum, (b) carcinoma arising inside
the ampulla of Vater, (c) carcinoma
of the terminal common bile duct and
(d) carcinoma of the head of the
pancreas.
The immediate risks of a Whipple
operation and the long-term outlook
depend largely upon which type of
tumour is resected (Tables I and II).
If a cancer originates in the duo
denum, ampulla of Vater or terminal
common bile duct, the long-term out
look after resection is, on the aver
age, reasonably good and the oper
ation itself can be carried out with
an acceptably low mortality. Results
such as these are reported only from
the centres particularly engaged in
pancreatic surgery. One inescapable
lesson from the last three decades is
that the expectation that the Whipple
operation would prove to be safe in
the hands of those who only occa
sionally perform pancreatic surgery
has not been realized. The second
lesson is that if the tumour resected is
a cancer of the head of the pancreas
itself, the risks of the operation are
formidable, even in the hands of the
expert and the long-term results are
not much better than those obtained
after purely palliative surgery. This is
the moment perhaps to add that the
prospects in regard to resection of a
cancer of the body of the pancreas
are worse still (Table III). In more
than 30 years of endeavour I have yet
to resect a cancer of the body of
the pancreas and see the patient sur
vive for as long as 3 years.
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Cancer of the pancreas, then, poses
a problem that is just about as serious
now as it was before the Whipple
operation was developed; the ad
dition of adjuvant chemotherapy or
radiotherapy, or both, has only mar
ginally improved the situation. Some
theoreticians have rationalized the
problem to their own satisfaction by
concluding that the Whipple oper
ation should be reserved for all duo
denal, ampullary and bile-duct tu
mours, tumour of the pancreas itself
being treated by palliative surgery
only. This, of course, presupposes that
the distinction can always be made
and this is far from being so. At oper
ation a zone of pancreatitis surround
ing a quite small periampullary tu
mour can closely resemble a bulky
cancer of the head of the pancreas.
Two other objections to an oversim
plified philosophy based solely upon
statistics may be stated. Resection
offers the only chance of cure, even
if this is small, and resection may
often be the best palliative procedure.
On balance there is a good deal to
say for resecting the resectable, what
ever the statistical outlook—a prin
ciple that applies to many cancers. Let
us accept, though, that nobody is
happy about the surgical treatment of
pancreatic cancer. How, then, can we
do better? Should we become not less
radical but more radical?
The Case for Total
Pancreatectomy

There are valid arguments, both
theoretical and practical, for aban
doning the Whipple operation for pan
creatic cancer in favour of total pan
createctomy. The theoretical argu
ments are based upon the fact that if
there is a cancer in the head of the

pancreas, cancer cells can often be
demonstrated, sometimes in the ob
structed pancreatic duct and often
in the lymphatics at the level of the
pancreatic body and tail, and that on
pathological grounds the only logical
operation is total pancreatectomy. The
practical argument is that the main
cause of mortality following a Whipple
operation is breakdown of the pan
creatojejunal anastomosis and that a
total pancreatectomy eliminates this
danger point.
Let us take this second argument
first. If the pancreatic substance, and
in particular the pancreatic capsule, is
tough and sutures placed in it do not
tend to cut through, and if the an
astomosis is accurately performed and
is supported by a properly sited stent,
a pancreatojejunal anastomosis should
not break down and retention of the
external pancreatic section is an ad
vantage. If, however, the pancreas is
soft and friable with sutures tending
to cut through, then however expertly
the operation is performed, break
down is probable and if it occurs it
likely will kill the patient. In such
circumstances the argument that total
pancreatectomy is to be preferred is
a strong one.
As to the argument based upon
pathology, this of course leads logic
ally to the following question: Con
sidered from this point of view is
even total pancreatectomy adequate?
Should we not adopt a much more
radical philosophy based upon the
operation described as “regional pan
createctomy", not only removing the
whole pancreas but with it all the fat,
fascia and lymphatics in the surround
ing retroperitoneum, sacrificing blood
vessels such as the portal vein when
this is necessary and adding any
necessary vascular reconstruction.

Table I— Operative Risk with Pancreatoduodenectomy, 1946 to 1979

Location of tumour
Duodenum, ampulla
Distal common bile duct
Head of pancreas

No. of
patients

No. of
deaths

M ortality, %

148
70
44

3
5
9

2.7
8.5
20.4

262

17

6.5

What guidance can be given in this
perplexing situation, when the present
position gives satisfaction to no one
but it is not clear whether a more
radical approach is any better? I
shall try to summarize the lessons I
think I have learned and the conclu
sions I believe should be drawn, al
though a philosophy that suits me may
not suit others.
1. Resection of a pancreatic cancer
is a dangerous operation and carries
a high risk even in the hands of a
technically accomplished general sur
geon if he has no particular experi
ence of pancreatic surgery. The
general surgeon in a nonspecialized
department, therefore, should not
resect a pancreatic cancer. He should
transfer the patient to a department
of surgery specializing in pancreatic
surgery or, if this is impracticable, he
should rely upon palliative surgery.
2. The choice of even palliative
surgery requires some care. The tra
ditional cholecystojejunostomy will
serve only temporarily if the cystic
duct joins the common bile duct at a
low level and near the tumour, which
may extend into and occlude this junc
tion. In such cases the jejunum should
be anastomosed to the common
hepatic or common bile duct and not
to the gallbladder. Since duodenal
obstruction is common, a gastrojeju
nostomy should usually be added to
the biliary short circuit. The pan
creatic duct is also obstructed in most
cases and it is worth remembering that
decompression of the pancreatic duct
merely by inserting a T-tube and lead
ing the long end of this through the
gastric lumen to the exterior can
materially diminish pancreatic pain in
patients with this problem.
3. Within the specialized depart
ment or unit, the formal Whipple
operation remains the procedure of
choice for carcinomas of the duo
denum, ampulla of Vater or terminal
bile duct, including small doubtful
tumours possibly originating in the
terminal pancreatic duct.
4. Surgery for the more bulky
cancer of the head of the pancreas is

Table I I I — Carcinoma of
the Pancreatic Body,
1946 to 1972
Table II— Long-Term Survival after Pancreatoduodenectomy, 1946 to 1975
Location of tumour

3-year survival, %

5-year survival, %

50
36
10

35
19
6

Duodenum, ampulla
Distal common bile duct
Head of pancreas
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Explored, no.
Resected, no. (% )*
M o rta lity , %

110
8 (7 )
0

‘ A verage survival afte r resection was 7 mo
and a fte r no resection 5 mo (excluding
years 1966 to 1972).
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much more debatable. First comes
the question, should it be resected at
all? I believe that it is still logical
to carry out resection, but only if the
groove behind the neck of the pan
creas in which the portal vein lies is
not invaded by tumour. If there is
malignant infiltration of the vein it
self, the chance of improving the out
look by resection is minimal and I
would perform palliative surgery only.
If resection is to be performed, should
it be the traditional Whipple operation
or a total pancreatectomy? I must
admit that I find this a difficult ques
tion to answer and I believe that the
arguments are very finely balanced
between routinely performing a total
pancreatectomy for all resectable pan
creatic carcinomas and sticking to the
traditional Whipple procedure for car
cinoma of the head of the pancreas.
I am, however, convinced that if dur
ing a Whipple operation the pancre

atojejunal anastomosis is difficult be
cause sutures cut through an unusually
friable pancreas, the body and tail of
the pancreas should be removed as
well. Better no pancreas at all than
a pancreatojejunal anastomosis that
later breaks down!
5. Regional pancreatectomy is not
for me. I concede the theoretical
validity of the basic arguments, that
the malignant cells are found not only
in the lymph nodes but in perineural
lymphatic vessels some distance from
the pancreas, that therefore the
Whipple operation and even total pan
createctomy are theoretically inade
quate and that all the immediate can
cer cells can only be encompassed by
a much more extensive ablation of the
retroperitoneum. If only the argu
ments did not have such a familiar
ring about them. Were we not going
to produce much better results in
applying this philosophy to cancers of
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the stomach, of the breast and of the
colon? And did we? Our literature is
full of persuasive papers based upon
the same argument, that the results
of resection in cancer of this organ
or that are bad because we are not
being radical enough and that if we
perform a much more radical exci
sion results will improve.
It may be that a few, a very few,
surgeons should try to advance the
frontiers of knowledge by seeing
whether better results can be ob
tained by employing regional pancre
atectomy— after all, Dr. Fortner,
being a man of great technical skill
can complete this operation in as
little as 9 or 10 hours— and should
come back in 10 years and tell us
what they have achieved. And if, they
are able to say, “We are now curing
patients. Most of them are living for
many years”, this will be an event
unique in the history of surgery for
cancer. Since the human body appears
to obey the same rules, whatever organ
one considers, I believe with some sad
ness that it is unlikely to happen.
It seems to me that the position
today brings back memories of Sir
Winston Churchill who, when com
menting upon his Labour Party suc
cessor as Prime Minister and attribu
ting to him modesty as one of his
characteristics could not resist adding:
“Mind you— he has much to be
modest about.”
In the treatment of cancer of the
pancreas all of us have much to he
modest about.

coeur droit. Cl. d’Allaines, Ph. Blondeau, J-P. Cachera et autres. 175 pp.
Illust. Masson. Paris, 1980. Prix non
mentionne, broche. ISBN 2-22567760-3.
Acute Disorders of the Abdomen. Diag
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paperbound. ISBN 0-387-90483-2.
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Stark. 350 pp. Illust. Little, Brown and
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5. Nonoperative Treatment for Carcinoma of the Pancreas
M archant E. T ulloh , m b , bs , dmrt , f r c p [c ]*

Carcinoma of the pancreas, presenting
so often at an inoperable stage, has
been the subject of many nonoperative
therapeutic regimens. Radiotherapy
using high-dose techniques has been
shown to produce 45% palliation.
The author discusses in detail radical
techniques, with and without
chemotherapy, that have resulted in
a modest improvement in survival.
But because a median survival time
of little more than 1 year is
achieved by even radical radiotherapy,
investigational uses of radiation, both
interstitial and intraoperative, are
reviewed. As chemotherapy becomes
more sophisticated and drug toxicity,
interaction and synergism are better
understood, previous response rates
of 10% to 15% are now reaching
30% to 45%. The latest results of
multimodality therapy show some
improvement over single modality
treatment. The author presents a
broad review of nonoperative
techniques including discussion
of current trends and future
possibilities.
Le cancer du pancreas detecte si
souvent a un stade inoperable, a ete
I’objet de plusieurs regimes therapeutiques non operatoires. La radio
therapie a haute dose s'est averee
palliative dans 45% des cas. L’auteur
discute en detail les techniques
radicales qui, avec ou sans chimiotherapie, ont entraine une modeste
amelioration de la survie. Cependant,
meme avec la radiotherapie radicale,
on n'a pu atteindre une duree de
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survie qui depasse a peine 1 an.
Aussi discute-t-on de ('utilisation
ex p e rim e n ta l de la radiation interstitielle et de la radiotherapie peroperatoire. Avec le perfectionnement
de la chimiotherapie et une meilleure
connaissance de la toxicite, des
interactions et des synergies des
medicaments, les taux de remission
qui etaient autrefois de 10% a 15%
atteignent maintenant 30% a 45% .
Les derniers resultats des traitements
associant plusieurs modalites montrent
une certaine amelioration sur le
traitement unique. L'auteur presente
une vaste revue des techniques
non operatoires, il commente les
tendances actuelles et les
possibilites futures.

I have been asked to discuss present
and future nonoperative methods of
treatment for carcinoma of the pan
creas. I should like to broaden this
subject slightly to include intraoper
ative therapy and adjuvant therapy for
resectable disease. These methods will
be discussed under four headings:
radiotherapy, chemotherapy, com
bined therapy and experimental meth
ods under investigation.
R adiotherapy

Radiotherapy for carcinoma of the
pancreas may be delivered externally,
interstitially or intraoperatively.
E xternal Radiotherapy

Carcinoma of the pancreas with
pain (particularly back pain), which
is associated with a relatively high
local recurrence rate after operation
(50% in the Montreal General Hos
pital series'), is ideal for radiation
therapy. However, because pancre
atic tumours were previously thought
to be radioresistant and because the
pancreas is situated deep in the ab
domen surrounded by relatively radio
sensitive normal structures, radio
therapy has not been fully explored
until recently.
Palliative radiotherapy, defined as
a dosage of less than 6000 rad in 6
weeks or its equivalent, has been re
ported in detail. In numerous other
papers the palliative effect of external
radiotherapy has been suggested.
Green and associates2 reported on 22

patients treated palliatively with a low
dose (1600 rad in 10 days). They
found no difference between the re
sults obtained in patients given 5fluorouracil (5-FU) concomitantly
and those not given 5-FU. Of the 22
patients, 17 had appreciable pain
relief.
Haslam and associates3 using a
higher dose of radiation (4000 to 5000
rad) found that palliation was “good”
in 45%, "fair” in 24% and “of no
benefit” in 31%. They reported relief
of symptoms in 13 of 29 patients.
Problems of delivering palliative
radiation arise because the patients
are usually in poor general and nu
tritional condition, and epigastric
upper abdominal irradiation will in
crease nausea and vomiting that may
already be present. However, appre
ciable palliation can be achieved.
The use of radical radiotherapy has
recently been reported by Haslam and
associates,3 Dobelbower and col
leagues4 and the Gastrointestinal
Tumor Study Group (GTSG) in the
United States.5 In the series of
Haslam and coworkers, 20 patients
who had local or regional disease were
treated with 6000 rad in 10 weeks
with 2 weeks between each 2000 rad
dose. Anterior and posterior fields
only were used. Mean survival was 8
months. Of those patients who also
had chemotherapy, 11 survived 10
months, and of those who did not, 9
survived 8 months. Toxicity was
marked in 10%, moderate in 38%
and mild in 52% of the patients.
The amount of radiation delivered
to the kidney through these large an
terior and posterior fields was not
quoted but must have been high. In
a series of patients with a mean sur
vival of 8 months renal toxicity may
not be a problem, but if it is anti
cipated that patients will survive
considerably longer the probability
of renal toxicity must be taken into
account.
Dobelbower and colleagues reported
on 18 patients treated radically using
lateral 45-MeV photon fields and
anterior 20-MeV electron fields. The
target volume was identified by sur
gical clips but computerized axial
tomography was rarely used. The
dosage was 6300 to 6700 rad to the
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90% level at 180 rad/d. One eighth
to one half of the renal parenchyma
was included in the high-dose volume.
Sixteen of the 18 patients tolerated
treatment well and 10 of 13 had
relief of pain. The mean survival was
11.8 months. Seven patients were
alive at the time of the report—from
11 to 57 months after diagnosis and
10 to 26 months after treatment. Four
of these seven patients also received
5-FU with or without cyclohexylchloroethylnitrosourea. The addition
of chemotherapy appeared to improve
survival although not significantly.
Seven patients who received chemo
therapy had a mean survival of 13
months; those not receiving chemo
therapy had a survival of 7.5 months.
The GTSG as part of a randomized
study of high-dose radiotherapy, highdose radiotherapy with chemotherapy
and moderate-dose radiotherapy with
chemotherapy, reported that a group
of 25 patients who received 6000 rad
without chemotherapy had a mean
survival of 5 months.
Interstitial Radiotherapy
In an attempt to deliver a maximal
dose of radiation locally with minimal
side effects, interstitially administered
radiotherapy has been reported by
Fortner and D'Angio6 in 19 patients.
Hilaris and Roussis7 added 10 patients
to this group. Twelve of the 29
received supplemental external ra
diation. Palliation was achieved in
80% and 17% survived 1 year.
Shipley and Cohen8 reported on 12
patients all of whom received supple
mental external radiation and sur
vived 9 months. Barone8 described
eight patients who had interstitial
radiotherapy using radon seeds
but received no supplemental radia
tion. The mean survival of these eight
patients was 8.2 months.
Radiotherapy fractionation tech
niques similar to interstitial radiother
apy, have been used experimentally
by Pierquin and associates10 in France.
They reported one patient receiving
3500 rad in 5 days at continuous lowdose radiation who had a good re
sponse.
Intraoperative Radiotherapy
This technique was pioneered by
Abe and associates11 in Japan. The
rationale is that the bowel is removed
from the radiation field and post
operative complications are decreased
while a relatively high dose of radia
tion can be delivered to the tumour
at the time of operation. The initial
report from Japan was not en
couraging. When not receiving supple
180

mental external radiotherapy patients
survived only 2 to 8 months.
Goldson12 at Howard University has
reported that 15 patients receiving a
similar dose (3000 rad) with the elec
tron beam and no external radiation
survived 2 to 15 months. Ten patients
had some relief of pain.
At the Massachusetts General Hos
pital, Suit and Gunderson (personal
communication, 1980) have treated
nine patients with an intraoperative
dose of 1500 rad followed by an ex
ternal dose of 4000 to 5000 rad. They
appear to have developed a more
rational technique and two of their
patients have survived longer than
2 years.
Chemotherapy
Single-agent chemotherapy (Table
I) , for which 5-FU is still the agent of
choice, is associated with a wide varia
tion in objective response and some
of the results obtained have not been
duplicated. The duration of response
is short.
Combination chemotherapy (Table
II) is being rigorously investigated.13,14
The studies have shown an increased
survival to 13 or more months in
patients without liver metastases. Hall
and colleagues,15 in their study of
Ftorafur, Adriamycin and l,3-bis(2chloroethyl)-l-nitrosourea (BCNU), re
ported toxicity and fever of unknown
origin. Macdonald and associates16
used a combination of 5-FU, Adria
mycin and mitomycin C and ob

tained a 30% response rate and a
mean length of survival of 6 months.
In the study reported by Wiggans and
colleagues,17 with 5-FU, streptomycin
and mitomycin C, there was a 43%
response rate and the mean duration
of survival was 6 months.
Kovach and associates18 showed an
additive effect: 5-FU produced a re
sponse in 5 (16%) of 31 patients,
BCNU produced no response in 21
patients, but a combination of the two
gave a 33% response. These figures,
however, have not been duplicated;
Stephens and colleagues19 reported a
16.7% response using this combina
tion.
Moertel20 did not find streptozotocin
with cyclophosphamide and strepto
zotocin with 5-FU nor the addition
of lactones—aspartate inhibitors—of
value, but Waddell and coworkers11
reported a mean survival of 5 months
for patients treated with 5-FU and
Coumadin and a mean survival not
yet reached at 21 months (more than
50% still alive) with 5-FU and
testolactone. New studies have been
proposed by the Eastern Cooperative
Oncology Group (ECOG) to test the
following three medications: N(phosphonoacetyl)-l-aspartic acid, di
sodium salt (PALA) (an inhibitor
of aspartate transcarbamylase), 4'-(9acridinylamino)-methansulfon-m-anisidide (M-AMSA) (an acridine deriva
tive) and the combination of strepto
zotocin, Adriamycin and mitomy
cin C.

T a b le 1— S in g le -A g e n t C h e m o th e ra p y
O b je c tiv e
res p o n s e , %

N o . of
p a tie n ts

Agent
5 -flu o r o u r a c il ( 5 - F U )
1 , 3 -b is (2 - c h lo r o e t h y l) - l- n it r o s o u r e a
(B C N U )
A d ria m y c in
M e th y lc y c lo h e x y l-c h lo r o e th y l-n itr o s o u r e a
(M e C C N U )
F lu o ro m e th o lo n e
C y c lo h e x y l-c h lo r o e th y l-n itro s o u re a (C C N U )
M ito m y c in C
Z in o s ta tin

D u r a tio n of
re s p o n s e , mo

72

26

4.5

33
29

18
38

4
5

15
14
11
11
3

13
7
NK
27
33

4
NK
NK
7
NK

NK = not know n.

T a b le I I — C o m b in a tio n C h e m o th e ra p y

C o m b in a tio n
5 -F U + B C N U o r cy c lo p h o s p h a m id e
5 -F U + F lu o r o m e th o lo n e o r m ito m y c in C
F t o r a fu r -)- A d r ia m y c in 4 - B C N U
5 -F U + A d r ia m y c in + m ito m y c in C
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O b je c tiv e
re s p o n s e , %

D u ra tio n of
res p o n s e, m o

1 0 -1 8

5.5

26
43

10
6.5
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consistencies in correlating immuno
suppression and survival.
The most interesting work in non
Some experimental work that is
operative treatment of pancreatic can being considered is embolization of
cer has been with the combination pancreatic tumours using superselectof radiotherapy and chemotherapy ive catheterization and intraductal ir
(Table III). The GTSG5 has reported radiation.
on this treatment. Using three ran
The future of nonoperative methods
domized regimens of 5-FU given as a is uncertain, as is the treatment of
500-mg bolus on days 1, 2 and 3 of carcinoma of the pancreas generally,
a split course of treatment with a 2- but because of the high local recur
week break between courses, the rence rate after surgical treatment,
GTSG reported that only 3% of pa the cause of death being most often
tients had severe nausea and vomiting, the local disease, adjuvant programs
there was no acute or chronic enteritis should be developed in cases of re
and toxicity was at acceptable levels, sectable tumours, adjuvant to post
only 10% of patients having a platelet operative radiotherapy, chemother
count of less than 100 X 109/1. The apy and combined therapy.
mean survival was notably lower in
The development of new drug pro
the group receiving irradiation alone grams will be of value and the 5-FU/
and this portion of the study was Adriamycin/mitomycin C and strepdropped. The mean survival is now tozotocin/ Adriamycin/methylcyclohe39 weeks for the 79 patients receiving xyl-chloroethyl nitrosourea regimens
6000 rad and 31 weeks for 75 pa are already showing promise. There
tients receiving 4000 rad. Local pro should he improvement in radiation
gression occurred in 50% and hema localization with computed tomo
togenous spread in 30% of patients in graphy. Visualization of tumour re
all three groups. Therefore, 5-FU sponse by computed tomography
appears to be a radiosensitizer; should enable higher doses to be
Adriamycin, a known radiosensitizer delivered more accurately. Improved
is now undergoing study in combina drug use by means of new fraction
tion with radiotherapy. Klaassen and ation techniques and better dosage re
Catton are carrying on a similar study gimens should be studied. The pos
but no appreciable difference has yet sibility of sensitizing the tumour to
been noted (unpublished data).
chemicals and radiation by hyperther
mia and the use of heavy particle ther
Experimental Methods under
apy should be explored.
Investigation
In protocols now under way, heavy
particle therapy, streptozotocin, highExperimental work in progress in dose methotrexate, multiple-combina
volves (a) the use of sensitizers to both tion drugs and irradiation, and the use
radiotherapy and chemotherapy; in of different fractionation techniques
cluded in this group are metronidazole in radiotherapy with adjuvant pro
and misonidazole and (b) experiments grams for resected tumours are all
using heavy particle radiation or pi- being explored.
meson therapy in which the oxygen
enhancement ratio is decreased (un
published data).22
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both the cellular integrity of
tHe T)ramand thfecentral ner
vous system function.
t C t e shock has progressed
Tbevond its early stage, fluid,
administration alone is usu-

seveire shock threatens each link in the
body’s chain of organ system^
Solu-Medrol exerts a protective effectontheceli
to preserve tissue function and increase survival rates

The actions of Solu-Medrol
ally not sufficient to reverse
affect all of the body’s systems:
the haemodynamic and cel
lular disruptions.
• In the kidney, increased per
fusion reverses the anoxic state
Solu-Medrol, administered in
and
improves organ function
pharmacologic doses as part
as evidenced clinically by an
of a comprehensive treatment increase in urine output.1
► regimen, can reduce vasocon
• Improvement in the pulmonary
striction and increase tissue
vasculature is demonstrated by a
perfusion. The multiphasic
reduction in shunting and an
activity of Solu-Medrol helps
increase in oxygen consumption.2
»restore haemodynamic bal
a n c e , preserve lysosome and • The affinity of haemoglobin for
oxygen is reduced permitting
cell membranes, and protect
increased delivery of oxygen by
cellular and intracellular
the blood to the tissues.3
structures and function.
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• A positive inotropic effect is
exerted on the heart further
increasing the flow of blood.4
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Pancreatic lysosomes are
stabilized halting the production
of MDEf
Capillary membranes in the brain
are stabilized, and capillary
permeability reduced.6
Through its network of protective
actions, Solu-Medrol strengthens
the chain of organ systems and
increases the shock patient’s
chances of survival.

PR E V E N T IN G A N AERO BIC
IN FE C T IO N
(continued from page 141)

Sterile,

Solu-Medrol
(methylprednisolone sodium succinate)
Action:
Solu-Medrol, like other corticosteroids, exerts its action
by its anti-inflammatory effect.
Indications and Clinical Uses:

Intravenous administration of Solu-Medrol is indicated
in situations in which a rapid and intense hormonal
effect is required.
Shock:

In severe shock adjunctive use of intravenous methyl
prednisolone sodium succinate (Solu-Medrol) may aid
in achieving hemodynamic restoration. Corticoid
therapy should not replace standard methods of
combating shock, but present evidence indicates that
concurrent use of large doses of corticoids with other
measures may improve survival rates. In particular,
large pharmacological doses of Solu-Medrol have been
proven useful in bacteremic or endotoxin shock,
hemorrhagic shock, traumatic shock, and cardiogenic
shock.

Symptoms and Treatment of Overdosage:

Contraindications:

Except when used for short-term or emergency therapy
as in acute sensitivity reactions, Solu-Medrol is
contraindicated in patients with arrested tuberculosis,
herpes simplex keratitis, acute psychoses, Cushing’s
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:

Existence of diabetes, osteoporosis, chronic psychoses,
active tuberculosis, renal insufficiency or predisposition
to thrombophlebitis requires that Solu-Medrol be
administered with extreme caution. In the presence of
infection, the causative organism must be brought
under control with appropriate anti-bacterials, or
therapy with Solu-Medrol should be discontinued.
While therapy with corticoids does not appear to be
contraindicated in pregnancy, caution is recommended,
particularly during the first trimester. Also, newborn
infants of mothers who received such therapy during
pregnancy should be observed for signs of hypoadrenalism and appropriate measures instituted if such
signs are present. Since Medrol, like prednisolone, sup
presses endogenous adrenocortical activity, it is highly
important that the patient receiving Solu-Medrol be
under careful observation, not only during the course
of treatment but for some time after treatment is
terminated. Adequate adrenocortical supportive
therapy including ACTH, must be employed promptly
if the patient is subjected to any unusual stress such as
surgery, trauma, or severe infection. Patients should be
advised to inform subsequent physicians of the prior
use of Solu-Medrol.
There have been a few reports of cardiovascular
collapse associated with the rapid intravenous admini
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause
and relation to other medications (i.e., diuretics) is not
known at this time, but physicians should be alert to
this possibility.
Adverse reactions are not likely to result from short
term intravenous administration of Solu-Medrol, but
may be anticipated if continued therapy with oral or
intra-muscular corticosteroid preparations is to follow.
Medrol has less tendency than prednisolone to induce
retention of sodium and water, and in some cases has
been observed to produce diuresis and an increased
excretion of sodium. Likewise, therapy with Medrol
appears to produce less nervousness and psychic
stimulation than that produced by prednisolone. While
epigastric distress has not been totally lacking in
patients receiving Medrol, the incidence and severity of
this side reaction to date suggest that although Medrol
has an enhanced anti-inflammatory potency when com
pared with prednisolone on a weight basis, the socalled ulcerogenic potential of this corticosteroid is no
greater, and may even be less, than that of
prednisolone.
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Single large doses of Solu-Medrol do not have any
apparent toxic effect and require no specific therapy.
Continuous overdosage would require careful gradual
reduction of dosage in order to prevent the occurrence
of acute adrenal insufficiency.
Dosage and Administration:

In treating severe shock there is a tendency in current
medical practice to use massive (pharmacological)
doses of corticosteroids. The following are Solu-Medrol
doses suggested by various authors:
Author

Dose

Repeat

Oaks
Weil
Melby
Cavanagh
Dietzman

100 mg
200 mg
250 mg
15 mg/kg
30 mg/kg

Every 2-6 hours
100 mg. every 4-6 hours
Every 4-6 hours
Every 24 hours
In 4 hours if needed

Therapy is initiated by administering Solu-Medrol
intravenously over a period of at least 10 minutes. In
general high dose corticosteroid therapy should be
continued only until the patient’s condition has
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose
short term corticoid therapy are uncommon, peptic
ulceration may occur.
In other indications initial dosage will vary from 10 to
500 mg depending on the clinical problem being
treated. The larger doses may be required for short
term management of severe, acute conditions. The
initial dose usually should be given intravenously over
a period of at least 10 minutes. Subsequent doses may
be given intravenously or intramuscularly at intervals
dictated by the patient’s response and clinical
condition.
Availability:

As Solu-Medrol (methylprednisolone sodium succinate)
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials
with water for injection.
Product monograph is available on request.

Adverse Reactions:

With the exception of the differences noted in the
preceding paragraph, Medrol is similar to hydro

cortisone and prednisolone in regard to the kinds of
adverse reactions and metabolic alterations to be
anticipated when treatment is intensive or prolonged.
Negative nitrogen balance is usually counteracted by a
high protein intake. In patients with diabetes mellitus,
Solu-Medrol may increase insulin requirements during
the period of administration. Ecchymotic manifesta
tions, while noted only rarely during the clinical
evaluation of Medrol, may occur. Excessive loss of
potassium is not likely to be induced by effective
maintenance doses of Medrol. If such reactions are
serious or distressing to the patient, reduction in
dosage or discontinuance of corticoid therapy may be
indicated. While a retardant effect on wound healing is
seldom encountered, except in high doses, it should be
a matter of consideration when Solu-Medrol is admin
istered in conjunction with surgery.
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6. Care in the Terminal Stage of Carcinoma
of the Pancreas
P e t e r H.S. G e g g i e ,

Palliative care of the patient with
terminal cancer of the pancreas
concerns itself with pain, anorexia,
nausea and vomiting, bowel and
bladder disturbances, sleep aberrations,
jaundice, hydration, nutritional state,
neuropsychiatric disorders and
attitude of patient and family towards
the disease and its implications.
Each of these facets has a bearing
on the quality of life remaining.
The administration of pain
medication should consider the role
of anxiety in the intensification of
pain and an anxiolytic or sedative
agent can be added if necessary.
Specific kinds of pain should be
dealt with in specific ways. Gastro
intestinal conditions such as constipa
tion, nausea and obstruction should
be eliminated. Anorexia may cause
debilitation and may also rob the
patient of purpose and emotional
pleasure.
Chez le malade atteint d'un cancer
du pancreas en phase terminate,
les soins palliatifs s'interessent a
la douleur, I’anorexie, la nausee et
aux vomissements, aux troubles de
I’intestin et de la vessie, aux
perturbations du sommeil, a I’ictere,
I’hydratation, I'etat nutritionnel, aux
troubles neuropsychiatriques et a
I'attitude du patient et de sa famille
devant la maladie et des implications.
Chacun de ces aspects influent sur la
qualite de ce qui reste de la vie.
La medication antalgique devrait
tenir compte du rdle joue par
I'anxiete dans ('intensification de la
douleur, et un anxiolytique ou un
sedatif pourra etre ajoute au besoin.
Des types specifiques de douleur
doivent etre traites de facon specifique.
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On doit veiller a eliminer les
troubles digestifs tels que constipation,
nausee et obstruction. L'anorexie peut
causer de la debilite et aussi soustraire
au malade le plaisir a la fois utile
et emotionnel d’un repas.

Cancer of the pancreas leads to death
by inanition, biliary obstruction, local
extension or distant metastatic disease.
To compound these effects of the
disease, depression and a sense of
impending doom are associated with
this neoplasm far more frequently
than with other abdominal neoplasms.
Palliative care of any disease begins
at the time of diagnosis, is fostered
by a sincere doctor—patient relation
ship, and ends with the cure of the
disease or death of the patient. Cancer
of the pancreas, with its increasing fre
quency, its myriad presenting forms
and its severe symptoms coupled with
the generally dismal results of treat
ment, exemplifies the problems facing
the health care team. Interestingly
Cicely Saunders1 noted that of the
patients admitted to St. Christopher's
Hospice in 1976, less than 5 % had
carcinoma of the pancreas.

Clinical History
As for any medical problem, close
attention to the clinical history is vital
to an understanding and rational treat
ment of the patient’s problems. In the
terminal stage of a disease from any
cause a problem-oriented approach is
usually more efficient than a system
review. For carcinoma of the pan
creas, the following specifics should
be clarified.
• With respect to pain, the site,
areas to which it radiates, its intensity,
and whether it is time- or positionrelated should all her noted. It is also
important to know what alleviates the
pain and what aggravates it. Is it con
tinuous or intermittent? How many
days or weeks has it been present?
• Questions about appetite should
be concerned with its presence or ab
sence, whether the sight of food causes
nausea and whether anything alleviates
the nausea.
• It is important to know when
and how often nausea and vomiting

occur, what provokes them or what
improves them.
• Does the patient have any dis
turbance of bowel or bladder func
tion?
• The sleep patterns before the
onset of the illness and after should
be sought, including the time rela
tion of any aberration and any regular
feature present on waking, such as
pain or the need to urinate.
• If jaundice is present is it con
stant or intermittent, stable or wor
sening? Is pruritus present?
• Performance status may be
assessed according to the Karnofsky
scale,2 or the Eastern Cooperative On
cology Group method.3 While these
methods of evaluation are designed as
purely physical status measurements,
they correlate reasonably well with
the patient’s quality of life and may
provide a rough guide to the manage
ment of the individual.

Physical Examination
After a precise history of the ill
ness has been obtained, a thorough
physical examination should be done
with emphasis on problems already
identified and the following.
• Look for early signs of pressure
sores. This is vital in all cancer pa
tients because they tend to lose weight
and may become partially or com
pletely bedridden. Prevention is the
best treatment for pressure sores.
• Examine the mouth and tongue.
They will give early clues to the de
gree of hydration and the patient’s
nutritional status and may identify
ulceration or early fungal infection
requiring attention.
• Check the abdomen for disten
sion, state of any stomas, and pre
sence of any masses, ascites or hepa
tomegaly. A rectal examination is
mandatory to check for impaction and
perianal infection.
• Make a careful neurologic ex
amination, recognizing that the dis
tinction between the symptoms of
metastatic disease and neuropsychi
atric disorders may be difficult.
Having completed the physical
examination the physician must be
certain that everything found is attrib
utable to the cancer and not to a
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treatable complication. If the findings
indicate the possibility of a treatable
disorder, a careful therapeutic decision
must be made in conjunction with the
patient, the family and the other at
tending physicians. In this context a
decision on whether conventional ther
apy, such as radiotherapy, surgery,
chemotherapy and hormone adminis
tration has been exploited fully must
be taken. The physician must take
care not to be too rigid in applying
the “cure or care” philosophy, but
rather ensure that the treatment is
appropriate for all stages of the
disease.
Psychologic Assessment

A psychologic assessment of the
patient must be attempted. In the
context of terminal disease two strong
emotions clash: fear of the unknown
and grief over leaving the familiar
world.
These strong emotions vary from
patient to patient and from time to
time within the same patient. They
also vary with age, responsibilities,
expectations and previous life experi
ences. Regardless of the psychologic
balance of the individual, communica
tion with the patient on his or her
level, not on the level of the health
care professional, is the key to the
psychologic support a dying patient
requires. One must not forget the
family for the answer to the question
“how will they get along after I am
gone?” will either be a source of
strength or anxiety for the patient.
Pain

Benoleil4 wrote in 1974, “if most
nurses carry the notion that pain is
usual with cancer, then one must as
sume that many nurses believe that
pain and cancer always go hand in
hand (as does the public at large)".
In fact, about 50% of patients with
advanced cancer have no pain or
negligible pain, 40% severe pain and
10% mild pain. Unfortunately pan
creatic cancer usually causes severe,
boring abdominal and back pain, thus
successful pain management is the
key to management of patients with
terminal pancreatic carcinoma.
Relief of pain should be a priority
even at the time of initial diagnosis.
This can be achieved by bilateral
operative resection of the splanchnic
nerves or by injecting alcohol or
phenol into them or into the celiac
ganglion. The possible roles of chemo
therapy and radiotherapy in pain
relief should be considered; how
186

ever, because of the poor response of
pancreatic carcinoma to these modal
ities their roles are still uncertain. I
would be encouraged to use them in
the interest of a clinical trial but not
at random.
The physician must also assess the
degree to which the intensity of pain
can be attributed to anxiety or other
somatic conditions. Pain medication
should be prescribed accordingly.
Since there are so many pain medica
tions available I have reduced my list
to one or two preparations to suit the
degree of pain intensity: for mild pain,
aspirin or Tylenol: for moderate pain,
codeine or Percodan; for severe pain,
Levo-dromoran; for very severe pain,
oral morphine solution (methadone
if available).
At each level of pain intensity an
anxiolytic or sedative agent may be
added.
Maintenance of normal bowel func
tion is important in patients with
pancreatic cancer since constipation is
common. A program of laxatives and
diet with or without suppositories and
enemas should be instituted and
must be given in conjunction with the
pain medication.
The pain associated with cancer of
the pancreas is chronic, a constant
state rather than episodic acute pain.
Sedation is thus undesirable and the
analgesic effect of the medication
should be as prolonged as possible.
The drugs should be given orally at
regular intervals, in an attempt to
abolish the memory of the pain state
and at a dosage that is individually
determined.
Specific causes of pain may require
more specific therapy. Bone pain is
often helped by the addition of an
anti-inflammatory agent such as indomethacin or prednisone. These drugs
probably work by inhibiting prosta
glandin synthesis while the steroids
offer the added advantages of appetite
stimulation and mood elevation. Nerve
compression pain may also be helped
with steroids. Palliative radiotherapy
also has a role to play in reducing
severe localized soft tissue and bone
pain. Infection should be treated.
Diversion therapy by visits of family
and friends, use of television and
other social activities should be en
couraged as much as feasible.
Gastrointestinal Complaints

Treatable gastrointestinal conditions
should be eliminated. For example,
nausea and vomiting may be due to
drugs such as morphine or to hyper
calcemia or gastric irritation or may
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reflect impending or actual intestinal
obstruction. One must never forget
the possibility of raised intracranial
pressure in this context.
It is best to prevent intestinal ob
struction. In instances where obstruc
tion is a possibility, a program of diet
and laxatives should be instituted at
the time of diagnosis. Obstruction
caused by terminal disease progresses
slowly and intermittently providing
many chances for therapeutic inter
vention if one is attuned to the need.
If the care is good there is little
need for nasogastric tubes, intravenous
lines or palliative colostomies. Initially
a diet with or without a stool softener
(Colace or Metamucil) and a laxative
(Senokot daily or every second day)
is used. As the obstruction increases
painful colic may be present. This is
often well controlled with Lomotil. If
the problem continues to worsen the
Colace should be discontinued and the
patient may require analgesia or an
tiemetics given by injection or sup
pository. With good management of
the pain and nausea the patient may
be quite comfortable with only one or
two episodes of vomiting a day. The
occasional episode of vomiting with
out concomitant nausea is generally
more acceptable than a nasogastric
tube.
Terminally the patient will become
dehydrated. The most distressing
symptom of dehydration is a dry
mouth, which can usually be helped
by frequent sips of water or crushed
ice.
Another gastrointestinal complaint
that often causes much distress is
anorexia. Eating is normally associated
with good health, so when a cancer
patient has no appetite, not only is
he concerned but so is his family. In
the context of a terminal illness the
family meal may be the last social
function that the patient is able to
tolerate and thus when he cannot or
is unwilling to partake of the family
meal, the level of anxiety often in
creases. Attention to this should be
given early while the patient still has
an appetite. Intelligent counselling to
ensure as palatable and nutritious a
meal as possible is only feasible when
the patient still has the desire to eat.
Some useful tricks include the pro
vision of small portions of attractively
prepared food, catering to the patient's
whims and fancies and perhaps an
aperitif before meals. One must be
cognizant of the taste aberrations re
ported by DeWys and Walters5 and
compensate by the judicious use of
spices and seasoning. The only drugs
that have been shown to be effective
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in treating anorexia are glucocorticosteroids. Prednisone orally (5 mg tid)
may improve appetite within a week
and sometimes also reduces the taste
aberrations.
There are five main groups of anti
emetics. Usually the symptoms can
be controlled with an adequate dose
of one agent, but they can be com
bined if required.
• Phenothiazines such as chlorpromazine and prochlorperazine also
have a tranquillizing effect.
• Antihistamines, such as cyclizine, in my experience are generally
less effective in treating the nausea
associated with terminal illness than
the phenothiazines.

• Metoclopramide (Maxeran) has
the added advantage of stimulating
normal bowel peristalsis and thus is
often useful for patients with ab
dominal tumours.
• Anticholinergics (e.g., hyoscine),
are useful in reducing bowel motility
but they also reduce saliva production
which is a major disadvantage.
• Dexamethasone has been shown
to reduce the vomiting associated
with chemotherapy. (Much has been
written about the use of cannabis in
the same situation.)
In conclusion, the patient with can
cer of the pancreas in its terminal
stage needs a physician who under
stands his needs both physically and

emotionally. Adequate relief of pain
and gastrointestinal symptoms are of
primary importance.
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7. Panel Discussion
Chairman: J.E. Mullens
Panelists: P.H.S. G eggie, C-S. H o , A.H. Q izilbash, Lord Smith of M arlow, M.E. T ulloh

Dr. Mullens: Dr. Ho. in your series
one patient died as a result of the
pancreatic biopsy. Would you tell us
more about this?
Dr. Ho: One patient did die as a re
sult of percutaneous fine-needle
aspiration biopsy; this has not been
reported as yet. This woman had per
sistently elevated levels of carcinoembryonic antigen and therefore un
derwent investigation for occult malig
nant tumour in the abdomen. Endo
scopic retrograde cholangiopancrea
tography (ERCP) and computerized
axial tomography (CAT) both showed
evidence of a small mass in the head
of the pancreas so we did a fineneedle aspiration biopsy of this area.
The next day pancreatitis developed.
It could not be controlled. She had
a couple of operations for drainage of
the pancreatic bed and died several
weeks later.
Dr. Mullens: At autopsy was a car
cinoma found?
Dr. Ho: The pancreas was so badly
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destroyed that it was impossible to
say whether there was a malignant
lesion or not.
Dr. Mullens: It is unusual to have a
death from aspiration biopsy.
Dr. Ho: We have done biopsies in
about 100 patients and this is the only
death we have had.
Dr. Mullens: While we are speaking
of needle biopsies, I would like to ask
Dr. Qizilbash a question. Dr. Qizil
bash. you indicated that you were
satisfied with the quality of needle
biopsies. Does this also apply to the
needle biopsy you receive for frozen
section for the intraoperative diagnosis
of carcinoma of the pancreas?
Dr. Qizilbash: You mean needle biop
sy rather than cytology?
Dr. Mullens: Yes. The needle biopsy
specimen obtained at the time of
operation for diagnosis in the oper
ating room.
for. Qizilbash: 1 think needle biopsy
should be done most of the time if
possible, and personally, as a pathol
ogist, I have no problems looking at
needle biopsies. As I said, the problem
really is not in the interpretation but
in sampling. If the first specimen
shows no tumour we should get an
other one, taking two or three biop
sies if necessary. As long as the
surgeon is willing to do the biopsy, 1
am sure the pathologist would be
eager to look at it.
Dr. Mullens: l.ord Smith, when you
are trying to decide whether to carry
out resection, do you use biopsy or

needle aspiration, or do you depend
upon the macroscopic findings?
Lord Smith: Well, we often use biopsy
for a possible metastasis in the liver,
for what appear to be metastatic
lymph nodes or for a large tumour
of which you can obtain only a peri
pheral piece and which is a long way
from the pancreatic duct. What wor
ries me about this insistence upon
biopsy or even cytology with a fine
needle is that histologic help of this
kind is only a help to me if I
am in doubt about how I am going
to proceed. If I intend to resect
whatever the biopsy shows, I see no
advantage in doing it at all, and I am
convinced as was Dr. Cattell (who
was right in so many things) that the
good results of the Whipple operation
are almost always obtained when you
cannot feel a tumour at all. When
there is a small tumour in the lower
end of the common bile duct, it
is extremely difficult to get a
representative piece of primary tu
mour. These are the only circum
stances in which the long-term results
of the Whipple operation are ex
tremely good. If the tumour is large
and you can be certain of getting a
representative specimen by biopsy, or
if there are metastatic lymph nodes,
which give the game away anyhow,
you can get a positive biopsy readily:
but these are the cases in which you
are not going to get a very good re
sult. So in my practice I use biopsy
infrequently.
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Dr. Mullens: Is there any problem
then, with your radiotherapists or
chemotherapy colleagues, or the pa
tient’s family, when you tell them that
the diagnosis is not histologically
established, but you have done a
palliative operation for carcinoma?
Lord Smith: Certainly there is. And
when you write up a series of patients
in whom you have, for instance, per
formed palliative surgery and then
followed it up with chemotherapy and
radiotherapy, and you have to accept
that some of these are not going to be
histologically proven, this militates
against the value of your paper, but
you can’t help that. If I had a patient
with malignant jaundice, tumour in the
head of the pancreas, no metastatic
nodes and nothing in the liver, my
reason for not resecting that tumour
is local infiltration. I am not going to
do a biopsy just for curiosity, or
because I want to make a definitive
diagnosis for some paper I might
write later on. I have seen a number
of cases in which the surgeon has
made a large hole with a needle into
the middle of an edematous head of
pancreas with a tumour in it. It has
been good for his curiosity, but the
patient has died of acute pancreatitis.
This is a real risk.
Dr. Mullens: Dr. Tulloh, if a patient
is referred to you for radiotherapy, I
presume that you do not like to give
them radiotherapy unless you have a
histologic diagnosis. I do not want to
harp on this point, but it seems that
this is one of the reservations the non
operative team has before it will
proceed to other forms of treatment.
Am I correct in this?
Dr. Tulloh: I don't think so really. If
you are dealing with an individual, the
real problem is that you may be work
ing within a study protocol, and you
have to take certain steps in your pro
tocol before the patient can be ac
cepted into that series. One of these
is always histologic proof. However, I
have no problem in accepting, for
example, your or Lord Smith’s opinion
of what is cancer or what is not. If
you see the tumour in the pancreas
and you believe that it is malignant
but that biopsy is not justified, then I
think there is no problem in irradiating
that patient or in giving chemotherapy.
Dr. Mullens: With the combination of
chemotherapy and radiation discussed
in your paper, there has been some
improvement in the duration of sur
vival of patients with carcinoma of the
pancreas, but I gather that you are not
enthusiastic about radiotherapy alone.
Now that we are able to diagnose car
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cinoma before operation, is there any
merit in preoperative radiotherapy?
Dr. Tulloh: I think there is, but the
main argument for the use of preoperative therapy is to kill the tumour
at its edges to prevent hematogenous
spread. In carcinoma of the pancreas,
the history of the disease is one of
local recurrence and this would not
be affected by preoperative therapy.
Also preoperative therapy would pos
sibly militate against a successful re
section.
Dr. Mullens: Dr. Geggie, in your
paper you talked about splanchnic
nerve division and celiac ganglion al
cohol block. Would you elaborate?
Dr. Geggie: First, could I say some
thing about diagnosis and chemotherapists, since this is an area in which
I work all the time? I see about one
patient per year with a large mass
somewhere in the area of the pancreas
and a pathologic diagnosis of undif
ferentiated carcinoma made on a small
piece of tissue that has been snipped
out of this mass. There is an entity,
histiocytic lymphoma, that may arise
in this area and for which the treat
ment is quite different. The prognosis
is infinitely better than it is for car
cinoma of the pancreas. From the
point of view of chemotherapy I
would make a plea that every effort
be made to diagnose it because treat
ment of histiocytic lymphoma may
offer some hope for long-term sur
vival, much more so than carcinoma
of the pancreas. If you do not distin
guish histiocytic lymphoma from car
cinoma of the pancreas, you will be
treating some of these lesions inade
quately. Now let us consider the treat
ment of someone with chronic pain.
Chronic pain tends to cloud every
activity of that patient. The ideal
situation is to treat the pain without
oral or parenteral medication. Celiac
axis block with alcohol represents the
ideal form of pain management for
patients with pancreatic carcinoma. It
is done by anesthetists in our pain
clinic. It is rapid and relief comes
within 30 minutes or so from the
time of injection. The relief persists
and the injection can be repeated if
necessary later.
This procedure provides, from my
point of view, the optimal physical
state for that patient. If you relieve
pain, the patient’s appetite and sense
of well-being improve. You can always
add other medication if it is required,
but you can practically guarantee the
patient relief of pain.
Dr. Mullens: Lord Smith, would you
comment.
Lord Smith: Before commenting, I
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want to return to the important ques
tion of diagnosis with or without
biopsy. I must quote Dr. Cattell again.
He said that if a surgeon is operating
on a jaundiced patient and is having
trouble making a diagnosis on a pan
creas with a lumpy and irregular head,
his problem is that he is looking at
the wrong part of the patient; he
should be looking at the common bile
duct. If the common bile duct is 1V2
to 2 inches wide, is thin walled and is
not inflamed, that means that the pa
tient has a tumour. Although there are
some inflammatory conditions that
cause a lumpy pancreatic head and
jaundice, these are pancreaticobiliary
inflammatory processes, and the com
mon bile duct is thick walled, white
and opaque and looks quite different.
I believe that this point is true and I
would like to put a question to my
fellow panelists. If you have a patient,
a man or a woman 65 years of age,
who was perfectly well until 6 weeks
ago but then started getting jaundice
that has deepened inexorably, and you
find that the gallbladder is much en
larged, that is, a Courvoisier gallblad
der, that there is a very large common
bile duct which is not inflamed and is
thin walled, and that there is a local
mass in the head of the pancreas, on
how many occasions have any of you
found that this was not a cancer? I
cannot remember a single case ever.
Dr. Mullens: Is that a rhetorical ques
tion? Since no one answers, I assume
that no one else has seen such a case.
Lord Smith, what would you recom
mend to the surgeon Who discovers a
periampullary carcinoma in the oper
ating room and is not prepared to do a
Whipple operation?
Lord Smith: Is the patient jaundiced?
Dr. Mullens: I presume the patient is
jaundiced.
Lord Smith: I believe that the surgeon
should do a cholecystostomy. Bring
the little tube out a long way laterally,
as far away from the operative area as
possible, and transfer that patient to a
centre where a Whipple operation can
be performed. 1 do not think the sur
geon should do an anastomosis of
the biliary tree to the intestine. This
procedure can make the operative area
surgically unapproachable. A simple
cholecystostomy with a catheter in the
fundus of the gallbladder but a long
way out laterally will not interfere
with a resection.
Dr. Mullens: Suppose the patient has
had the gallbladder removed previous
ly?
Lord Smith: Then you can put a Ttube in the common bile duct. I think
that a surgeon who has not done a
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than that. I think that the passage of
time is the only treatment.
Speaker from Audience: I would like
to ask Lord Smith if he performs a
vagotomy when he does a Whipple
operation?
Lord Smith: No. You must perform a
vagotomy or divide the stomach high
up. In the original Whipple operation,
the stomach was divided just above
the pylorus. In a high percentage of
patients who had this operation stomal
ulceration developed. Dr. Cattell wrote
that this did not happen at the Lahey
Clinic, but Kenneth Warren, who
analysed these cases many years later,
found that in fact there were a great
number of patients who had stomal
ulceration. So, I think that you have
to do one of the two. My preference,
having to divide the stomach some
where, is to take a few more minutes
and divide it high up rather than
open the mediastinum to do a vago
tomy as well. I am always very con
scious, when doing a Whipple oper
ation that bile or pancreatic fluid
should not leak into the retroperitoneum. Nevertheless there may be
occasional temporary small leaks, and
1 am not certain that these would be
inconsequential if there was access
into the mediastinum.
Dr. Mullens: There is time for one
more question. Lord Smith, all carci
nomas of the pancreas are not neces
sarily obstructive and if you encounter
a patient who is not jaundiced but
who has an enlarged head of the pan
creas and you suspect carcinoma what
would you do?
Lord Smith: Is this a nonjaundiced
patient with epigastric pain, backache
and loss of weight?
Dr. Mullens: Yes, I presume so.
Lord Smith: If you find the lesion re
sectable it should be resected but as I
have pointed out earlier this should
not be attempted if the tumour in
volves the groove in which the portal
vein lies. If it does not then you can
carry out a resection. Most of these
patients have metastases in the liver,
and often local recurrence occurs in
1 or 2 months, so I do not think that
you improve the outlook. But I would
resect it if I think it is a tumour, and I
think that it is resectable. I would like
to refer back to my remarks about the
common duct. A local mass in the
head of the pancreas or in any part of
the pancreas with the rest of the pan
creas looking normal is hardly ever
anything else but a tumour. If you
think it is a cyst you can put a needle
into it and see, of course. You must
be careful not to miss a cystadenocarcinoma. This is very important be-

Whipple operation before, or who has
not helped his chief do at least three,
should not seize upon this case, and
say “this is my great opportunity to
do a Whipple operation”.
Dr. Mullens: If you are going to do a
bypass operation to relieve the jaun
dice and you think that the cancer is
unresectable, would you inject alcohol
directly into the celiac plexus at that
time?
Lord Smith: No, but there is another
way to relieve pain that has not been
mentioned so far. These tumours
cause obstruction to three systems:
the biliary tree, the alimentary tract
and the pancreatic duct. The pan
creatic pain is often due to increased
tension in the pancreatic duct. This is
easy to relieve. If the tumour is in the
head of the gland and there is ob
struction of the pancreatic duct, the
duct may be as large as a little finger.
One can incise this duct, put a T-tube
in it and bring out the long limb
through the lumen of the stomach to
the exterior. This creates a pancreaticogastric fistula and in a high per
centage of cases it will stop pancreatic
pain. If it does not, then you can
consider paravertebral blocks and
other methods. We use them in some
cases.
Dr. Mullens: Dr. Ho, are there any
hazards to injecting contrast media
into an obstructed pancreatic or bile
duct?
Dr. Ho: Yes, it can be risky to inject
contrast medium into an obstructed
system. With percutaneous transhepatic cholangiography we give anti
biotics prophylactically, but it is even
better to relieve the obstruction. When
we get into the common bile duct we
leave a catheter in the duct and bring
it out through the liver and through
the skin. We may be able to pass the
catheter through the site of obstruc
tion and into the duodenum to drain
the system internally. If the obstructed
system is drained there is less chance
of complications.
Dr. Mullens: You advocated the use
of isotopic liver scanning in your pre
sentation. Some of us on this platform
and in the audience I know believe
that liver scanning has been sup
planted by more accurate methods of
diagnosing liver metastases. Would
you comment on this?
Dr. Ho: Yes, I appreciate that liver
scanning may be misleading. That is
why fine-needle aspiration biopsy may
be helpful here too. We use the liver
scan to guide the needle to the area
where the lesions are indicated. By
using it in association with a needle
biopsy, it becomes more accurate, and

the pathologist may even tell us the
origin of the metastases. Each modal
ity used for diagnosing metastases is
valuable for different reasons. When
isotope scanning is used with aspira
tion biopsy we can avoid making false
positive diagnoses.
Dr. Mullens: Dr. Tulloh, you are an
expert on isotopes, would you com
ment on this?
Dr. Tulloh: We are getting into a
controversial area. Needle biopsy
guided by ultrasonography or by com
puted tomography is a more precise
way to diagnose liver metastases. I
would like to return to the subject
of celiac plexus injections. The re
sults are extraordinarily good. Ap
proximately 80% of pain is relieved
and about 90% of these patients have
no further pain until death. However,
there is one thing that troubles me;
if we relieve visceral pain and bowel
obstruction develops later, are we
going to be misled when trying to
make a diagnosis?
Dr. Mullens: I will refer that question
to Lord Smith or Dr. Geggie.
Lord Smith: I am not sure that I have
the answer to that, but I think it is
unlikely that the clinical presentation
of obstruction will be masked. The
clinical presentation of obstruction is
quite different from the boring pan
creatic pain that you have tried to
relieve. I think that if obstruction de
velops you will be able to diagnose this
clinically and confirm it radiologically
without putting the patient in any jeo
pardy.
Dr. Mullens: Lord Smith, why is it
that gastroenterostomies drain so
poorly when they have been done as
palliation for a carcinoma of the
head of the pancreas obstructing the
duodenum?
Lord Smith: I do not know why this
is true, but it is so. It is true not
only of the patient who has under
gone a palliative gastroenterostomy,
but also of the patient who has had a
successful Whipple operation and has
a wide open stoma between the
divided stomach and the jejunum. You
often find that it takes a long time
before the gastroenterostomy will
work. The surgeon may get very
worried about this and may even be
impelled to reoperate, thinking that
there must be an edematous stoma
and that the anastomosis should be
revised. I believe this poor drainage
must be due to the splanchnic effect.
I think it, is functional. Tt certainly is
not organic. You may have a wide
open gastroenterostomy but, neverthe
less, there is no drainage for 7 to 10
days, and occasionally for even longer
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cause cystadenocarcinomas are very
different from carcinoma simplex.
Many patients who have had a cystadenocarcinoma removed will live for
many years.
Dr. Mullens: Our time has expired. To
summarize: we have covered a few of
the aspects of carcinoma of the pan
creas. it is now possible to make an
accurate diagnosis of carcinoma of
the pancreas with the various radiol
ogic modalities and by percutaneous
transhepatic
cholangiography.
At
operation the diagnosis is one that is
made primarily by the surgeon on
evaluating the local tumour. A needle
biopsy may be taken, but histologic
diagnosis should not slavishly he
sought if it puts the patient in jeo
pardy: there may be circumstances in
which it is indicated and at these
times the pathologist may give a
quick-section diagnosis from a needle
biopsy. The combination of operation,
postoperative chemotherapy and ra
diotherapy offers reasonable palliation
for carcinoma of the pancreas, but
cure rates are still depressingly low.
The operation for cure of carcinoma
of the pancreas has a high morbidity
and mortality in inexperienced hands
and it should not be essayed by sur
geons unfamiliar with the procedure.
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A consecutive group of 100 patients
over the age of 40 years, who were
operated upon for histologically proven
acute appendicitis, were reviewed.
Although there were no deaths, 36
had complications, of which 30 were
related to wound infection. Thirty-one
patients were found at operation
to have perforation. Of these 100
patients, 13 could have had their
appendices removed previously at the
time of an elective laparotomy.
The morbidity of incidental appen
dectomy was reviewed in 200
randomly selected patients, also over
the age of 40 years, who underwent
either elective hysterectomy or
cholecystectomy. Half had an incidental
appendectomy and the other half did
not. The indication for appendectomy
was the preference of the surgeon.
There was no important difference in
operative or postoperative problems
in the two groups of patients.
The authors conclude that incidental
appendectomy is a worthwhile and
safe procedure unless there are
specific contraindications.
On a etudie un groupe de 100 patients
consecutifs ages de plus de
40 ans qui ont ete operes pour une
appendicite aigue demontree a
I'histologie. Bien qu'on n'ait enregistre
aucun deces, 36 malades ont eu des
complications dont 30 etaient
rattachees a des infections de plaies.
A I'operation, une perforation a ete
constatee chez 31 malades. Sur les
100 patients, 13 malades auraient pu
subir la resection de I'appendice a
I'occasion d'une laparotomie non
urgente.
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La morbidity associee a une appendicectomie incidente a ete etudiee
chez 200 malades choisis au hasard
qui etaient aussi agees de plus de
40 ans et qui avaient subi une hysterectomie ou une cholecystectomie non
urgente. La moitie de ces patients
avaient eu une appendicectomie
incidente; I'autre moitie en avait ete
exemptee. L'indication de proceder a
I'appendicectomie dependait de la
preference du chirurgien. On n'a
observe aucune difference importante
dans les problemes per- et postoperatoires chez les deux groupes
de malades.
Les auteurs concluent que I'appen
dicectomie incidente est une inter
vention utile et sure a moins qu'il
existe des contre-indications
specifiques.

Acute appendicitis is a common sur
gical emergency. Over 100 000 pa
tients undergo appendectomy annually
in the United States.1 More than 15%
are over the age of 40 years.2 This dis
ease is associated with an appreciable
morbidity which is more pronounced
in the elderly.
Although appendicitis was once con
sidered uncommon in the older pa
tient, its prevalence in this age group
appears to be increasing perhaps be
cause of greater longevity but possibly
because of a decreased frequency in
young people.2 The elderly suffer
more complications associated with
serious problems.21 This may be owing
to several factors. Appendicitis in the
elderly may have unusual clinical fea
tures.2'4 Patients often delay seeking
medical attention and consequently
the rate of perforation found at oper
ation is higher. Peltokallio and
Jauhiainen5 claim that perforation ac
tually occurs earlier in the older
patient. Appendicitis in the elderly is
often difficult to diagnose further
complicating and possibly delaying
early institution of treatment. This

group of patients is further compro
mised by serious generalized degener
ative diseases that affect their ability
to respond to therapy and consequent
ly increase morbidity.
Acknowledging the problem of
appendicitis in the older patient, we
initiated this study to answer three
questions:
• What is the morbidity and mor
tality of appendicitis in the patient
over 40 years of age?
• How many elderly patients in
whom appendicitis develops could
have been spared the disease by an
incidental appendectomy performed
at the time of a previous laparotomy?
• Does incidental appendectomy
increase the morbidity of elective
laparotomy?
Patients and M e th o d

This retrospective study consisted
of three groups of patients. All were
over the age of 40 years and each
group comprised 100 patients admitted
to the Kingston General Hospital be
tween 1971 and 1979.
Group 1 consisted of patients (60
men and 40 women) admitted conse
cutively with a diagnosis of acute
appendicitis. Only those whose diag
nosis was confirmed microscopically
were included. Their mean age was 55
years (range 40 to 92 years). Oper
ative and postoperative complications
were recorded. A careful analysis was
also made of previous abdominal oper
ations to determine whether an in
cidental appendectomy could have
been performed without jeopardizing
the welfare of the patient.
In group 2 were 100 patients (age
range 40 to 88 years, Table I) selected
at random who underwent elective
cholecystectomy. Half the group had
a concomitant incidental appendec
tomy, while the other half did not. The
decision to perform the appendectomy
was the surgeon’s and was not in-
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fluenced by other factors. Group 3
patients (age range 40 to 81 years,
Table 1) were similar to those in group
2 except that the patients all under
went an elective gynecologic operation.
Again half had an incidental appen
dectomy for the same reasons as
patients in group 2.
Morbidity and mortality were de
termined for each group.
Results
Group 1

Thirty-one patients had a perforated
appendix identified at operation. The
complication rate was 36%. The most
common complication was wound in
fection which occurred in 30% over
all and in 42% of the patients with
perforation. Other complications in
cluded prolonged paralytic ileus (three
patients), pneumonia (two patients)
and mechanical bowel obstruction
postoperatively (one patient). There
were no postoperative deaths and the
average hospital stay was 9.8 days.
Of these 100 patients the records
revealed that 13 had previously un
dergone an elective abdominal oper
ation during which an incidental ap
pendectomy could have been per
formed. These 13 operations con
sisted of 6 gynecologic procedures, 4
cholecystectomies, 1 urologic proce
dure and 2 laparotomies done for
other reasons.
Group 2

There was little difference in the
duration or difficulty of operating or
in the mean length of hospital stay
postoperatively.
The complication
rate in both groups was 10% (Table
I). There were no important wound
infections in either group. The com
plications included four cases of urin
ary tract infection, one of bile fistula,
one of pneumonia, two of prolonged
atelectasis, one of common bile duct
stenosis after duct exploration and
sphincterotomy and one of severe
confusional state.

Group 3

The elective gynecologic operations
included hysterectomy with or without
salpingo-oophorectomy and with or
without repair of the pelvic floor. All
hysterectomies were abdominal. The
mean age difference between those
who did and did not have appendec
tomy was slight. The duration of the
operation was not prolonged by ap
pendectomy and there was no dif
ference in the length of hospital stay
postoperatively. The complication rate
was the same (12%). There were no
postoperative deaths. Two of three
patients who had wound infection had
had appendectomy. Neither of two
patients who had a pelvic abscess had
had appendectomy.
Discussion

The performance of an incidental
appendectomy is still a contentious
issue. Why it has not been resolved
by a carefully controlled prospective
trial remains an enigma. Perhaps it is
because so many surgeons take appen
dicitis for granted and consider it a
readily soluble condition. However,
appendicitis in the older patient is
far from a benign disease. The
proponents of incidental appendec
tomy claim that appendicitis in the
elderly is preventable and the anta
gonists fear complicating a simple
elective operation by an unnecessary
adjunct. Our data indicate that 13%
of patients over 40 years of age could
have been spared the disease.
The reported complication rate of
acute appendicitis in patients over
60 years of age is about 40%,5,8 sim
ilar to the rate reported in our group
1 patients.
The proponents of incidental appen
dectomy report that it is a safe and
useful procedure that does not com
promise the primary operation.7"10
Powell and associates11 pointed out
that in addition to preventing sub
sequent acute appendicitis, incidental

Table I— Incidental Appendectomy
Cholecystectomy

No. of patients
Mean age, yr (range)
Duration of
operation, min
Complications, %
Postoperative
hospital stay, d

Hysterectomy

Without IA

With IA

Without IA

With IA

50
55 (40-88)

50
57 (40 84)

50
51 (41 81)

50
47 (40 70)

92
10

95
10

129
12

101
12

7.1

7.9

8.0

8.3
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Conclusion]

Acute appendicitis in the older
patient gives rise to appreciable mor
bidity. Many of these patients could
be spared the condition by removing
the appendix at an earlier operation;
such incidental appendectomies can
be carried out without undue risk
to the patient.
Adjuvant procedures must always
be considered carefully in the light of
the patient’s general condition and
any extenuating circumstances before
and during operation, but routinely
denying the patient this procedure is
unwarranted.
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appendectomy also eliminated one
important cause of abdominal pain
in the elderly. Abdominal pain is
always a diagnostic challenge and is
made somewhat easier by eliminating
one possible process.
Taniguchi and Kilkenny12 reported
acute inflammation in 10% of appen
dices removed incidentally. Other
pathologic conditions of the appendix
which may otherwise be overlooked
can also be discovered.
It has been claimed that appendec
tomy results in an increased risk of
colon cancer13 but this has been re
futed by Moertel and associates.14

/
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A Case of Bilateral Renal Cell Carcinoma
in Polycystic Kidneys
Solomon K. Sogbein ,

b sc , m b , bs ,*

The authors present the seventh
reported case of bilateral renal cell
carcinoma in polycystic kidneys. They
-eview the literature on benign and
malignant tumours in polycystic
kidneys emphasizing the diagnostic
problems created by this condition.
The diagnosis can be made by renal
angiography. Therefore the authors
suggest that this procedure should
be carried out in all patients with
polycystic renal disease who have
hematuria.
Les auteurs decrivent le septieme
cas signale de cancer bilateral des
cellules renales dans la maladie
polykystique renale. Ms passent en
revue la litterature sur les tumeurs
benignes et malignes dans la
polykystose renale et ils soulignent
les problemes de diagnostic crees
par cette maladie. Le diagnostic peut
etre pose par angiographie renale.
En consequence, les auteurs suggerent

D avid E. M oors ,

md ,

FRCs[c]f

and

fundi and an 8-cm ballotable, nontender
mass in the left upper quadrant. He had
no urinary symptoms.
There was no family history of renal
disease or hypertension. However, there
was a strong family history of intra
cranial tumours.
Both the brain scan and carotid angio
gram were normal. An intravenous pyelogram revealed bilateral polycystic
kidneys. A renal angiogram showed an
abnormal vascular pattern, pooling of
contrast medium and tumour blush in
the mid-portion of the right kidney. The
left kidney showed vascularity compa
tible with a polycystic kidney, but no
tumour vessels (Figs. 1 and 2).
The right kidney was explored and
nephrectomy then performed. Histologic
examination confirmed the presence of
multifocal renal cell carcinoma, meas
uring 0.7 to 2.5 cm in diameter in the
mid-portion and lower pole of the right
kidney. At the time of discharge from
hospital the patient’s blood urea nitrogen
level was 15 mg/dl (urea, 5.36 mmol/1)
and the creatinine value was 1.4 mg/dl
(123.76 u.mol/1).

que cette intervention devrait etre
pratiquee chez tous les malades
porteurs d'un polykystose renale qui
presentent une hematurie.

The occurrence of renal cell carci
noma in a polycystic kidney is rare.
Its precise frequency is not known.
When it does occur, diagnostic and
therapeutic problems arise. This report
describes a patient with bilateral poly
cystic kidneys in which renal cell car
cinomas arose.
Case R eport

A 40-year-old man was referred to the
Ottawa Civic Hospital in 1972 because
of a 4-month history of right-sided
hemiparesis. On examination, his blood
pressure was 170/120 mm Hg. He had
grade 2 hypertensive change in both
From the divisions of urology and
nephrology, Ottawa Civic Hospital,
Ottawa, Out.
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His hypertension was controlled by a
low salt diet and administration of
hydrochlorothiazide. His condition re
mained stable for 6 years. Then for 3
months before the second admission he
had recurrent bouts of painless hema
turia. Abdominal examination revealed
a ballotable mass, 5 cm in diameter, in
the left upper and middle quadrants. His
BUN was 25 mg/dl (urea, 8.93 mmol/1)
and creatinine was 1.6 mg/dl (141.44
p.mol/1). An intravenous pyelogram
showed changes typical of polycystic
disease and a calcific area in the left
kidney.
A renal angiogram showed widespread
neovascularity of the left kidney with
formation of multiple venous channels
(Fig. 3).
A left nephrectomy was performed.
Histologic examination of the excised
kidney confirmed the presence of mul
tiple tumour nodules (3 cm to 5 cm in
diameter). Renal cell carcinoma was
present, involving the upper pole and
mid-portion of the left kidney. There
was calcification within a large nonmalignant cyst in the upper pole. Survey
for metastases, consisting of a chest film,
bone scan and liver scan gave normal
results. Postoperatively the patient was
maintained on hemodialysis. His HLA
antigen profile is HLA-Aw 23. 8; A29;
Bw22. 40; Cwl, 3.
D iscussion

FIG. I—Renal angiogram showing
vascularity of left kidney compatible
with polycystic disease. Tumour vessels
(arrow) arc present in mid-portion of
right kidney.

FIG. 2—Selective right renal arterio
gram. Note tumour vessels in mid-por
tion of right kidney (arrow).

A tumour arising in a polycystic
kidney is rare. Since 3 cases of a
malignant tumour in a polycystic kid
ney were reported by Walters and
Braasch,1 36 others have been re
ported including ours.
Both benign and malignant tumours
have been described. Angiomyolipomas have been reported in association
with polycystic disease in eight pa-

F1G. 3— Left renal angiogram show
ing widespread neovascularity (arrows).
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Lobectomy and Bronchoplasty for Cancer
C.L.N. Robinson,

md , fccp , frcs , frcs[c 1,*

The experience with lobectomy and
bronchoplasty in the management
of patients with lung cancer at the
University of British Columbia is
described for the period 1959 to 1979.
Thirty-eight patients underwent
resection, the majority for squamous
cell carcinoma. The early mortality
was 5% . Of 16 patients operated on
before 1974, 5 (31% ) survived for
more than 5 years. Seventeen (44% )
of the 38 are still alive at periods
of 1 to 10 years after resection.
On decrit I'experience acquise a
I’Universite de Colombie-Britannique
entre 1959 et 1979 avec la lobectomie
et la bronchoplastie dans le traitement
du cancer du poumon. Trente-huit
malades, pour la plupart porteurs
d'un epithelioma malpighien, ont subi
une resection. La mortaiite precoce
fut de 5%. Des 16 patients operes
avant 1974, 5 (31% ) ont survecu
pendant plus de 5 ans. Des 38 sujets,
17 (44 % ) sont toujours vivants
de 1 a 10 ans apres la resection.

During the early development of sur
gery for lung cancer, removal of the
whole lung was considered the only
curative procedure for all tumours.
Then lobectomy was recommended,
especially for peripheral tumours,
where malignant tissue could be re
moved adequately. The mortality and
morbidity for lobectomy was lower
than for pneumonectomy, the cure
rate was higher and the quality of
life was better. A further advance in
the concept of limited resection in
selected cases of lung cancer was the
use of bronchoplastie procedures,

From the department of surgery,
faculty of medicine, University of
British Columbia, Vancouver, BC

mb ,
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and

lobectomy with sleeve resection or
wedge resection of the main bronchus.
The first reported local resection of
the main bronchus was by Price
Thomas,1 who removed a portion of
the wall of the right main bronchus
for an adenoma; the patient recovered
with no complications. He later car
ried the idea further2 and resected a
tuberculous stricture of the main
bronchus.
D’Abreu and MacHale3 also de
scribed sleeve resection for benign
lesions and later used it for conser
vative treatment of lung cancer.
Others4-8 have reported treatment of
carcinoma by lobectomy with resec
tion of a portion of the main bronchus
and reanastomosis, with results com
parable to lobectomy and better than
pneumonectomy.
This paper describes the use of
lobectomy and bronchoplasty to treat
38 patients with lung cancer between
Jan. 1, 1959 and Dec. 31. 1979. The
38 procedures represent about 2 % of
all pulmonary resections for cancer
done by the senior author.
Patients

The age of these 32 men and 6
women ranged from 40 to 78 years
(Table I).
In 32 patients the procedure was
done deliberately as an alternative to
pneumonectomy. In six it was done
as a compromise because the patient
had limited pulmonary reserve; in this
group, the obstructive lung disease
was severe enough to preclude pneu
monectomy.
Radiologic studies, including tomo
graphy and bronchoscopy, and pul
monary function tests were used rou
tinely.
Operative Technique
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Early in the series, a sleeve or cylin
der of the main bronchus was removed

T a b le

A g e .y r

Accepted for publication Nov. 17, 1980
Reprint requests to: Dr. C.L.N. Robinson.
Ste. 208, 750 West Broadway,
Vancouver, BC V5Z IH7
196

D. H olmes ,

— A g e D is t r ib u tio n

N o . o f p a tie n ts

4 0 -4 9

1

5 0 -5 9

13

60

69

18

70

80

6

VOLUM E 24, NO. 2, M A R C H 1981

/

W.R.E. J amieson,

md, frcs [c ]*

routinely with the lobe. Later, how
ever, in the majority of patients, a
generous wedge of the main bronchus
was removed with the lobe, leaving a
ribbon of bronchial wall on the medial
side in continuity. The distal part of
the main bronchus was tailored by
cutting it obliquely, while the proximal
end was cut transversely. The an
astomosis was done using
primarily
horizontal mattress sutures with the
knots on the outside. Initially, the
suture material used was silk, but
later Dexon was substituted. The ten
sion was taken off the main suture
line by adding a few horizontal mat
tress sutures overlapping the main
anastomosis, through the peripheral
layer of the bronchial wall.
In 24 patients, a right upper lobec
tomy was done and in 13 a left upper
lobectomy. One patient had a right
lower and middle lobectomy including
a wedge of the medial wall of the main
bronchus, adjacent to the upper lobe.
In one patient a sleeve of the pul
monary artery was taken with the
bronchus. In many it was necessary to
put a clamp on the pulmonary artery
proximally and distally while the
branches were divided close to the
main artery and then to close by
suture.
Results

There were two deaths in hospital,
a mortality of 5 % . One man died sud
denly from a massive gastrointestinal
hemorrhage 5 days after the operation,
during an otherwise smooth recovery.
The other died of a bronchopleural
fistula, pleural infection and pneu
monia, after having undergone a com
promise procedure in the presence of
an extensive small cell carcinoma.
The nonfatal complications included
empyema (in one patient), temporary
atelectasis (in two) and stricture (in
three).
There were 19 late deaths from a
variety of causes (Table II). Progres
sive local recurrence presented as a
late stricture in three patients. It was
treated with cobalt teleradiation and
tumour growth was arrested in one
patient. One patient had bilateral
primary cancers at the time of first
diagnosis. One side was treated by
an upper lobectomy and a wedge re-
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section of the main bronchus. A peri sected hilar or mediastinal) or when
pheral tumour on the other side was carcinoma in situ had been detected
treated by standard lobectomy. The at the resection line. It was used later
patient survived less than a year. An when a local recurrence developed,
other patient was found to have an frequently presenting as hemoptysis or
independent carcinoma of the head stricture. In one patient cobalt treat
of the pancreas 18 months after lung ment was used for a contralateral
resection and this was fatal. In an new primary lesion.
Of the 16 patients who underwent
other patient, a second primary
tumour developed in the contralateral resection before 1974, 5 (31%) sur
lung 3 years after the bronchoplasty vived more than 5 years. One patient
procedure; the tumour was irradiated who had a resection at 73 years of
age survived for 16 years without re
but the disease was not cured.
The histology of the tumours and currence. Of the 38 patients 17 (44%)
the incidence of lymph-node involve are still alive. None of the patients
ment are shown in Table III. The with a small cell carcinoma, or the
majority of tumours were well dif one with the mucoepidermoid car
ferentiated squamous cell cancers. Un cinoma, were long-term survivors.
differentiated small cell tumours were
resected in the early part of the series;
Discussion
they occurred usually in the com
Lobectomy with bronchoplasty has
promise group.
Several patients had adjuvant cobalt proven most useful in patients with
teleradiation. Six patients had pre well differentiated squamous cell car
operative treatment (1600 to 1800 R cinoma or large cell carcinoma. These
over 3 days) as part of a trial in an tumours are in general of low biologic
other series. Of these, one is a long malignancy. They spread by direct
term survivor and another died of extension and by lymphatic permea
pneumonia due to Candida albicans tion, thus lending themselves to sur
12 months following resection, but gical resection or radiotherapy, or
both.
was free of cancer at the time.
The biologic malignancy of some
Postoperatively radiotherapy was
given to the mediastinum in 16 pa squamous cell tumours of the lung
tients, usually in a dose of 3000 R in may be compared to other squamous
opposing parallel pairs. This was done cell cancers in the body. Some well
early in the case of nodal disease (re differentiated squamous lung cancers
are comparable to those of the lip,
but are not as aggressive as squamous
cancer of the tongue or cervix uteri.
Table II—Late Deaths
Hence, a local resection with a nom
inal clearance of healthy mucosal
No.
margin is feasible.
of deaths
Cause
With upper lobe tumours it is pos
8
Distant metastases
sible to do as radical an operation with
3
Progressive local recurrence
sleeve resection and node clearance
3
Pneumonia
1
as with pneumonectomy, because the
Respiratory failure
Massive hemoptysis:
lymphatic spread is cephalad. It is,
1
bronchopleural fistula
therefore,
reasonable to preserve the
Bilateral resection:
lower lobe. Also it is now established
1
multiple primaries
Carcinoma of pancreas:
that the bronchus heals quite well
1
second primary
after resection and reanastomosis. This
1
Lung carcinoma: second primary
is contrary to the early teaching that
19
Total
the bronchus had a poor blood sup
ply and healed with difficulty.

Table III -Histology and Lymph-Node Involvement
Lymph nodes involved

Lobectomy with resection of a cy
linder or wedge of the main bronchus
is feasible in cases of squamous cell
and large cell cancers that are too
close to the main bronchus. This
usually means that the tumour is at
the origin of the lobar bronchus, per
haps with some local spread to the
contiguous wall of the main bronchus.
The presence of involved local, hilar
or
mediastinal
(tracheobronchial)
lymph nodes is not a contraindication.
They can be resected en bloc with the
lobe and. if necessary, cobalt treat
ment can be given to the mediastinum
to supplement the resection and steril
ize small areas of tumour that may
have been missed at operation. As for
pulmonary function, the procedure
may be done in patients who would
tolerate a lobectomy. It may be done
in patients who have some obstructive
lung disease, in whom a pneumonec
tomy would be contraindicated. The
lower margin of safety for resection,
using dynamic tests as a guide, would
be a forced expiratory volume of
about 1.5 litres (1 second).
Undifferentiated oat cell tumours
are almost never localized and do not
lend themselves to this kind of resec
tion. The presence of distant rnetastases, poor general condition and ad
vanced age are contraindications for
this as for any other type of resection.
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Cosmesis in Segmental Mastectomy
R ichard G. M argoi.e se ,

The controversy about the best
treatment for primary breast cancer
will be settled only when properly
designed clinical trials are completed.
Most surgeons would rather await the
results of such trials than participate
in them. Prominent among the reasons
for this view is the belief that an
adequate cancer operation can seldom
be performed with appropriate
cosmetic preservation of the breast
and, therefore, the trial of an unproven
operation is not justified, because
nothing can be gained.
The poor cosmetic result is often
owing to lack of experience with
segmental mastectomy. From experi
ence with 400 patients in the National
Surgical Adjuvant Breast Project
(NSABP) protocol has emerged an
appreciation of the technical points
that permit adequately wide local
excision with minimal cosmetic loss.
The results should stimulate both
patients and surgeons to consider
appropriate clinical trials for primary
breast cancer surgery.
This paper considers the causes of
cosmetic failure and suggests the
means of overcoming them.
La controverse qui entoure le choix
du meilleur traitement pour un
cancer primaire du sein ne sera
resolue que lorsque des essais
cliniques proprement concus auront
ete completes. La plupart des chirurgiens prefererait attendre les resultats
de ces etudes plutot que d'y
participer. Parmi les raisons invoquees,
une des plus importantes est I'idee
qu’une operation adequate contre
le cancer peut rarement etre pratiquee
avec une conservation cosmetiquement
acceptable du sein et, qu'en conse
quence, I'essai d’une operation
experimentale n’est pas justifie
puisqu'aucun gain ne peut en
resulter.
Des resultats cosmetiques pauvres
sont souvent dus au manque
*Director, department of oncology,
The Sir Mortimer B. Davis—Jewish
GeneraI Hospital, Montreal. PQ
Accepted for publication July 30, 1980
Reprint requests to: Dr. Richard
G. Margolese■ Sir Mortimer II. Davis—
Jewish General Hospital,
3755 Cote Ste-Catherine Rd.,
Montreal, PQ H3T 1E2
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d'experience avec la mastectomie
segmentaire. L’experience accumulee
chez 400 patientes avec le protocole
du National Surgical Adjuvant Breast
Project (NSABP) a permis une
appreciation des points techniques
qui permet une excision locale suffisamment large avec le minimum de
perte sur le plan cosmetique.
Ces resultats devraient inciter les
patientes aussi bien que les chirurgiens
a s’engager dans des essais cliniques
appropries de la chirurgie du
cancer primaire du sein.
Cette publication discute des
causes des echecs cosmetiques et
propose des moyens pour les
surmonter.

the accompanying psychosocial prob
lems that women endure as part of
breast cancer.
Since there can be no direct thera
peutic gain for the patient—the results
of this operation will not be better
than those of radical resection—there
must be demonstrable cosmetic gain to
offset present statistical uncertainty
about segmental resection. Improperly
performed segmental operations give
unsatisfactory cosmetic results and
weaken the case for the use of this
procedure. One of the major obstacles
in convincing surgeons of the accept
ability of this procedure, and even
of the NSABP, is the question of
cosmesis.
Many surgeons are of the opinion
Although segmental mastectomy is that an adequate cancer operation
accepted as standard therapy by sev cannot be done with cosmetic preser
eral major European cancer centres vation of the breast and, therefore,
and a few individuals in North Amer that the patient should not be exposed
ica, it is still viewed by most surgeons to the uncertainty of an unproven
on this continent as an unproven operation. Part of the reason for this
operation. Occasional reports indicate opinion is the surgeon’s lack of ex
that segmental resection (also known perience with segmental mastectomy
as partial mastectomy, lumpectomy and the admittedly poor cosmetic re
and tylectomy) is equivalent to radical sult that many obtain when they first
or modified radical mastectomy in attempt it. This communication de
terms of 5- and 10-year survival scribes some salient points of the tech
rates.1’7 However, these studies are, nique and shows that an adequate
in the main, retrospective and have cancer operation can be done with
sufficient flaws in their design or minimal cosmetic loss.
execution to render them unacceptable
All the arguments against segmental
as guidelines for standard therapy.
mastectomy, such as incompleteness
The problem remains controversial. of resection, inadequacy of axillary
Some evidence indicates that total re clearance and multicentricity of the
moval of the breast may not always tumour have been discussed812 and
be necessary to achieve the best will not be considered here. These
chance for cure, but this evidence is questions can only be answered in
not reliable proof. To obtain the sci the context of a properly designed
entific proof needed there must be and conducted study, such as the
ongoing clinical trials. These are jus NSABP protocol.
tified by the existing body of un
resolved evidence that segmental re
Technique of Segmental
section and total mastectomy are
Mastectomy
equivalent.U7
General Principles
The National Surgical Adjuvant
Breast Project (NSABP) is currently
An ellipse of skin containing the
comparing the role of segmental mas previous biopsy incision (Fig. 1) and
tectomy, with and without breast irra then the entire biopsy cavity are ex
diation, to modified radical mastec cised, including a zone of normal tis
tomy. The United States National sue about 2 cm beyond the biopsy
Cancer Institute is conducting a sim site. To do this an elliptical skin island
ilar trial. Should it be proven that sur is created and flaps are raised super
vival following segmental mastectomy iorly (Fig. 2) and inferiorly (Fig. 3).
is equivalent to that following mod When the flaps have been adequately
ified or radical mastectomy, the gain undermined, the incision is deepened
for patients will be in the realm of in guillotine fashion perpendicularly to
cosmetic appearance and alleviation of the surface of the pectoralis muscle.
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The entire specimen is removed with
its underlying fascia without break
ing into the original biopsy site. With
careful attention to the above points
an adequate cancer operation can be
done with an acceptable cosmetic
result (Fig. 4).
Specific Problems
There are five main reasons for
cosmetic failure: poor placement of

FIG . 1— Original biopsy
planned skin incision.

site

and

the incision, improper reconstruction
of the breast, improper use of drains,
removal of too much breast tissue
and poor technique in closure of skin.
Placement of the skin incision.—
For lesions in the upper half of the
breast, a transverse or circumferen
tial incision should be used but for
lesions in the lower half of the breast,
a radial incision is better. Half of all
breast cancers are in the upper outer
quadrant and most surgeons would
instinctively use a radial approach to
deal with the primary tumour and per
form an axillary dissection through
the same incision. Axillary dissection
should be done in all cases for ac
curate staging of the cancer to deter
mine the need for chemotherapy postoperatively.
Radial incisions in the upper part
of the breast often heal with contrac
ture and broadening of the scar (Fig.
5). This is particularly unfortunate
because it limits the type of clothing
the patient can wear without exposing
scar. Circumferential incisions, on the
other hand, follow the natural lines of
cleavage of the skin and will heal
with thin linear scars and virtually no
distortion of the surface contour of

the breast. A second incision for
axillary dissection is then made just
behind the edge of the pectoralis mus
cles in the anterior axillary fold. This
incision is invisible after healing. It
lies in a crease, leaving no cosmetic
defect (Fig. 6). For more peripheral
tumours one transverse incision allows
both parts of the operation to be
accomplished in continuity. (En bloc
removal is not a consideration. These
nodes are removed for staging, not
for treatment.)
In either case, postoperatively, the
pull of gravity on the breast when the
patient is erect keeps the skin from
adhering to the chest wall. This helps
in maintaining the normal contour
of the breast and in obliterating the
defect by filling in with serum
and fibrin. The circumferential or
transverse incision avoids contracture
and allows cosmetic moulding to take
place in the breast, which achieves a
consistency and appearance indistin
guishable from normal.
However, transverse incisions in
the lower half of the breast pose a
different problem. The defect result
ing from removal of tumour will be
filled in by the remaining breast tissue,

F IG . 2— Superior flap is raised.
F IG . 4— Postoperative result.

Fig. 6b

FIG . 3— Inferior flap is raised.
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F IG . 5— R adial incision in upper outer
quadrant showing contracture.

F IG . 6— Proper placem ent o f incision
and postoperative result, (a) O blique
view o f transverse and axillary incisions,
(b) F ro n t view.
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causing conspicuous distortion, loss of
volume and deviation of the nipple
inferiorly (Fig. 7). This can be avoided
by using a completely different tech
nique, one that is similar to the re
construction used after reduction
mammoplasty. To facilitate this type
of reconstruction, a radial incision is
preferred.
Reconstruction.— Reconstruction is
necessary only for lower quadrant
lesions. In these cases, after the
tumour and the surrounding zone of
normal tissue are excised, the fascia
should be undermined in both direc
tions across the entire lower half of
the breast, that is from the 3 o’clock
to the 9 o’clock positions. The mobil
ized double tail of breast tissue should
be then brought together inferiorly
and sutured with absorbable catgut
sutures (Fig. 8). This will provide sub
stance inferiorly and keep the breast
from collapsing (Fig. 9). The linear
incision is closed from the areolar
end outward towards the inferior
aspect of the incision. At this point,
some “dog-earing” of the skin might
become apparent. In this case, a small
triangular wedge should be removed
on each side of the incision. The
defect can then be closed with a small
transverse suture line hidden in the
lower skin fold.
The breast should not be recon
structed at all after removal of seg
ments of the upper half because this
will cause deformity. The best way
to handle this defect is to let it fill in
with serum and fibrin as happens
after pneumonectomy. The resulting
organization will give a consistency
quite similar to normal breast and
preserve the contour and density of
normal breast tissue. If care is taken
to ensure that there is no active bleed
ing at the time of wound closure this
method invariably gives excellent cos
metic results.
Use of drains.—In the superior
half of the breast the cavity can be
left undrained if hemostasis is com
plete. If the surgeon is unsure about
his ability to prevent hematoma for
mation in a specific case, a 0.6-cm
Penrose drain can be placed in the
cavity for 24 hours. FTemovac or suc
tion drains should not be left in the
cavity as they will cause collapse of
the skin and increase the chance of
retraction of the skin with deformity.
Lesions situated inferiorly should
have the defects closed as described
above and a Penrose drain may be
left in for 24 hours, if necessary, but
suction should not be applied.
The axillary dissection, which is
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done through a separate incision,
should then be handled in traditional
fashion with suction or Hemovac
drainage to prevent formation of
seroma or hematoma and to maintain
the appropriate concavity for a nor
mal postoperative appearance and
function.
Removal of too much tissue.—It
should be remembered that most
breast cancers are smaller than they
appear clinically; a tumour that meas
ures 3 or 4 cm in diameter on palpa
tion may only be 1 or 2 cm on cut
section. Furthermore, it is not un
common for the pathologist to report
that the preliminary excisional biopsy
specimen contained all apparent breast
tumour and the subsequent mastec
tomy specimen showed no residual
tumour at the biopsy site. With this
in mind, it should be apparent that
most patients can have adequate sur
gical control of their breast tumour
without removal of a large mass of
breast tissue. There is always the
chance of microscopic permeation of
tumour to the line of resection but
this can be controlled, as it is in the
NSABP protocol: sutures are placed
superiorly and laterally to orient the
pathologist who subjects the entire

outer circumference of the specimen
to step sectioning in paraffin blocks.
By preliminary marking of the edges
of the specimen with India ink, he can
be quite confident in reporting
whether any tumour is present at
lines of resection.
Patients whose breasts have exten
sive permeation of tumour to lines of
resection are not suitable for seg
mental resection and will have to un
dergo subsequent total mastectomy. It
is unlikely that taking more tissue at
the time of segmental resection would
be of help in this problem and it must
be recognized that some patients will
require total mastectomy. The tech
nique described for segmental mas
tectomy, however, should relieve the
surgeon of any anxiety about inade
quate excision and thus keep him
from performing too radical a proce
dure. While this procedure is not a
subtotal mastectomy, neither is it
merely a biopsy. In fact this is truly a
cancer operation with short but care
fully dissected skin flaps and deliber
ate limits to the lines and depth of
resection. As Fig. 10 shows, a substan
tial volume of tissue is indeed re
moved with a completely acceptable
cosmetic result (Fig. 11).

F IG . 7— Unacceptable distortion of
breast after excision of low er quadrant
lesion, caused by weight of breast tissue
pulled into defect by gravity.

FIG . 9— Postoperative result.

FIG . 8— D iagram indicating method
of repairing defects in low er quadrant
lesions.
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FIG . 10— Specimen with axillary com 
ponent.
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Skin closure.—Since segmental
mastectomy is an operation with im
portant cosmetic aspects, appropriate
consideration must be given to skin
closure. The traditional vertical mat
tress sutures using 3-0 silk, which are
left in for 1 week or more, often
create cross-hatching and unsightly
scarring (Fig. 12). However, if the
subcutaneous fascia is approximated
with interrupted 4-0 plain sutures, the
skin can be properly closed with sub
cuticular 5-0 catgut which can be re
inforced with a few 0.3-cm adhesive
skin strips.
Discussion
This article deals with the tech
nique of segmental resection in pa
tients for whom it is suitable. Clearly
there will be patients with breasts too
small, lesions too central or tumour
too large to be handled this way.
Nevertheless, most breast cancers can,
from the technical aspect, be ade
quately handled by this approach
with acceptable, even excellent, cos
metic results. There is mounting
evidence that a partial or segmental
operation may be as effective for long-

M cD onald AM : Cancer research campaign
term control as total mastectomy. To
study of the management of “early” breast
obtain conclusive proof, more surgeons
cancer. World J Surg 1977; 1: 317-9
10.
A uchincloss H jr : The nature of local
should be encouraged to enter patients
recurrence following radical mastectomy.
into the prospective clinical trial now
Cancer 1958; 11: 611-9
11.
Idem: Significance of location and num 
in progress. As long as this question
ber of axillary metastases in carcinom a
remains unanswered, no surgeon
of the breast. Justification for conserva
operation. Ann Surg 1963; 158: 37-46
should be confident that he is treat 12. tive
C r il e G j r ; Multicentric breast cancer.
ing his patient properly with any
The incidence of new cancers in the hom o
lateral breast after partial mastectomy.
operation now being used. The
Cancer 1975; 35: 475-7
evidence calls into question our con
tinued use of radical or modified
radical mastectomy as our basic oper
ation. Currently, we have no scientific
NOTICES
answer to this problem. The ethical
approach is to obtain the answer by
means of appropriate clinical trials
so that surgeons and patients will
Clinical Application of
know what is best. With proper atten
Hyperbaric Oxygen
tion to the technical elements of this [
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Fig. lib
FIG. 11—Postoperative result: (a) at
1 week and (b) at 1 year.

Renal Biopsy Pathology
in Medical Disease

The Department of pathology of the
University of Texas Health Science
Centre at Dallas will present a 3-day
program, April 30 to May 2, 1981
on
renal biopsy pathology in medical
9. M urray J, M acIntyre J, Simpson JS,
disease.
This program is designed for pa
thologists, nephrologists, internists
and other physicians with a special
interest in recent advances in diagno
sis of medical renal disease and will
emphasize clinicopathologic correla
tions.
Application is being made for 22
hours of Category 1 credit of the
AMMA and LCCME.
For further information please con
tact Dr. Edwin H. Eigenbrodt, De
partment of pathology, University of
Texas Health Science Center at Dal
las, 5323 Harry Hines Blvd., Dallas,
TX 75235 or telephone (214) 688FIG. 12—Improper suturing of skin 2133.
with poor cosmetic result. Cross-hatching
is caused by use of vertical mattress
sutures.
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Priapism after Aortic Valve Replacement
T omas A. S a l e r n o , md , f r c s [c ], E dward J.P . C h a r r e t t e , m d , fr c s [c ]
and A lvaro M orales , m d , facs , fr c s [c ]*

An unusual case of priapism is
described. The cause was unknown
but the onset of the condition
coincided with the start of Coumadin
therapy which was given orally to a
65-year-old man who had undergone
aortic valve replacement. Management
of this patient was difficult.
Conservative measures failed, but
a corpus spongiosum-cavernosum
shunt successfully resolved the
problem. The authors emphasize that
priapism must be treated urgently
if potency is to be maintained. They
also consider the various possible
causes and treatment of priapism.
Cette publication decrit un cas
inusite de priapisme. La cause
demeure inconnue mais le debut a
coincide avec la mise en route d'un
traitem ent au Coumadin administre
par voie orale chez un homme de 65
ans, apres un remplacement de valvule
aortique. La conduite du traitement
fut marquee de nombreuses difficultes.
Les mesures conservatrices echouerent
mais une anastomose du corps
spongieux au corps caverneux a
permis de resoudre le probleme.
Les auteurs soulignent la necessity de
traiter le priapisme en urgence si
Ton veut conserver la virilite du
malade. Ms commentent egalement les
diverses causes possibles et les
methodes de traitement du priapisme.

madin orally after aortic valve repla
cement. We do not claim that there
was a causal relation between priapism
and Coumadin therapy, but rather
stress the management of this condi
tion under unusual circumstances after
valve replacement.

Case Report
A 65-year-old man with a long history
of rheumatic aortic stenosis underwent

aortic valve replacement. A no. 25
Bjork—Shiley prosthesis was used. His
initial postoperative course was normal,
but 24 hours after anticoagulant therapy
(Coumadin, 10 mg initial dose then
5 mg/d, orally) was begun, priapism
was noted (Fig. 1). The patient became
progressively more uncomfortable and
cold saline enema and sedation failed
to reduce the persistent erection. Thirtysix hours after onset of the priapism a
corpus spongiosum-cavernosum shunt1
was performed under local anesthesia
(Fig. 2). The condition resolved imme
diately. When the surgical adhesive dress
ing was removed 12 hours later the
penis remained flaccid (Fig. 3). During
this time the patient’s prothrombin time
remained at 23 minutes (control 11
minutes). He was discharged from hos
pital 4 days after the urologic procedure,
still taking Coumadin because of the
prosthetic valve operation. He was well
at 5-month follow-up.
Discussion

FIG . 1— Penis 12 hours after onset of
priapism. N ote edema of foreskin and
flaccidity
of
glans
(corpus
spon
giosum).

In 81% of patients with priapism
the cause is either unknown or is re
lated to sickle cell disease. Other
causes include tumours (such as mye
loma), leukemia, thrombocythemia,
inflammatory diseases,
neurologic
conditions, trauma, psychosis or
drugs.1’3 5 The association of priapism
with febrile conditions is known.6 The
pathophysiologic mechanism of this
condition is thought to be a decrease
in penile venous outflow, probably due

Priapism, an abnormally prolonged
and painful erection not related to
sexual desire, may be associated with
several different conditions including
sickle cell disease, tumours, trauma
and drug use.1 Although heparin has
been implicated as a cause of this
condition* we are unaware that
Coumadin is a causative agent. We
report a case in which priapism developed in a patient receiving CouFrom the departments of surgery and
*urology, Queen’s University, Kingston,
Out.
Supported by Ontario Heart Founda
tion grant 2-4
Accepted for publication Apr. 30, 1980
Reprint requests to: Dr. T.A. Salerno,
Division of cardiovascular and thoracicsurgery, Kingston General Hospital,
102 Stuart St., Kingston, Ont.
K7L 2V7
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FIG . 2— A fter shunting there is free
flow of saline from corpus spongiosum
to cavernosum.

VOLUME 24, NO. 2, MARCH 1.981

/

F IG . 3— Penis 12 hours after shunt.
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to neurovascular spasm or cellular
aggregation and blockage.1 Treatment,
such as exchange transfusion in sickle
cell disease,1 plasmapheresis in mye
loma5 and discontinuation of the in
citing drugs is usually directed at the
cause.2,7,8 Initial treatment consists of
sedation, cold saline enemas and, if
available, intermittent pneumatic com
pression.6 Although heparin has been
implicated in this condition,2 it is
still used after shunting procedures9
since rethrombosis
is common.
To our knowledge Coumadin has not
been implicated as a cause, nor has
digoxin which the patient had been
taking for several years. In view of
the number of patients who receive
anticoagulants orally one would expect
a higher frequency of priapism if
Coumadin was implicated. Although
priapism development coincided with
start of anticoagulant therapy in our
patient, we cannot be certain and
actually doubt that there was a causal
relationship. Therefore, the anticoagu
lant was not discontinued since the
patient had had a prosthetic valve in
serted and would require the drug
indefinitely. Similarly, a spinal block
N OTICES
(continued from pape 201)

Postgraduate Course in
General Surgery
The annual postgraduate course in
general surgery is presented by the
department of surgery and the
Howard C. Naffizger Surgical Society
of the University of California School
of Medicine in San Francisco and
sponsored by extended programs in
medical education. It will take place
Apr. 9 to 11, 1981 at the Fairmont
Hotel, Sa'n Francisco, California. This
.year the course is being dedicated to
Dr. J. Englebert Dunphy, emeritus
professor of surgery, in recognition of
his outstanding accomplishments.
This clinically oriented program
will offer general surgeons an inten
sive overview of problems encoun
tered in daily practice. The emphasis
will be on breast cancer, biliary dis
eases, trauma, the liver and spleen,
intestinal diseases, endocrine disorders,
abdominal infection and nutritional
problems.
This course is approved for AM A/
CMA Category I (formal) continuing
education credit.
For further information please write
to Extended Programs in Medical
Education, Rm. 569-U, University of
California, San Francisco, CA 94143,
or call (415) 666-4251.
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was not advisable because his pro
thrombin time was elevated. When
conservative measures failed, a shunt
procedure was performed by a urol
ogist under local anesthesia, and the
problem resolved immediately. The
spongiosum-cavernosum shunt, de
scribed by Winter1 was chosen for sev
eral reasons: it can be performed
under local anesthesia, surgery is
minimal and there is no risk of hemor
rhage. All these considerations were
relevant to our patient. The effect
iveness of the shunt was clearly de
monstrated by injecting saline solution
into the corpus spongiosum and ob
serving the fluid coming through the
incision in the glans (Fig. 2).
It is important to recognize the
urgency of this condition which tends
to deteriorate if conservative meas
ures fail.9 Despite early surgical treat
ment, only about 50% of patients
regain sexual potency.6 The longer
the delay in treatment the poorer is
the result, since four out of six patients
treated by operation remain im
potent.10
Our patient will require long-term
follow-up to determine whether per

manent damage to the erectile tissue
was avoided and whether sexual func
tion will return to normal.

Technology Assessment Forum

This meeting, for which no regis
tration fee will be charged, is open to
the public. The Center encourages
attendance by health professionals
and interested private citizens.
For technical information please
write Dr. Michael Eliastam, special
assistant to the director, National Cen
ter for Health Care Technology,
Parklawn Building, Rm. 17A-29, 5600
Fishers Lane, Rockville, MD 20857,
or call (301) 443-4097.
For administrative information,
write to Elaine Kokiko, executive vice
president, Moshman Associates, Inc.,
6400 Goldsboro Rd., Washington, DC
20034, or call (301) 299-3000.

The National Center for Health Care
Technology (Centre) in collaboration
with the National Heart, Lung and
Blood Institute is conducting a tech
nical assessment forum to study the
economic, ethical, legal and social
issues related to coronary artery by
pass surgery. This forum will take
place Apr. 21 to 23, 1981 at the She
raton Washington Hotel, Washington,
DC. Among the issues to be consi
dered are: costs, organization and use
of resources, ethical and legal consi
derations and quality of life. This
conference will draw upon informa
tion presented and conclusions reached
at the previous consensus development
conference on medical and scientific
aspects held on Dec. 2 to 5, 1980 by
the National Heart, Lung and Blood
Institute in conjunction with the
Health Care Technology Center. Pre
sentations and critiques will be given
by cardiologists, cardiac surgeons,
economists, ethicists, health planners,
lawyers and behavioural and social
scientists.
The Center was authorized by
Congress in 1978 to conduct and sup
port assessments of medical tech
nology; its mission is to evaluate the
medical, economic, ethical, legal and
social implications of health care
technologies.
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Association of Surgeons
of South East Asia
The Association of Surgeons of South
East Asia is presenting its third bien
nial general scientific meeting June
18 to 20, 1981 at the Hotel Sari Pa
cific in Jakarta. This will be a 2'/2-day
meeting which will include scientific
sessions dealing with surgical problems
of regional interest in South East
Asia.
The registration fee is US $30.00
for members and US $50.00 for non
members.
For further information please
contact Professor Raden Sjamsuhidajat, 6 Salemba Raya, PO Box 487,
Jakarta, Indonesia.
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BOOK REVIEWS

INTERNATIONAL ADVANCES IN
SURGICAL ONCOLOGY. Volume 3.
Edited by Gerald P. Murphy. 374 pp.
Illust. Alan R. Liss, Inc., New York,
1980. $44. ISBN 0-8451-0502-7.

This volume is the third in a series deal
ing with advances in diagnosis, therapy
and management of a variety of condi
tions. It is of interest not only to sur
gical oncologists, but also to other clinic
ians dealing with patients who have
cancer.
Each of the 13 chapters is written by
an authority in the field. Two chapters
are devoted to breast reconstruction fol
lowing mastectomy; they are excellently
presented with numerous illustrations
detailing techniques and results. Of par
ticular interest are the methods of con
structing the nipple-areolar complex.
Nakayama and his group from Japan
have contributed two chapters on the
esophagus. The first covers the diagnosis
and clinical evaluation of early cancer
and the second provides an interesting
and detailed analysis of 405 cases of
esophageal tumours other than squamous
cell carcinoma. Of these. 149 were
benign and 256 malignant (representing
2.1% of malignant tumours other than
squamous cell carcinoma in their sur
gically resected cases). Both chapters
contain excellent tables, diagrams and
other illustrations.
The diagnosis, classification and treat
ment of the various types of thyroid
cancer are described in a well written
section by a group from Roswell Park
Memorial Institute. An extensive and
up-to-date bibliography on the subject
is included.
The chapter proposing the more ex
tensive varieties of “regional pancreatec
tomy for cancer of the pancreas by
Fortner and Papachristou is interesting
but unconvincing. As the authors stress,
this procedure is still under trial and
should not be practised widely until the
indications are more clearly defined and
the results further analysed. They stress
that regional pancreatectomy is as
sociated with a high morbidity and mor
tality although in their experience the
2-year actuarial survival of those who
survived the procedure was 46%.
A statistical analysis of 8282 patients
with squamous cell carcinoma of the skin
of the extremities seen at the M.D.
Anderson Hospital in Houston makes
for interesting reading but does not in
dicate any startling new advances.
Post-laryngectomy speech rehabilita
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tion is dealt with in a concise review
which includes a brief description of
the various techniques and a current bib
liography. The value of computed
tomography of the abdomen in diag
nosing cancer and other diseases of
the abdomen and pelvis is demonstrated
by excellent illustrations. This new
imaging technique is still in its infancy
and we can look forward to further ad
vances in instrumentation to render
diagnosis of intra-abdominal conditions
more accurate and precise. The biblio
graphy is generous and up to date.
Doctors Nael Martini and Edward J.
Beattie, Jr., from the department of sur
gery of the Memorial Sloan-Kettering
Cancer Center, give a concise but super
ficial overview of current concepts in
the diagnosis and treatment of primary
pulmonary carcinoma. The role of sur
gery is emphasized, particularly in can
cers other than oat cell carcinoma. The
use of combinations of newer antineoplastic drugs is not sufficiently detailed.
One chapter deals with a statistical
analysis of 137 patients with Wilms'
tumour seen at the Cancer Institute in
Lima, Peru between May 1953 and April
1977. The authors emphasize the major
role played by combination chemother
apy (actinomycin D and vincristine) in
this series in greatly increasing patient
survival.
An informative chapter on hormonal
receptors in human neoplasia will ac
quaint the surgical oncologist with some
of the major features of receptors in
various tissues, with particular emphasis
on those in breast cancer. The authors
consider the significance of receptors in
the decision regarding treatment for
breast cancer and the correlation be
tween the presence or absence of the
receptor and the course of the disease.
The importance of receptors in other
organs and neoplasia—including mela
noma, prostatic, colonic, endometrial
and hepatic cancer—is also briefly dis
cussed.
A final chapter on adjuvant therapy
for brain tumours reviews the more
recent advances that have been made
in this field. In addition to surgery and
radiotherapy the increasing role of che
motherapy is discussed in detail. The
chapter is well written and has an
extensive bibliography.
On the whole this is an interesting and
informative text providing an up-to-date
survey of a variety of neoplastic condi
tions that is of value not only to sur
geons but also to medical oncologists.
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radiation oncologists and others dealing
with cancer.
E dward J. T abah,

m d . facs , frcs [c ]

Associate professor,
Department of surgery.
Royal Victoria Hospital,
Montreal, PQ
NUTRITION AND CANCER. Edited
by Jan van Eys, Mildred S. Seelig and
Buford L. Nichols, Jr. 297 pp. Illust.
SP Medical & Scientific Books, New
York, 1979. $25. ISBN 0-89335-068-0.

For those interested in the nutritional
support of the hospitalized patient, nu
trition and its relation to cancer therapy
is a topical subject. This book is a col
lection of papers presented at the June
1977 meeting of the American College
of Nutrition, edited by three senior
members of the college. It suffers from
the problems of all multiauthored texts,
namely variable quality of writing style
and uneven emphasis on different topics.
Metabolism in the cancer patient is
covered in 4 pages, while chapters on
single trace elements extend to 15 pages.
The book comprises two sections. The
first deals with the recognition of protein
calorie malnutrition, its possible causes
in the cancer patient, and the impact of
reversing the malnourished state on treat
ment and outcome. These aspects are
being actively investigated under the
auspices of the National Institutes of
Health. Much of the information in this
section will be familiar to those dealing
daily with nutritional support, particular
ly the chapters on patient assessment,
nutrition and immunity and general
nutritional concepts. However, for those
less familiar with the field, this section
will be informative. It may also provide
a better understanding of techniques and
expectations when administering nutri
tional support to patients with cancer.
Incidentally, it is encouraging to see
a chapter on enteral nutrition—an area
that is proving to be very promising for
the nutritional support of the cancer
patient. Nonelemental diets are not men
tioned.
The second section contains three
chapters on anorexia which perhaps
belong in the previous section. This
rather poorly defined area is not
well clarified in these chapters. The
remainder of the section deals with trace
elements and vitamins in relation to
cancer, from both etiologic and thera
peutic viewpoints. This is interesting but
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R o b e r t J. F a ir f u l l -S m it h . m b ,
f r c s [c

]

Department of surgery,
Ottawa General Hospital,
Ottawa, Ont.
PRIMARY LIVER TUMORS. Falk
Symposium 24. Edited by H. Remmer,
H.B. Bolt, P. Bannaseh and others.
511 pp. Illust. University Park Press,
Baltimore, 1978. $29.50. ISBN 0-83911226-2.

Although these proceedings do not re
present a comprehensive textbook on
liver tumours, they do give the reader
a concise concept of the factors that may
be involved in the development of hepa
tocellular carcinoma. The evidence for
an association between hepatitis B virus
and primary liver cancer is compelling.
It appears that the virus acts either as a
carcinogen or a cocarcinogen. Chronic
alcoholism appears as a second factor,
more important when the hepatitis B
carrier rate is low. The known hepatocarcinogens—vinyl chloride, the nitroamines and the aflotoxins—as potential
risks in human liver cancer and the
metabolism of these carcinogens are
both discussed.
Several short chapters are devoted
to the epidemiology of hepatic cell can
cer in different areas of the world. The
very high prevalence in Mozambique is
noteworthy as is the involvement of
younger patients where the frequency
is highest.
With respect to the relation between
sex hormones, anabolic steroids and liver
tumours, it is suggested that adenoma
and focal hyperplasia are part of the
spectrum of liver neoplasia. The treat
ment of nodular hyperplasia of the liver
should be conservative as these lesions
may subside spontaneously when hor
mone therapy is discontinued.
Considerable space is devoted to dis
cussion of the biotransformation of
chemical carcinogens at the intracellular
level and to the possibility of influencing
these processes by medication.
One chapter deals with the possibility
of early diagnosis in liver cancer using
a-fetoprotein determinations in in
dividuals with cirrhosis or hepatitis B
virus infection. Angiography has been
shown to be effective in demonstrating
small tumours.
The book should be very useful for
the biochemist, the pathologist and the
surgical scientist interested in the epi
V O L U M E 24, NO. 2. M A R C H 1981

only to the cancer victim whose immu
nologic and nutritional state may be suboptimal, but also to all patients who
undergo surgical procedures.
The well presented chapter dealing
with the design of prospective clinical
trials describes the importance of such
L a w r e n c e G . H a m p s o n , m d , f r c s [c ]
trials in medical research and presents
the essentials in the design of these trials.
Department of surgery,
The Montreal General Hospital,
The steps to be taken to avoid bias and
Montreal, PQ
errors in the interpretation of results are
detailed. The chapter emphasizes how
important and necessary prospective
clinical trials are to advance knowledge
PRINCIPLES AND MANAGEMENT
through investigation and experiment
OF UROI.OGIC CANCER. Edited by
and to improve therapy for our patients.
Masser Javadpour. 533 pp. Illust. The
The last eight chapters of the text
Williams & Wilkins Company, Balti
book describe in detail the clinical
more; The Macmillan Company of
aspects of tumours of the adrenal glands
Canada Limited, Toronto, 1979.
and urinary system in adults and chil
$64.95. ISBN 0-683-04463-X.
dren. These chapters are current in
After carefully reviewing this book, 1 content. They present clearly the diag
believe it is an excellent reference text
nostic approaches and the results that
for the clinical or academic urologist and
may be anticipated by a team approach
the urologic oncologist (immunologist,
which provides the patient with a treat
radiotherapist and chemotherapist). It
ment plan incorporating the best avail
is also a first-class textbook for resi able therapy provided by surgery, radio
dents training in these disciplines. Diag therapy, chemotherapy and immunothernostic and management approaches to
apy.
patients with urologic cancer are well
In general, this is an excellent, up-todescribed and are up to date. The text date textbook and an essential addition
clearly stresses the need for a team ap to the library of residents and attending
proach utilizing surgery, radiotherapy,
physicians and surgeons who deal with
chemotherapy and immunotherapy to
urologic malignant conditions.
provide the patient with the benefits that
are presently available for the manage D o u g l a s D . M o r e h o u s e , m d ,
ment of these malignant tumours. The
f r c s [c ] , FA C S
need for members of all four disciplines
Department of urology,
to discuss treatment plans before any
Royal Victoria Hospital,
therapy is instituted so that an overall
Montreal, PQ
approach may be developed for each pa
tient is emphasized. The role of tumour
markers in the diagnosis and subsequent
follow-up of patients with urologic
malignant lesions is described; great
stress is placed on the importance of
serum markers in diagnosing, staging
and managing patients with nonseminomatous germinal testicular tumours.
The roles played by radiology, nuclear
medicine and pathology are clearly de
scribed and illustrated. Current theories
regarding the etiology and epidemiology
of urologic malignant conditions are well
presented and current.
The reader is placed at the brink of
Classified Advertising
new and exciting horizons in the diag
nosis and management of genitourinary
tumours, especially in the areas of radio
therapy, immunology and chemotherapy.
The ongoing and future developments in
these fields may spare the cancer victim
from many of the radical surgical pro
FELLOWSHIP GENERAL SURGEON
cedures with their associated morbidity
needed in Vanderhoof, BC
that are performed today.
Get away from the competition of city
practice. Come to a small town in the out
An excellent up-to-date review of cur
door paradise of the interior of British
rent concepts in the prophylaxis and
Columbia. Practise your science with chal
lenge and commitment.
management of surgical infections de
This is a well-established practice with a
scribes the indications and contraindica
wide ranging area. New 65-bed hospital with
a well-equipped operating room. Partnership
tions for using antibiotics prophylacis available.
tically. The increased wound infection
If you are interested please contact:
rate associated with shaving patients
is described and the factors that predis
Dr. C. H. Stephen or Dr. G. C. Joly
pose to surgical infection in and out of
R.R. # 2 , Vanderhoof, BC VOJ 3A0
or telephone: (604) 567-2201
the operating room are well presented.
This information is of importance not

demiology and development of liver can
cer but it will be of limited use for the
clinical surgeon because little space is
devoted to the treatment or results of
treatment for liver cancer.

does not really tell us if the knowledge
gained from these studies will ever be
of practical value. It is in such a situa
tion that the personal viewpoint of a
single author is often most useful to
the reader.
This book can be recommended as a
reference text to those who wish to in
crease the depth of their knowledge of
nutritional support for the cancer patient.
It is too fragmented to be recommended
as a manual.
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SENIOR FELLOW

GENERAL SURGEON: BC

required for Division of General Surgery, To
ronto General Hospital, beginning July 1st,
1981. Must be a fully trained general surgeon
with at least three years experience in
clinical and laboratory aspects of liver and
intestinal transplantation. Duties would in
clude supervision of laboratory program in
liver and intestinal transplantation. Clinical
duties would involve undergraduate and
graduate teaching, direction of patient clinics
and Emergency Department coverage Apply
in writing with curriculum vitae to: Head,
Division of General Surgery, Toronto General
Hospital, Eaton Bldg. N 9-236, Toronto, Ont.
M5G 1L7. Closing date for receipt of applica
tions is March 30th.
—S81-008

required to replace retiring surgeon working
in association with 6 general practitioners.
Privileges in 150-bed Regional Hospital.
vSalary or fee-for-service negotiable. Excellent
recreation facilities. For further details please
contact: Dr. H. C. Coburn, Greene Clinic, 501
McBride Street, Prince Rupert. BC Telephone:
(604) 624-9121
—S81-012

128, ,129

Lederle Pharmaceutical

Amicar

150

GENERAL NEUROSURGEON
PQ

McNeil Laboratories
Zomax

171, 172,

173,

The Sir Mortimer B. Davis Jewish
General Hospital, a 600-bed McGill
University teaching hospital current
ly has a position available for a
general neurosurgeon.

174

Norwich-Eaton Pharmaceuticals
Vivonex

112

Organon Canada Limited
Hexadrol

111

Interested candidates should dire ct th e ir
enquiries and curriculum vitae to:

Parke Davis (Canada) Inc.

Elase
109
Thrombin
116,
Tucks
190

P. L. Heilpern, MD, FRCP(C)
Director of Professional Services
SIR MORTIMER B. DAVIS
JEWISH GENERAL
3755 Cote Ste. Catherine Road
Montreal, Quebec H3T 1E2

117

Roussel Canada inc.
Sofra-Tulle

162,

163

Schering Canada Inc.
Netromycin

133,

134,

135,

Neurosurgeon
A 450-bed
general hospital is
accepting applications
for a neurosurgeon.
We will also welcome
applications for a
neurosurgical team.

—S81-007
136,

137,

138

Upjohn Company of Canada, The
Dalacin C 142, 143, 144
Gelfoam
158, 159
Solu-Medrol 182, 183, 184

CLINICAL FELLOWSHIP
Ewart Angus Surgical
Intensive Care Unit

See also page 205
PERIPHERAL VASCULAR AND
GENERAL SURGEON
A full-tim e surgeon with complete training
in general and peripheral vascular surgery
required for 265-bed non-university hospital.
Certification from Royal College of Physicians
and Surgeons of Canada is essential. A ppli
cations should be submitted to: Dr. Stephen
A. Silverberg, Chief, Department of Surgery,
Northwestern General Hospital. 2175 Keele
Street, Toronto, Ontario M6M 3Z4. —S81-009

WELLESLEY HOSPITAL, TORONTO
Available July 1, 1981 for a period of one
year in a multidisciplinary acute surgical
unit with 600 admissions per year. Duties
w ill include patient care and clinical research
in a strong academic and teaching unit with
all types of patient population excepting
cardiac surgery.
Reply to:

Dr. D. P. Jones
Director, Surgical ICU
Suite 219, E. K. Jones Building
160 Wellesley Street East
Toronto, Ont. M4Y 1J3
Telephone: (416) 966-6656
—S81-010

Applications and nominations
should be forwarded
immediately to:
Dr. R. A. Haliburton
Chairman,
Search Committee
HOTEL-DIEU HOSPITAL
1030 Ouellette Avenue
Windsor, Ontario
N9A 1E1
—S81-004

H EA D — DIVISION OF ORTHOPEDIC SURGERY

TORONTO GENERAL HOSPITAL
The Department of Surgery and the Board of Trustees
of Toronto General Hospital invite applications for the
position of Head, Division of Orthopedic Surgery. The
position calls for administrative and leadership capabil
ity to develop research and educational programs and
would require an individual with an established reputa
tion at the national and international level.
The initial appointment will be for a five-year term,
effective July 1, 1981.
Applications accompanied by a curriculum vitae must
be received by A pril 30th, 1981 and addressed to:
Dr. F. G. Pearson, Surgeon-in-Chief
Eaton Building 10-233
TORONTO GENERAL HOSPITAL
Toronto, Ontario M5G 1L7

Applications are invited from Ophthalmologists with
subspecialty training, for appointment to the Staff of
fi i ^ ° 'm s General Hospital, which shares the new
Health Sciences Centre with the Medical School of
Memorial University. The post would carry a joint
appointment with the Medical School. An Ophthalmol
ogist with training in the medical aspects of retinal
disease and an interest in diabetic retinopathy would
be particularly welcome. Canadian certification in
Ophthalmology is required.
A pp lica tion s w ith curriculum vitae, or requests for
fu rth e r details should be sent to:

— 1295
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OPHTHALMOLOGIST WANTED FOR
UNIVERSITY HOSPITAL

Dr. E. S. Wright, Chairman, Department of Surgery
HEALTH SCIENCES CENTRE
St. John’s, Nfld. A1B 3V6
—S81011
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Individually blister-packed. 6 sterile
instruments per box. Regular or wide
stainless steel staples. Preloaded with
35 staples. Staple extractors 12 to a box.
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Ti-cron, a braided polyester suture
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